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Summary	
Autophagy	 is	 a	 cellular	 recycling	 pathway	 that	 delivers	 material	 from	 the	 cytosol	 to	 the	lysosomal	lumen.	In	yeast,	this	process	is	initiated	by	the	fusion	of	small	vesicles	to	form	a	double-membrane	 sheet,	 the	phagophore.	 The	phagophore	 is	 continuously	 expanding	 and	thereby	engulfs	its	cytosolic	cargo.	Finally	the	membrane	is	sealed,	giving	rise	to	a	double-membrane	vesicle	called	autophagosome	which	fuses	with	the	lysosome	(or	vacuole	in	yeast)	to	 release	 its	 contents	 for	degradation.	Autophagy	was	 initially	 discovered	 as	 response	 to	starvation	 to	 ensure	 the	 cell’s	 survival	 by	 degradation	 of	 bulk	 cytosol.	 However,	 during	nutrient-rich	 conditions	 autophagy	 is	 selectively	 capturing	 cargo,	 such	 as	 damaged	 or	superfluous	organelles	or	large	protein	aggregates.	It	is	thus	vital	for	cellular	homeostasis	and	plays	a	role	in	the	protection	against	cancer	and	neurodegenerative	diseases.		Autophagy	 is	 driven	 by	 a	 set	 of	 autophagy-related	 (Atg)	 gene	 products.	 The	 initiation	 of	starvation-induced	autophagy	requires	the	transmembrane	protein	Atg9	and	the	Atg1	kinase	complex.	Atg9	is	sorted	from	the	Golgi	to	a	dedicated	set	of	small	vesicles	that	are	recruited	to	the	site	of	autophagosome	formation	by	the	Atg1	kinase	complex.	The	latter	is	activated	in	response	to	a	starvation	signal	which	induces	the	assembly	of	the	complex.	The	active	Atg1	kinase	 complex	 nucleates	 phagophore	membranes	 by	 tethering	 Atg9	 vesicles	 in	 order	 to	prepare	them	for	subsequent	fusion.	Atg17,	the	principle	tethering	subunit	of	the	Atg1	kinase	complex,	is	only	active	during	starvation.	How	selective	autophagy	is	initiated	remains	thus	an	open	question.		Several	in	vivo	studies	demonstrated	that	another	autophagy-specific	factor,	Atg11,	interacts	with	Atg9	and	subunits	of	the	Atg1	kinase	complex	during	selective	autophagy.	However,	the	molecular	function	of	this	protein	remained	unclear.	In	the	present	thesis	this	question	was	addressed	by	reconstituting	autophagy	initiation	from	purified	components	in	vitro.	It	could	be	 shown	 that	 Atg11	 binds	 to	 Atg9	 reconstituted	 in	 liposomes	 and	 is	 able	 to	 tether	 such	vesicles.	However,	 this	requires	dimerization	of	Atg11	which	 is	 inhibited	by	 its	C-terminal	domain.	The	activation	of	Atg11	occurs	through	binding	of	autophagic	cargo.	Moreover,	Atg11	and	 Atg17	 compete	 for	 binding	 of	 Atg9	 proteoliposomes,	 but	 Atg17	 is	 inactive	 under	physiological	 conditions.	 This	 allows	 Atg11	 to	 initiate	 selective	 autophagy.	 The	 cargo-dependent	activation	of	Atg11	ensures	that	selective	autophagy	only	occurs	if	cargo	is	present	and	spatiotemporally	links	the	nucleation	of	the	phagophore	to	such	cargo.	Starvation	induces	the	degradation	of	Atg11	and	activates	Atg17,	which	nucleates	phagophores	independently	of	cargo.			 	
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1 Introduction	
1.1 Vesicular	trafficking	
A	 hallmark	 of	 eukaryotic	 cells	 is	 their	 compartmentalization	with	membranes	 generating	confined	 spaces	 within	 the	 cytosol.	 However,	 it	 is	 vital	 for	 the	 cells	 that	 cargos	 can	 be	exchanged	 between	 the	 different	 organelles	 which	 happens	 through	 small	 vesicles	 in	 a	process	 called	 vesicular	 trafficking.	 This	 vesicular	 trafficking	 depends	 on	 a	wide	 range	 of	proteins	facilitating	sequestration	of	cargo	and	budding	of	transport	vesicles	(coat	proteins),	transport	to	their	cellular	destination	(cytoskeleton	and	motor	proteins)	as	well	as	tethering	to	 (tethering	 factors)	 and	 fusion	 with	 the	 target	 membrane	 (SNAREs).	 In	 addition,	 this	process	needs	to	be	tightly	regulated,	which	is	maintained	via	Rab	GTPases	and	their	effector	molecules.		
1.1.1 The	role	of	Rab	GTPases	
Rab	GTPases	are	a	group	of	small	GTPases	switching	between	an	active	GTP-bound	and	an	inactive	GDP-bound	state.	They	are	reversibly	 linked	to	membranes	via	a	 lipid	anchor	and	regulate	trafficking	processes	via	diverse	interactions.	The	exchange	of	GDP	by	GTP,	and	thus	activation,	 is	 facilitated	 by	 guanine	 nucleotide	 exchange	 factors	 (GEFs).	 Rab	 GTPases	 are	rendered	inactive	by	hydrolysis	of	GTP	to	GDP.	The	intrinsic	GTPase	activity	is	enhanced	by	GTPase	activating	proteins	or	GAPs	(Stenmark,	2009).	Sec4	was	the	first	Rab	GTPase	that	was	shown	to	be	required	for	fusion	of	exocytic	vesicles	with	the	plasma	membrane	(Salminen	and	Novick,	 1987).	 Sec4-GTP	 interacts	with	 a	 subunit	 of	 the	 exocyst	 complex	 that	 tethers	these	vesicles	to	the	plasma	membrane	(Guo	et	al.,	1999).	Ypt7	is	another	example	for	a	Rab	GTPase	 required	 for	 a	 fusion	 step,	 as	 it	 was	 reported	 to	 play	 a	 major	 role	 in	 tethering	preceding	 homotypic	 vacuole	 fusion	 by	 interaction	 with	 the	 tethering	 factor	 HOPS	(Ungermann	et	al.,	1998).	Another	Rab	GTPase,	Ypt1,	is	required	for	the	regulation	of	ER-Golgi	and	intra-Golgi	transport	via	its	interactions	with	the	TRAPP	tethering	factors	(Morsomme	and	Riezman,	2002).	Due	 to	 their	 defined	 cellular	 localization	 and	 their	 interaction	 with	 specific	 downstream	factors,	Rab	GTPases	can	confer	membrane	identity	during	vesicular	trafficking.	Another	way	to	specify	membrane	identity	is	via	the	different	phosphorylation	states	of	the	phospholipid	phosphatidylinositol	(PI).	Rab	GTPases	coordinate	the	recruitment	of	effectors	that	change	the	phosphorylation	of	the	inositol	ring.	This	allows	the	recruitment	of	downstream	factors	with	lipid	binding	domains	(Christoforidis	et	al.,	1999).		
Introduction	
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1.1.2 SNARE	proteins	
The	fusion	of	membranes	is	an	energetically	highly	unfavorable	event	and	requires	additional	force	to	overcome	the	energy	barrier.	This	step	 is	catalyzed	by	a	set	of	SNARE	(Soluble	N-ethylmaleimide-sensitive-factor	 attachment	 protein	 receptor)	 proteins.	 Most	 SNAREs	 are	permanently	anchored	in	membranes	via	a	C-terminal	transmembrane	domain,	while	some	are	recruited	for	the	fusion	event	using	lipid	binding	motifs	or	lipid	anchors.	Their	fusogenic	activity	derives	from	SNARE	motifs.	These	are	initially	unfolded	but	form	a	stable	four-helix	bundle	when	they	pair	with	three	compatible	partner	SNARE	motifs	(Sutton	et	al.,	1998).	The	interaction	 interface	between	 the	 four	helices	 is	 lined	with	unpolar	 amino	 acids.	Only	 the	center	of	 the	bundle	harbors	polar	headgroups:	 one	arginine	 (R)	 and	 three	glutamine	 (Q)	residues	 (Kloepper	 et	 al.,	 2007).	 Based	 on	 these	 residues,	 SNAREs	 are	 classified	 into	 R-SNAREs	 and	 Q-SNAREs.	 Depending	 on	 additional	 structural	 similarities,	 Q-SNAREs	 are	further	subcategorized	into	Qa-,	Qb-,	and	Qc-SNAREs.	One	SNARE	protein	of	each	of	the	four	groups	is	necessary	to	form	a	fusogenic	SNARE	complex,	the	so-called	trans-SNARE	complex	or	SNAREpin	(Südhof	and	Rothman,	2009).	Calculations	showed	that	the	formation	of	three	SNAREpins	releases	enough	energy	to	drive	membrane	fusion	(Li	et	al.,	2007).	After	fusion,	the	resulting	cis-SNARE	complex	needs	 to	be	disassembled	 in	order	 to	be	used	 in	another	round	of	fusion.	This	requires	the	ATPase	NSF	(Mayer	et	al.,	1996).	SNAREs	localize	to	distinct	organelles	and	membranes.	In	vitro	studies	showed	that	not	all	combinations	of	R-,	Qa-,	Qb-,	and	Qc-SNARE	drive	membrane	fusion.	Instead,	fusion	was	only	observed	with	specific	sets	of	SNAREs	that	were	found	to	act	 in	a	common	pathway.	Thus,	cellular	localization	of	SNAREs	provides,	in	addition	to	Rab-proteins	and	PIPs,	another	layer	of	 specificity	 to	 ensure	 that	 transport	 vesicles	 fuse	 with	 their	 correct	 target	 membranes	(McNew	et	al.,	2000;	Parlati	et	al.,	2000).		However,	 even	 though	 SNAREs	 alone	 can	 drive	 fusion	 in	 vitro,	 this	 requires	 an	unphysiologically	high	concentration	of	proteins.	In	vivo,	additional	factors	are	required.	The	SM	(Sec1/Munc18-like)	protein	 family	are	key	regulators	of	SNARE-mediated	 fusion.	They	bind	 to	 a	 common	 N-terminal	 Habc	 domain	 which	 can	 be	 found	 in	 all	 Qa-SNAREs.	 This	regulatory	 domain	 adopts	 a	 three-helical	 structure	 and	 forms	 a	 complex	with	 the	 SNARE	motif.	This	inhibits	SNAREpin	formation	until	the	Habc	domain	is	released	by	the	interaction	with	SM	proteins	(Demircioglu	et	al.,	2014).	Moreover,	SM	proteins	could	act	as	a	template	for	SNARE	complex	formation	as	it	was	reported	for	Vps33,	a	subunit	of	the	HOPS	tethering	complex	(Baker	et	al.,	2015).		For	 several	 SNARE	 proteins	 a	 role	 in	 autophagy	 was	 described.	 The	 exocytic	 Qa-SNARE	Sso1/2	and	Qbc-SNARE	Sso9	are	required	during	initial	steps	of	autophagosome	biogenesis.	
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While	exocytic	R-SNAREs	are	dispensable	for	autophagy	a	requirement	for	the	ER-Golgi	R-SNARE	Sec22	was	reported,	suggesting	the	existence	of	autophagy-specific	SNARE	complexes	(Nair	et	al.,	2011).	Furthermore,	autophagy	depends	on	the	other	ER-Golgi	SNAREs	Bet1,	Bos1	and	Sed5	(Tan	et	al.,	2013).	After	the	autophagosome	is	fully	formed	it	has	to	fuse	with	the	vacuolar	membrane	to	release	its	content	for	degradation.	Similar	to	other	vacuolar	fusion	events	 this	 specifically	 requires	 the	 Q-SNAREs	 Vam3,	 Vam7	 and	 Vti1	 on	 the	 vacuolar	membrane	and	the	R-SNARE	Ykt6	located	on	the	autophagosome	(Bas	et	al.,	2018).			
1.1.3 Tethering	factors	
Tethering	 factors	are	 responsible	 in	bringing	 two	membranes	 into	close	proximity,	before	SNARE	mediated	fusion	can	occur.	They	are	Rab	effectors,	their	specificity	is	thus	provided	by	the	localization	and	activation	of	Rab	GTPases.	Some	tethers	are	known	to	regulate	SNARE	complex	formation	and	hence	accelerate	the	fusion	between	the	tethered	membranes	(Yu	and	Hughson,	2010).	Generally,	tethering	factors	a	grouped	into	two	categories,	coiled-coil	tethers	and	 multi-subunit	 tethering	 complexes.	 A	 prominent	 example	 for	 coiled-coil	 tethers	 are	golgins.	They	form	long,	extended	structures	that	capture	vesicles	and	transport	them	to	the	site	 of	 fusion.	 Multi-subunit	 tethering	 complexes	 (MTCs)	 are	 composed	 of	 three	 to	 eight	subunits	 and	 span	 a	 rather	 short	 distance	 compared	 to	 coiled-coil	 tethers.	 Through	 their	different	subunits	they	regulate	membrane	recognition	and	SNARE-mediated	fusion	(Kuhlee	et	al.,	2015).	For	autophagy,	two	MTCs	play	a	major	role.	The	HOPS	complex	is	required	for	fusion	 events	 with	 the	 vacuole	 including	 autophagosome-vacuole	 fusion.	 The	 other	 MTC,	TRAPPIII,	 is	an	autophagy-specific	variant	of	 the	TRAPPI	complex	and	seems	to	direct	ER-derived	vesicles	to	the	PAS	(Tan	et	al.,	2013).		
1.1.3.1 The	HOPS	complex	
The	HOPS	(homotypic	fusion	and	vacuole	protein	sorting)	complex	is	a	well-studied	example	for	a	multi-subunit	tethering	complex.	It	is	an	effector	of	the	Rab	GTPase	Ypt7	which	is	located	at	the	vacuolar	membrane.	As	a	result	it	facilitates	the	homotypic	fusion	of	vacuoles	as	well	as	fusion	of	the	vacuole	with	late	endosomes	or	multivesicular	bodies,	autophagosomes	and	vesicles	of	 the	AP-3	pathway	(Kuhlee	et	al.,	2015).	The	complex	contains	 two	Rab-binding	sites,	one	each	in	the	Vps39	and	the	Vps41	subunit.	These	two	subunits	are	positioned	on	the	opposite	ends	of	the	complex,	enabling	HOPS	two	tether	two	different	membranes	(Bröcker	et	al.,	2012).	 In	addition	to	 its	tethering	ability,	HOPS	also	has	a	regulatory	role	 in	SNARE-mediated	 fusion	 of	 the	 tethered	membranes.	 Vacuolar	 fusion	 depends	 on	 a	 special	 set	 of	
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SNAREs:	the	Q-SNAREs	Vam3,	Vam7	and	Vti1	and	either	of	the	two	R-SNAREs	Nyv1	and	Ykt6.	It	 is	 possible	 to	 fuse	membranes	 in	 vitro	 only	 in	 presence	 of	 these	 four	 SNARE	 proteins.	However,	 this	 requires	 an	 unphysiologically	 high	 SNARE	 concentration.	 At	 low	concentrations,	 fusion	 only	 occurs	 when	 Ypt7-GTP	 and	 HOPS	 are	 present	 (Stroupe	 et	 al.,	2009).	This	is	due	to	the	HOPS	subunit	Vps33	that	functions	as	a	SM	protein	and	facilitates	SNAREpin	 formation	 (Baker	 et	 al.,	 2015).	 In	 contrast	 to	 the	 other	 SNAREs,	 Vam7	 is	 not	anchored	 in	 the	membrane	via	 a	 transmembrane	domain	but	by	binding	 to	PI3P	via	 a	PX	domain.	 The	 HOPS	 subunits	 Vps16	 and	 Vps18	 interact	 with	 Vam7	 and	 thus	 aid	 in	 its	recruitment	(Krämer	et	al.,	2011).				
1.1.3.2 The	TRAPP	complex	
TRAPP	(transport	protein	particle)	is	another	example	for	a	multisubunit	tethering	complex.	In	yeast	there	are	three	different	TRAPP	complexes	that	all	act	as	GEFs	for	the	Rab	GTPase	Ypt1.	 The	 seven-subunit	 complex	 TRAPPI	 is	 required	 for	 ER-to-Golgi	 transport	 and	 was	shown	 to	 specifically	 interact	 with	 the	 Sec23	 subunit	 of	 COPII-coated	 vesicles	 (Cai	 et	 al.,	2007).	TRAPPII	 contains	additional	 subunits	 that	were	 reported	 to	block	binding	of	COPII	vesicles	but	instead	allow	interaction	with	COPI	vesicles.	This	way,	TRAPPII	functions	in	the	intra-Golgi	and	endosome-to-Golgi	transport	(Cai	et	al.,	2005).	More	recently,	a	third	TRAPP	complex	was	described.	The	TRAPPIII	complex	shares	all	its	subunits	with	TRAPPI	but	has	one	 additional	 subunit,	 Trs85.	 This	 subunit	 has	 no	 impact	 on	 the	 interaction	 with	 COPII	coated	vesicles	but	 is	 required	 for	efficient	autophagy	 (Lynch-Day	et	al.,	2010).	Moreover,	COPII	 vesicles	 localized	 to	 the	 site	 of	 autophagosome	 biogenesis	 and	 accumulated	 when	autophagy	was	 blocked	 (Tan	 et	 al.,	 2013).	 This	 is	 in	 agreement	with	 the	 observation	 that	autophagosomes	are	formed	closely	to	ER	exit	sites	(ERES),	where	COPII	vesicles	pinch	off	the	ER	membrane	(Graef	et	al.,	2013).	Like	the	other	TRAPP	complexes	TRAPPIII	is	a	GEF	for	the	Rab	GTPase	Ypt1.	Ypt1	was	reported	to	be	required	for	autophagy,	possibly	through	the	recruitment	of	the	autophagy	protein	Atg1	(Lynch-Day	et	al.,	2010;	Wang	et	al.,	2013a).			
	
1.2 Autophagosome	biogenesis	
Macroautophagy,	in	the	following	called	autophagy,	is	characterized	by	the	de	novo	formation	of	a	double-membrane	vesicle.	In	contrast	to	other	vesicular	trafficking	pathways,	cargo	is	not	transported	from	one	organelle	to	another	inside	small	vesicles.	Instead,	small	vesicles	fuse	to	form	a	double-membrane	sheet,	the	phagophore,	that	encloses	cytoplasmic	material	and	
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delivers	it	to	the	vacuole/lysosome.	This	process	relies	on	a	special	set	of	autophagy-related	(Atg)	 	 proteins	 and	 can	 be	 divided	 into	 four	 major	 events:	 initiation,	 expansion	 of	 the	phagophore	 membrane	 and	 capturing	 of	 cargo,	 sealing	 of	 the	 membrane	 to	 form	 an	autophagosome	and	fusion	with	the	vacuole	to	release	 its	contents.	Cargo	can	be	captured	either	 non-selectively	 as	 a	 response	 to	 starvation	 or	 selectively	 through	 specific	 cargo	receptors	to	maintain	cellular	homeostasis	(see	Figure	1).				
1.2.1 Initiation	
Autophagy	captures	cargo	selectively	during	vegetative	conditions	or	non-selectively	upon	starvation.	In	the	latter	case,	the	lack	of	amino	acids	inactivates	the	Target	of	rapamycin	(TOR)	complex.	This	in	turn	activates	the	Atg1-kinase	complex,	a	pentameric	complex	and	key	factor	in	autophagy	initiation,	through	the	dephosphorylation	of	its	subunit	Atg13.	The	Atg1-kinase	complex	then	recruits	and	tethers	Atg9	vesicles,	a	special	set	of	small	vesicles	containing	the	transmembrane	protein	Atg9.						
	
Figure	1:	 Autophagosome	 biogenesis.	 During	 initiation	 small	 autophagy-specific	 vesicles	 (Atg9	vesicles)	fuse	at	the	site	of	autophagosome	biogenesis	to	form	a	phagophore.	This	phagophore	expands,	thereby	capturing	cargo	either	non-specifically	as	a	response	to	starvation	(upper	panel)	or	specifically	to	maintain	cellular	homeostasis	(lower	panel).	In	the	latter	case,	cargo-receptors	ensure	that	no	unwanted	material	 is	 engulfed	 by	 the	 phagophore.	 Finally,	 the	membrane	 is	 sealed	 to	 form	 a	 double-membrane	vesicle,	the	autophagosome,	that	fuses	with	the	lysosome	or	vacuole	for	cargo	degradation.		
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1.2.1.1 Atg1-kinase	complex	
The	Atg1-kinase	complex	consists	of	five	different	subunits:	Atg1,	Atg13,	Atg17,	Atg29,	and	Atg31.	Atg1	is	a	kinase	that	phosphorylates	several	Atg	proteins	and	itself.	However,	its	kinase	activity	 is	 not	 required	 for	 initiation	 of	 autophagy	 (Matsuura	 et	 al.,	 1997).	 Atg1	 forms	 a	constitutive	 complex	with	Atg13	 independently	 of	 nutrient	 conditions	 (Kraft	 et	 al.,	 2012).	However,	Atg13	is	hyperphosphorylated	during	nutrient-rich	conditions	by	the	TOR	kinase,	whereas	 TOR	 is	 deactivated	 upon	 starvation	 and	 Atg13	 is	 partially	 dephosphorylated	(Kamada	et	al.,	2000).	The	other	three	subunits	of	the	Atg1-kinase	complex,	Atg17,	Atg29	and	Atg31,	form	a	stable	complex	in	the	cytosol	with	Atg31	linking	the	other	two	proteins.	The	formation	of	this	complex	is	as	well	independent	of	the	nutrient	status	of	the	cell	(Kabeya	et	al.,	2009).	However,	only	upon	starvation-induced	dephosphorylation	of	Atg13	the	trimeric	Atg17-Atg31-Atg29	complex	and	Atg1-Atg13	will	form	the	fully	active	Atg1	kinase	complex	(Kawamata	et	al.,	2008).		Structural	analysis	of	 the	Atg17-Atg31-Atg29	subcomplex	revealed	that	Atg17	has	a	three-helical,	 crescent-shaped	 structure	 leading	 to	 the	 hypothesis	 that	 it	 could	 bind	 curved	membranes.	 Additionally,	 Atg17	 dimerizes	 via	 its	 C-terminal	 domain	 and	 the	 resulting	 S-shaped	structure	was	suggested	 to	allow	vesicle	 tethering.	Atg31	binds	 to	Atg17	via	 its	C-terminal	helix,	thereby	forming	a	four-helix	bundle.	Atg29	only	interacts	with	Atg31	but	not	with	Atg17.	Atg31-Atg29	is	positioned	within	the	Atg17	crescent	which	suggests	a	regulatory	function	on	Atg17	membrane	binding	efficiency	(Ragusa	et	al.,	2012).		Previous	work	in	the	group	was	able	to	decipher	the	molecular	function	of	the	Atg1-kinase	complex	and	its	role	in	vesicle	tethering	(Rao	et	al.,	2016).	Atg17	specifically	binds	to	Atg9	that	 was	 reconstituted	 into	 liposomes.	 Furthermore,	 Atg17	 is	 sufficient	 to	 tether	 these	proteoliposomes	as	shown	by	dynamic	light	scattering	and	cryo-EM	experiments.	However,	Atg17	always	forms	a	stable	complex	with	Atg29	and	Atg31	in	the	cytosol.	Interaction	with	the	Atg31-Atg29	subcomplex	reduces	the	binding	of	Atg17	to	Atg9	and	inhibits	its	tethering	function.	This	inhibition	is	released	by	the	binding	of	Atg1-Atg13	to	form	the	fully	assembled	Atg1	 kinase	 complex	 (see	 Figure	 2).	 Thus,	 tethering	 of	 Atg9	 vesicles	 is	 prevented	 during	nutrient-rich	conditions	and	specifically	induced	upon	starvation.			
1.2.1.2 Atg9	
Atg9	is	the	only	autophagy-specific	transmembrane	protein	essential	for	selective	and	non-selective	 autophagy	 (Noda	 et	 al.,	 2000).	 Atg9	 consists	 of	 a	 highly	 conserved	 core	 domain		
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Figure	2:	 Activation	of	the	Atg1	kinase	complex.	During	nutrient-rich	conditions	(left	panel)	Atg13	is	phosphorylated	 by	 the	 Tor	 kinase	 which	 prevents	 interaction	 with	 Atg17.	 Atg29-Atg31	 binds	 to	 the	crescent	 of	 Atg17	 thereby	 inhibiting	 interaction	 with	 Atg9.	 During	 starvation	 (right	 panel)	 Atg13	 is	dephosphorylated	and	the	full	pentameric	complex	can	assemble.	This	releases	the	inhibition	by	Atg29-Atg31	and	Atg17	can	bind	Atg9	vesicles.	Due	to	the	homo-dimerization	of	Atg17	through	its	C-terminal	domain	the	Atg1	kinase	complex	can	tether	two	vesicles.			comprising	six	transmembrane	helices	and	a	cytoplasmic	domain	between	helices	two	and	three.	 Additionally,	 Atg9	 contains	 largely	 disordered	 N-	 and	 C-terminal	 domains.	 These	regions	 have	 been	 suggested	 to	 be	 required	 for	 trafficking	 of	 Atg9	 ensuring	 its	 correct	intracellular	localization.	However,	the	core	domain	(residues	281	to	779)	is	sufficient	for	the	interaction	 of	 Atg9	 with	 the	 Atg1	 kinase	 complex	 in	 vitro	 (Rao	 et	 al.,	 2016).	 Atg9	 is	 co-translationally	inserted	into	the	ER	membrane	and	transported	to	the	Golgi.	Atg9	traffics	from	the	 Golgi	 to	 a	 specialized	 peripheral	 compartment	 that	 consists	 of	 small	 vesicles	independently	 from	 the	 secretory	 and	 endocytic	 pathways	 (Mari	 et	 al.,	 2010).	 Upon	starvation,	 the	 number	 of	 Atg9	 vesicles	 increases,	 suggesting	 that	 starvation	 stimulates	trafficking	of	Atg9	from	the	Golgi	to	its	peripheral	compartment	(Yamamoto	et	al.,	2012).	Yamamoto	et	al.	reported	that	the	diameter	of	these	Atg9	vesicles	is	in	the	range	of	30	–	60	nm	with	24	–	32	Atg9	molecules	per	vesicle.	It	was	suggested	that	three	Atg9	vesicles	coalesce	at	 the	 PAS	 in	 order	 to	 nucleate	 the	 phagophore	 but	 that	 no	 additional	 Atg9	 vesicles	 are	recruited	during	 later	 steps	 of	 autophagosome	biogenesis.	 Furthermore,	Atg9	 is	 primarily	located	at	the	outer	membrane	of	autophagosomes	but	is	not	accumulating	in	the	vacuolar	membrane.	Thus,	 a	mechanism	might	exist	 that	 recycles	Atg9	before	or	 immediately	after	fusion	of	autophagosomes	with	the	vacuole	(Yamamoto	et	al.,	2012).		
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1.2.2 Expansion	
After	 initiation	 of	 autophagosome	 biogenesis	 the	 phagophore	 expands	 to	 engulf	 its	cytoplasmic	 cargo.	 However,	 the	membrane	 sources	 for	 this	 process	 are	 still	 a	 matter	 of	debate.	While	Atg9	vesicles	 are	 suggested	 to	be	 required	only	 for	 initiation,	 an	 increasing	number	 of	 studies	 report	 evidence	 for	 a	 direct	 role	 of	 ER-derived	 COPII	 vesicles	 in	autophagosome	 biogenesis.	 Phagophore	 expansion	 also	 depends	 on	 a	 set	 of	 essential	 Atg	proteins,	 including	 an	 autophagy-specific	 PI3-kinase	 that	 generates	 binding	 sites	 for	downstream	factors.	Furthermore,	expansion	requires	two	ubiquitin-like	systems	that	lead	to	the	conjugation	of	the	small	protein	Atg8	to	the	phagophore	membrane.			
1.2.2.1 PI3-kinase	
There	 are	 two	 PI3-kinase	 complexes	 in	 yeast	 known	 so	 far	 that	 phosphorylate	phosphatidylinositol	 at	 the	D-3	position	of	 the	 inositol	 ring.	 They	 consist	 of	 four	 subunits	each,	three	of	which	are	shared	by	both	complexes.	Vps15	is	a	serine/threonine	kinase	that	is	linked	 to	 the	 membrane	 via	 a	 myristoyl-anchor.	 It	 phosphorylates	 and	 thereby	 activates	Vps34	that	bears	the	PI3-kinase	activity.	The	third	common	subunit,	Vps30,	is	linked	to	Vps34	by	the	specific	subunits	Atg14	or	Vps38	in	complex	I	or	II,	respectively.	These	subunits	define,	whether	the	PI3-kinase	complex	functions	in	autophagy	(complex	I)	or	in	the	CPY	pathway	that	transports	carboxypeptidase	Y	from	the	Golgi	to	the	vacuole	(complex	II)	(Kihara	et	al.,	2001).	 The	 interaction	 between	Atg14	 and	 the	N-terminal	 domain	 of	Atg13	 results	 in	 the	recruitment	of	the	PI3-kinase	I	to	the	PAS	(Jao	et	al.,	2013).	Atg14	was	also	implicated	in	the	regulation	of	the	size	of	autophagosomes	(Obara	et	al.,	2006).	The	 generation	 of	 PI3P	 allows	 the	 recruitment	 of	 a	 range	 of	 downstream	 factors	 to	 the	phagophore	membrane,	most	 importantly	Atg18	and	Atg21.	They	both	are	homologous	 to	each	other,	yet	Atg21	but	not	Atg18	was	reported	to	be	dispensable	for	starvation-induced	autophagy	(Krick	et	al.,	2006).	Both	proteins	contain	WD-40	repeats	which	are	predicted	to	fold	 into	a	β-propeller	structure.	This	domain	 facilitates	 the	specific	binding	of	proteins	 to	PI3P	as	well	as	to	PI(3,5)P2.	Atg18	and	Atg21	then	further	recruit	downstream	factors	to	the	growing	phagophore.	Both	proteins	were	reported	to	facilitate	the	recruitment	of	Atg16	and	Atg8	to	the	phagophore	membrane	(Nair	et	al.,	2010).			
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1.2.2.2 Ubiquitin-like	conjugation	systems	
During	 phagophore	 expansion,	 two	 different	 ubiquitin-like	 conjugation	 systems	 create	 a	covalent	 bond	 between	 Atg12	 and	 Atg5	 as	 well	 as	 the	 linkage	 of	 Atg8	 to	 phosphatidyl-ethanolamine	(PE)	on	the	phagophore	membrane.	The	canonical	ubiquitin	system	involves	the	processing	of	the	ubiquitin	precursor,	activation	by	conjugation	to	a	cysteine	in	the	active	center	of	an	E1	enzyme,	transfer	to	an	E2	enzyme,	and	finally	transfer	to	the	target	protein	with	the	help	of	an	E3	enzyme	(Hershko	and	Ciechanover,	1998).	Similarly,	Atg12	is	activated	by	a	 thioester	 linkage	 to	Atg7	 (E1-like)	and	 is	 then	 transferred	 to	Atg10	(E2-like).	Finally,	Atg12	 forms	 a	 covalent	 bond	 with	 Atg5	 without	 the	 requirement	 for	 an	 E3	 enzyme	(Mizushima	et	al.,	1998).	Atg5	binds	non-covalently	to	the	coiled-coil	protein	Atg16	forming	a	constitutive	Atg12-Atg5-Atg16	complex	(Mizushima	et	al.,	1998).	 It	was	further	reported	that	 Atg16	 is	 capable	 of	 oligomerization	 and	 drives	 the	 formation	 of	 a	 large	 complex	suggested	to	consist	of	a	tetramer	of	Atg12-Atg5-Atg16	(Kuma	et	al.,	2002).		Another	ubiquitin-like	conjugation	system	results	in	the	conjugation	of	Atg8	to	phosphatidyl-ethanolamine	 (PE)	 present	 in	 the	 phagophore	membrane.	 First,	 Atg8	 is	 processed	 by	 the	protease	Atg4	to	expose	a	C-terminal	glycine	residue	(Kirisako	et	al.,	2000).	Afterwards	it	is	conjugated	to	the	active	site	of	Atg7	and	transferred	to	Atg3	(E2-like).	Atg12-Atg5	functions	as	an	E3-like	ligase	that	facilitates	the	transfer	of	Atg8	from	Atg3	to	PE	(Hanada	et	al.,	2007).	In	contrast	to	Atg12-Atg5	conjugation	this	process	is	reversible	and	Atg8	can	be	cleaved	from	the	membrane	by	Atg4	(Kirisako	et	al.,	2000).	Another	difference	to	Atg12-Atg5	is	that	the	majority	 of	 Atg8	 molecules	 is	 not	 conjugated	 during	 vegetative	 conditions	 but	 Atg8-PE	strongly	increases	upon	starvation	(Huang	et	al.,	2000).	Interestingly,	although	all	Atg12-Atg5	is	bound	to	Atg16	in	vivo,	its	enzymatic	function	is	independent	of	Atg16	in	vitro	(Kaufmann	et	al.,	2014).		Further	 investigations	 using	 purified	 Atg12-Atg5-Atg16	 on	 model	 membranes	 with	conjugated	 Atg8	 revealed	 the	 formation	 of	 a	 meshwork-like	 protein	 coat.	 This	 scaffold	formation	is	dependent	on	the	oligomerization	of	Atg16	into	tetramers	with	an	anti-parallel	arrangement	 of	 dimers.	 The	 interaction	 between	 two	 Atg16	 dimers	 is	 also	 required	 for	normal	 levels	 of	 autophagy	 in	 vivo	 suggesting	 an	 essential	 role	 of	 the	 Atg12-Atg5-Atg16	scaffold	in	autophagosome	biogenesis	(Kaufmann	et	al.,	2014).		Atg8	 also	 plays	 an	 essential	 role	 in	 selective	 autophagy.	 If	 specific	 cargo	 is	 destined	 for	degradation	by	autophagy	it	is	marked	with	a	specific	cargo	receptor	protein.	These	receptors	harbor	 a	 conserved	 Atg8	 interacting	 motif	 (AIM)	 that	 links	 the	 cargo	 to	 the	 phagophore	membrane	(Noda	et	al.,	2008;	Kondo-Okamoto	et	al.,	2012).			
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1.2.3 Completion	of	autophagy	
After	the	phagophore	has	captured	its	cargo,	the	growing	edges	will	seal	to	form	the	complete	double-membrane	 autophagosome.	 Only	 then	 the	 autophagsome	 is	 able	 to	 release	 its	contents	 into	 the	 vacuolar	 lumen	 by	 fusion	 of	 its	 outer	 membrane	 with	 the	 vacuole	membrane.	However,	the	mechanism	behind	the	sealing	event	and	the	responsible	factors	are	still	unclear.		Prior	to	the	fusion	with	the	vacuole	the	PI3Ps	in	the	outer	membrane	of	the	autophagosome	are	dephosphorylated	by	the	phosphatase	Ymr1	in	order	to	release	the	autophagic	proteins	that	were	 recruited	via	 their	 lipid	binding	domains	 (Gebollero,	2012).	A	 recent	 study	also	reported	a	decrease	in	autophagic	flux	when	the	cleavage	of	Atg8	from	the	autophagosomal	membrane	 was	 blocked,	 indicating	 a	 possible	 requirement	 for	 Atg8	 deconjugation	 for	autophagosome-vacuole	fusion	(Nair	et	al.,	2012).		The	 fusion	 of	 the	 autophagosome	with	 the	 vacuole	 depends	 on	 factors	 involved	 in	 other	vacuolar	fusion	events.	One	of	those	is	the	Rab	GTPase	Ypt7.	It	is	activated	by	the	Mon1-Ccz1	complex	which	is	specifically	recruited	to	autophagosomes	via	its	Atg8	interacting	motif	(Gao	et	 al.,	 2018).	 Active	 Ypt7	 recruits	 the	 HOPS	 complex	 that	 tethers	 autophagosomes	 to	 the	vacuolar	membrane	and	facilitates	SNARE-mediated	fusion.	Two	vacuolar	SNAREs,	Vam7	and	Ykt6,	 contain	 lipid	 anchors	 instead	 of	 transmembrane	 domains	 and	 thus	 cycle	 between	 a	cytosolic	 and	 membrane-bound	 state.	 Recently,	 it	 was	 reported	 that	 both	 SNAREs	 are	specifically	recruited	to	autophagosomes	(Bas	et	al.,	2018;	Liu	et	al.,	2016).		In	contrast	to	other	autophagy	proteins	on	the	autophagosome	membrane,	Atg9	cannot	be	simply	released	from	the	autophagosome.	Atg9	is	not	degraded	in	the	vacuole,	indicating	that	it	is	preferentially	located	in	the	outer	membrane	of	completed	autophagosomes.	However,	the	absence	of	accumulated	Atg9	 in	the	vacuolar	membrane	suggests	that	Atg9	 is	recycled	(Yamamoto	et	al.,	2012).	Still,	it	remains	unclear	when	Atg9	is	retrieved	from	the	membrane	and	the	molecular	mechanism	of	this	process.				
1.3 Selective	autophagy	
During	nutrient-rich	conditions	cargo	is	selectively	degraded	by	autophagy.	This	process	is	essential	for	cellular	homeostasis	as	it	removes	damaged	organelles	and	protein	aggregates.	In	 yeast,	 selective	 autophagy	 has	 also	 a	 biosynthetic	 function:	 The	 cytoplasm-to-vacuole	targeting	(Cvt)	pathway	delivers	precursors	of	vacuolar	proteases	to	the	vacuolar	lumen.	In	contrast	 to	 starvation-induced	 autophagy	 Atg17	 is	 dispensable	 for	 selective	 autophagy.	
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Instead,	another	protein,	Atg11,	is	essential	for	the	initiation	of	selective	autophagy.	However,	its	exact	molecular	function	was	unclear.	The	different	cargoes	that	are	targeted	by	selective	autophagy	are	recognized	via	specific	cargo	receptors	through	their	interactions	with	Atg11	and	Atg8.			
1.3.1 The	Cvt	pathway	
The	Cvt	pathway	is	the	best-characterized	selective	autophagy	pathway	in	yeast.	It	delivers	precursors	of	vacuolar	proteases,	mainly	aminopeptidase1	(Ape1),	to	the	vacuole	where	they	are	activated.	The	premature	form	of	Ape1,	prApe1,	interacts	with	other	prApe1	molecules	to	form	a	homo-dodecamer	(Su	et	al.,	2015).	The	propetide	can	form	a	trimeric	coiled-coil	with	two	other	propeptides	which	 allows	 the	 interaction	of	 different	 dodecamers	 and	 thus	 the	formation	of	a	 large	aggregate,	called	the	Ape1	complex	(Yamasaki	et	al.,	2016).	The	Ape1	complex	is	then	targeted	by	the	Cvt	pathway	and	delivered	to	the	vacuole.	The	Ape1	complex	is	specifically	recognized	by	the	cargo	receptor	Atg19.	Atg19	binding	was	also	reported	to	limit	the	size	of	the	Ape1	complex	for	efficient	clearance	by	the	Cvt	pathway	(Yamasaki	et	al.,	2016).	There	are	also	other	cargo	molecules	targeted	by	the	Cvt	pathway,	for	example	Ams1	and	Ty1.	However,	 these	proteins	are	 incapable	of	 forming	 large	aggregates.	 Instead,	 they	bind	 to	 the	 Ape1	 complex	 and	 thus	 depend	 on	 Ape1	 for	 their	 transport	 to	 the	 vacuole	(Yamasaki	and	Noda,	2017).	At	 its	C-terminus,	Atg19	contains	an	AIM	for	 interaction	with	Atg8.	The	specific	binding	to	Atg8	is	essential	for	the	Cvt	pathway,	but	not	for	clearance	by	starvation-induced	autophagy,	as	it	might	favor	the	expansion	of	the	phagophore	membrane	around	the	Ape1	complex	while	excluding	other	cytosolic	material	(Noda	et	al.,	2008b).	Atg19	contains	also	a	C-terminal	Atg11	binding	site.	However,	binding	of	Atg11	to	Atg19	depends	on	the	phosphorylation	of	several	serine	residues	in	the	Atg11	binding	region	of	Atg19	by	the	Hrr25	kinase	(Pfaffenwimmer	et	al.,	2014).		
1.3.2 Mitophagy	
Being	 the	 energy-producing	 organelles	 of	 the	 cell,	 mitochondria	 can	 accumulate	 reactive	oxygen	species	(ROS).	An	excess	of	ROS	can	lead	to	DNA	damages	and	ageing	and	leakage	of	proteins	from	damaged	mitochondria	induce	cell	death	(Yen	and	Klionsky,	2008).	To	prevent	adverse	 effects	 on	 the	 cell,	 these	 organelles	 are	 removed	 by	 selective	 autophagy,	 termed	mitophagy.	Mitochondria	are	specifically	targeted	via	the	autophagy	receptor	Atg32	that	is	anchored	 in	 the	 outer	 mitochondrial	 membrane	 via	 a	 transmembrane	 domain.	 The	importance	of	Atg32	for	mitophagy	is	further	demonstrated	by	the	observation	that	Atg32	
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levels	increase	under	mitophagy-inducing	conditions,	for	example	increased	oxidative	stress	(Okamoto	et	al.,	2009).		Little	is	known	about	the	intra-mitochondrial	C-terminal	domain,	although	it	reportedly	plays	a	 role	 in	 the	 regulation	 of	 Atg32	 (Wang	 et	 al.,	 2013b).	 However,	 the	 cytosolic	 N-terminal	domain	plays	a	major	role	in	autophagy	as	it	contains	binding	sites	for	Atg8	and	Atg11.	Thus,	Atg32	provides	a	link	between	mitochondria	and	the	autophagic	machinery.	Upon	induction	of	mitophagy,	 residues	 Ser-114	 and	 Ser-119	 are	 phosphorylated	 and	 recruit	 Atg11	 to	 the	mitochondrial	 membrane.	 However,	 interaction	 with	 Atg8	 is	 independent	 of	 the	phosphorylation	state	(Aoki	et	al.,	2011).			
1.3.3 Pexophagy	
Superfluous	 peroxisomes	 are	 quickly	 degraded	 by	 autophagy,	 termed	 pexophagy.	 This	 is	initiated	by	the	binding	of	Atg36	to	the	peroxisomal	membrane	protein	Pex3.	Like	the	cargo	receptors	discussed	above,	Atg36	 is	 interacting	with	Atg8	and	Atg11	(Motley	et	al.,	2012).	Similar	 to	 Atg19	 in	 the	 Cvt	 pathway,	 phosphorylation	 of	 Atg36	 by	 the	 Hrr25	 kinase	 is	necessary	for	pexophagy	(Tanaka	et	al.,	2014).		
1.3.4 Aggrephagy	
Aggrephagy	 is	 the	 specific	 degradation	 of	 aggregates	 of	 misfolded	 proteins.	 In	 humans,	autophagy	 plays	 a	 major	 protective	 role	 in	 neurodegenerative	 diseases,	 e.g.	 Alzheimer’s,	Parkinson’s	and	Huntington’s	disease.	The	misfolded	proteins	are	ubiquitinated	but	cannot	be	cleared	by	the	proteasomal	pathway	due	to	their	aggregated	state.	These	aggregates	are	then	 captured	 by	 autophagosomes	 for	 lysosomal	 degradation	 (Hyttinen	 et	 al.,	 2014).	 In	humans,	the	poly-ubiquitin	binding	protein	p62	was	shown	to	enable	autophagic	degradation	of	ubiquitinylated	protein	aggregates	(Pankiv	et	al.,	2007).	However,	the	existence	of	a	similar	pathway	in	yeast	was	unknown.	Only	recently	a	study	identified	CUET	proteins,	a	new	class	of	ubiquitin	receptors	conserved	from	yeast	to	human.	Cue5	and	its	human	homologue	Tollip	facilitate	the	autophagy-dependent	degradation	of	polyQ	protein	aggregates,	which	are	linked	to	Huntington’s	disease	in	humans	(Lu	et	al.,	2014).		
1.3.5 Atg11	
Atg11	is	a	large	protein	of	1178	amino	acid	residues	and	a	molecular	weight	of	135	kDa.	Until	now	 its	 structure	 has	 not	 been	 solved	 but	 the	 presence	 of	 four	 coiled-coil	 domains	 was	
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predicted	 (Yorimitsu	 and	 Klionsky,	 2005).	 Several	 interaction	 partners	 are	 identified	 and	their	binding	regions	were	mapped	to	the	different	coiled-coil	domains	(CCs,	see	Figure	3).	The	C-terminal	domain	containing	CC4	is	indispensable	for	interaction	with	the	Cvt	pathway	cargo	receptor	Atg19	(Yorimitsu	and	Klionsky,	2005).	Likewise,	this	domain	is	also	required	for	interaction	with	the	mitophagy-specific	cargo	receptor	Atg32	(Aoki	et	al.,	2011).	The	C-terminal	 region	 is	 thus	 the	key	player	 in	 linking	specific	cargo	 to	 the	autophagic	pathway.	Coiled-coil	 domains	 CC2	 and	 CC3	 were	 reported	 to	 have	 several	 interaction	 partners,	including	core	components	of	the	autophagic	machinery	like	Atg17	and	Atg20	(binding	region	mapped	to	CC2)	as	well	as	Atg1	which	required	both,	CC2	and	CC3	(Yorimitsu	and	Klionsky,	2005).	 Furthermore,	 Atg11	 self-interaction	was	 reported	 via	 CC2	 and	 CC3.	 Another	 study	found	that	Atg11	is	interacting	with	Atg9	via	CC1	and	CC2	(Chang	et	al.,	2006).	More	recently,	interaction	between	Atg11	and	Atg29	was	reported,	which	requires	the	starvation-induced	phosphorylation	of	Atg29.	Binding	between	Atg11	and	phosphorylated	Atg29	or	Atg1	was	crucial	for	efficient	autophagy.	Thus,	Atg11	might	aid	in	non-selective	autophagy	as	well	by	recruiting	the	active	Atg1	kinase	complex	to	the	PAS	(Mao	et	al.,	2013).	These	data	suggest	a	fundamental	 role	 of	 Atg11	 in	 autophagy	 initiation	 and	 in	 linking	 selective	 cargoes	 to	 the	autophagic	 machinery.	 However,	 the	 molecular	 function	 of	 this	 protein	 remained	 poorly	understood.						
	
Figure	3:	 Interactions	with	Atg11.	Atg11	has	four	predicted	coiled-coil	domains	(CC1	to	CC4).	Several	interaction	 partners	 had	 been	 discovered	 by	 yeast	 two-hybrid	 and	 immunoprecipitation	 assays	 and	binding	regions	were	mapped	to	the	different	coiled-coil	domains.	Atg11	shows	self-interaction	via	CC2	and	CC3	and	interacts	with	Atg9	via	CC1	and	CC2	and	cargo	receptors	via	CC4.			
Introduction	
24	
1.4 Human	homologues	of	the	yeast	system	
Many	insights	that	were	obtained	from	studying	yeast	could	contribute	to	the	understanding	of	autophagy	in	human	cells.	Autophagy	is	a	highly	conserved	pathway	and	many	proteins	of	the	 core	 machinery	 in	 yeast	 have	 known	 human	 homologues	 (see	 Table	 1).	 Initiation	 in	human	cells	requires	the	Ulk1/2	complex	as	compared	to	the	Atg1-kinase	complex	in	yeast.	Ulk1/2	 and	 Atg13	 are	 homologous	 to	 yeast	 Atg1	 and	 Atg13,	 respectively,	 and	 FIP200	 is	considered	to	be	a	potential	homologue	of	Atg17	(Noda	and	Fujioka,	2015).	Because	of	 its	large	 size	 compared	 to	Atg17,	 FIP200	might	 comprise	 additional	 functions.	Thus,	 it	might	combine	the	function	of	Atg17	and	Atg31-Atg29,	as	for	the	latter	no	homologous	proteins	are	known	so	 far.	However,	 the	exact	role	of	FIP200	remains	unclear.	Also,	 it	 is	still	uncertain	whether	 there	 is	 a	 human	 homologue	 of	 Atg11.	 However,	 it	 was	 suggested	 recently	 that	Huntingtin	is	a	scaffolding	protein	comprising	a	similar	function	as	Atg11.	While	aggregates	of	mutant	Huntingtin	 cause	Huntington’s	 Disease,	 its	 normal	 function	was	 reported	 to	 be	required	 for	 selective	 autophagy.	 Moreover,	 its	 C-terminal	 domain	 shares	 structural	similarities	with	 Atg11	 and	 interacts	with	 the	 Ulk1/2	 complex,	 cargo	 receptors	 and	 Atg8	family	proteins	(Ochaba	et	al.,	2014).				
Table	1:	Human	orthologues	of	yeast	ATGs.	The	following	table	lists	several	autophagy-related	proteins	in	S.	cerevisiae	and	their	known	or	proposed	orthologues	in	humans.		
	 Yeast	 Human	
Autophagy	initiation	
Atg1	 Ulk1,	Ulk2	Atg13	 Atg13	Atg17	 FIP200?	Atg29/31	 Part	of	FIP200?	Atg11	 Huntingtin?	Atg9	 Atg9A	PI3-kinase	 Atg14	 Atg14/Bakor	PI3P	interactors	 Atg18	 WIPI2	
Conjugation	machinery	
Atg4	 Atg4A,	-B,	-C,	-D	Atg7	 Atg7	Atg10	 Atg10	Atg12	 Atg12	Atg5	 Atg5	Atg16	 Atg16-L1	Atg8	 LC3A,	 LC3B,	 LC3C,	 GABARAP,	GABARAPL1,	GATE-16		
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Human	homologues	have	also	been	identified	for	the	transmembrane	protein	Atg9,	for	the	PI3-kinase	subunit	Atg14	and	the	PI3P-binding	protein	Atg18	(Imai	et	al.,	2016;	Itakura	et	al.,	2008;	 Wilson	 et	 al.,	 2014).	 Furthermore,	 the	 proteins	 of	 the	 ubiquitin-like	 conjugation	machinery	are	highly	conserved	as	well	(Wilson	et	al.,	2014).	However,	while	most	of	them	have	only	one	orthologue,	several	homologues	have	been	identified	for	yeast	Atg8.	They	can	be	 divided	 into	 two	 subgroups,	 the	 LC3	 subfamily	 (LC3A,	 LC3B	 and	 LC3C)	 and	 the	GABARAP/GATE-16	 subfamily	 (GABARAP,	 GABARAPL1	 and	 GATE-16)	 which	 are	 both	required	 for	 autophagy	 but	 may	 act	 at	 different	 steps	 of	 autophagosome	 biogenesis	(Weidberg	et	al.,	2010).				
1.5 Aim	of	the	thesis	
The	 selective	 removal	 of	 cytoplasmic	 cargo	 by	 autophagy	 is	 a	 crucial	 process	 to	maintain	cellular	 homeostasis	 and	 plays	 an	 important	 role	 in	 the	 protection	 against	 cancer,	neurodegenerative	diseases	and	ageing.	In	contrast	to	non-selective	autophagy,	which	leads	to	the	degradation	of	bulk	cytoplasm,	selective	autophagy	exclusively	degrades	distinct	cargo.	Consequently,	differences	in	the	morphology	of	autophagosomes	and	the	composition	of	the	protein-machinery	exist	between	both	pathways.	It	is	therefore	of	high	interest	to	decipher	how	the	cell	switches	between	these	two	pathways	and	how	this	process	is	regulated.			One	 key	 player	 in	 selective	 autophagy	 is	 Atg11.	 Several	 interaction	 partners	 had	 been	identified	in	vivo	including	cargo	receptors,	the	transmembrane	protein	Atg9	and	subunits	of	the	Atg1	kinase	complex.	However,	 it	 is	not	essential	 for	starvation-induced	autophagy.	 In	contrast,	Atg17	is	required	for	non-selective	but	not	for	selective	autophagy.	It	functions	as	a	tether	for	Atg9	vesicles	during	autophagy	initiation	upon	starvation	but	tethering	is	impaired	during	nutrient-rich	conditions.	The	structure	of	Atg11	is	unknown	but	its	N-terminal	domain	shares	 some	 sequence	 homology	with	 Atg17.	 This	 gave	 rise	 to	 the	 hypothesis	 that	 Atg11	might	tether	Atg9	vesicles	during	selective	conditions	when	Atg17	is	inactive.		The	aim	of	this	thesis	was	to	decipher	the	molecular	function	of	Atg11	and	its	regulation.	This	required	 the	 reconstitution	 of	 autophagy	 initiation	 in	 vitro	 utilizing	 purified	 proteins	 and	artificial	Atg9	vesicles	as	it	was	previously	developed	to	investigate	the	function	of	Atg17.	One	goal	 was	 to	 examine	 physical	 protein-protein	 interactions	 in	 the	 defined	 in	 vitro	 system.	Furthermore,	 it	was	aimed	to	identify	a	possible	tethering	function	of	Atg11	its	regulation,	especially	in	respect	to	the	mitochondrial	cargo	receptor	Atg32.	Moreover,	it	was	investigated	whether	Atg11	and	Atg17	facilitate	the	recruitment	of	each	other	or	whether	their	binding	to	
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Atg9	vesicles	 is	 competitive.	Additionally,	 in	 vivo	experiments	 should	 support	 the	 in	vitro	observations.	The	findings	acquired	for	this	thesis	could	finally	contribute	to	a	new	model	of	autophagy	initiation	during	selective	conditions.		
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2 Materials	and	methods	
2.1 Materials	
If	not	mentioned	otherwise,	chemicals	were	purchased	from	Fisher	Scientific,	Roth,	Sigma-Aldrich,	 or	 Thermo	 Scientific.	 Enzymes	 for	 cloning	 were	 purchased	 from	 New	 England	Biolabs,	 lipids	 from	Avanti	Polar	 lipids.	Enzymes	used	 for	protein	purification	 (Sm	DNase,	PreScission,	TEV	protease)	were	produced	 in-house	by	the	MPIB	core	 facility.	DNA	primer	synthesis	and	sequencing	were	carried	out	by	Eurofins	Genomics.	More	details	on	E.	coli	and	S.	cerevisiae	strains,	plasmids	and	antibodies	are	summarized	in	Table	2	to	Table	5.		
2.1.1 Bacterial	strains	
Table	 2	 lists	 the	E.	 coli	 strains	 that	were	 used	 for	 cloning	 (XL-1	 Blue	 and	Omnimax)	 and	protein	expression	(BL21	and	Rosetta)	and	their	respective	phenotypes.	
Table	2:	List	of	E.	coli	strains.	
Strain	 Genotype	XL-1	Blue	 recA1	endA1	gyrA96	thi-1	hsdR17	supE44	relA1	lac	[F’	proAB	
lacIqZΔM15	Tn10	(Tetr)]	Omnimax	 F’	{proAB+	lacIq	lacZΔM15	Tn10(TetR)	Δ(ccdAB)}	mcrA	Δ(mrr-
hsdRMS-mcrBC)	φ80(lacZ)ΔM15	Δ(lacZYA-argF)	U169	endA1	
recA1	supE44	thi-1	gyrA96	relA1	tonA	panD	BL21	(DE3)	 E.	coli	B	F–	dcm	ompT	hsdS(rB–	mB–)	gal	λ(DE3)	Rosetta	(DE3)	 F-	ompT	hsdSB(rB-	mB-)	gal	dcm	(DE3)	pRARE	(CamR)	DH10Bac	 F-mcrA	Δ(mrr-hsdRMS-mcrBC)	Φ80lacZΔM15	ΔlacX74	recA1	
endA1	araD139	Δ(ara,	leu)7697	galU	galK	λ-rpsL	
nupG/pMON14272/pMON7124	XL10	Gold	 Tetr∆	(mcrA)183	∆(mcrCB-hsdSMR-mrr)173	endA1	supE44	thi-1	
recA1	gyrA96	relA1	lac	Hte	[F’	proAB	lacIqZ∆M15	Tn10(Tetr)	Amy	Camr]			
2.1.2 Plasmids	
Table	3	lists	the	plasmids	that	were	used	either	for	heterologous	expression	of	proteins	in	bacteria	 for	 subsequent	 purification	 or	 expression	 in	 or	 modification	 of	 yeast	 for	 in	 vivo	studies.		
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Table	3:	List	of	plasmids	for	bacterial	and	yeast	expression.	
Plasmid	 Details	 Source	pCoofy1	 pBR322-His6-PreScission-ccdB	ccdB	substituted	by	gene	of	interest	 MPIB	core	facility	pCoofy37	 pBR322-MBP-PreScission-ccdB-His6	ccdB	substituted	by	gene	of	interest	 MPIB	core	facility	pCoofy37-Atg11	 Expression	of	MBP-PreScission-Atg11-His6	 Nena	Matscheko	pCoofy37-Atg11-linker	 Expression	of	MBP-PreScission-Atg11-TEV-His6-linker-His6	 This	study	pCoofy37-Atg11ΔC	 Expression	of	MBP-PreScission-Atg111-677-His6	 Nena	Matscheko	pCoofy37-Atg11Δdim	 Expression	of	MBP-PreScission-Atg111-456-His6	 This	study	pCoofy1-Atg32	 Expression	of	His6-PreScission-Atg321-376	 Nena	Matscheko	pCoofy1-Atg32SE	 Expression	of	His6-PreScission-Atg321-376,	S114E	 Nena	Matscheko	pST39-Atg17TC	 Polycistronic	expression	of	His6-PreScission-Atg17-myc,	Atg29	and	Atg31	 Yijian	Rao	pST39-Atg17	 Expression	of	His6-PreScission-Atg17-myc	 Yijian	Rao	pST39-Atg29-Atg31	 Polycistronic	expression	of	His6-PreScission-Atg29	and	Atg31	 Yijian	Rao	pST39-Atg29SD-Atg31	 Polycistronic	expression	of	His6-PreScission-Atg29S197D,	S199D,	S201D	and	Atg31	 Yijian	Rao	pST39-Atg17TC,SD	 Polycistronic	expression	of	His6-PreScission-Atg17-myc,	Atg29	S197D,	S199D,	S201D	and	Atg31	 This	study	pET28a(+)-Atg9core	 Expression	of	Atg9281-779,	I327V,	L328F,	M439L-PreScission-StrepTag-His6	 Yijian	Rao	pCoofy37-Atg13-TEV	 Expression	of	MBP-PreScission-Atg13-TEV-His6	 Marco	Perna	pCoofy29-Atg1	 Vector	for	translocation	of	MBP-PreScission-Atg1-TEV-His6	into	bacmid	DNA	for	insect	cell	expression	 Marco	Perna	pTL58(pAtg11)-Atg11-3HA	 CEN	plasmid,	expression	of	HA-tagged	Atg11	in	yeast	under	endogenous	promoter	 Nena	Matscheko	pG-KJE8	 Expression	of	chaperones	dnaK,	dnaJ,	grpE,	groES,	groEL	 Takara	Bio	Inc.				
2.1.3 Yeast	strains	
Table	4	lists	the	yeast	strains	used	for	this	study.	Proteins	were	tagged	or	deleted	using	PCR	amplified	 cassettes	 as	 described	 in	 paragraph	 2.2.3.	 The	 respective	 selection	markers	 are	indicated.			
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Table	4:	List	of	yeast	strains.	
Strain	 Details	 Source	BY4741	 S288C	MATa	his3Δ1	leu2Δ0	met15Δ0	ura3Δ0	 Euroscarf	BY4741	Atg11-9myc	 BY4741	Atg11-9x	myc	tag	(natNT2)	 Nena	Matscheko	BY4741	Atg11-9myc	pdr5Δ	 BY4741	Atg11-9x	myc	tag	(natNT2)	pdr5::hphNT1	 Nena	Matscheko	BY4741	pdr5Δ	 BY4741	pdr5::hphNT1	 This	study	BY4741	atg7Δ	 BY4741	atg7::kanMX6	 Viola	Beier	BY4741	Atg17-9myc	 BY4741	Atg17-9x	myc	tag	(natNT2)	 Viola	Beier	BY4741	pep4Δ	 BY4741	pep4::kanMX6	 Viola	Beier			
2.1.4 Antibodies	
Table	5	lists	the	antibodies	that	were	used	in	experiments,	either	for	Western	blots	(the	used	dilution	 is	 given	 in	 brackets)	 or	 bound	 to	 Protein	 A	 coupled	 magnetic	 beads	 for	immunoprecipitation.	
Table	5:	List	of	antibodies.		
Target	 Host	organism	 Manufacturer	 Application	c-myc	 Rabbit	 Santa	Cruz	 Western	blot,	primary	antibody	(1:1,000)	c-myc	 Mouse	 (in	house)	 Immunoprecipitation	HA	 Mouse	 Santa	Cruz	 Western	blot,	primary	antibody	(1:200)	Ubiquitin	 Mouse	 Enzo	 Western	blot,	primary	antibody	(1:500),	Immunoprecipitation	Pgk1	 Mouse	 Invitrogen	 Western	blot,	primary	antibody	(1:1,000)	GFP	 Mouse	 Roche	 Western	blot,	primary	antibody	(1:1,000)	Mouse	IgG		(HRP-conjugated)	 Goat	 Thermo	 Western	blot,	secondary	antibody	(1:10,000)	Rabbit	IgG		(HRP-conjugated)	 Goat	 Rockland	 Western	blot,	secondary	antibody	(1:5,000)			
2.1.5 Insect	cell	lines	
Insect	 cells	 were	 used	 as	 an	 additional	 expression	 system	 for	 protein	 purification	 by	baculovirus	 infection	 of	 Sf9	 (derived	 from	Spodoptera	 frugiperda	 pupal	 ovarian	 tissue)	 or	High	Five	cells	(BTI-TN-5B1-4,	derived	from	a	Trichoplusia	ni	cell	line).	Sf9	cells	were	used	
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for	transfection,	virus	production	and	expression	whereas	High	Five	cells	were	only	used	for	expression.			
2.2 Molecular	biology	methods	
2.2.1 Competent	bacteria	
Chemocompetent	bacteria	for	plasmid	transformation	were	prepared	as	described	(Inoue	et	al.,	1990).	Bacteria	were	grown	in	100	ml	of	LB	medium	to	an	OD600	of	0.6	at	18°C.	The	cells	were	collected	and	resuspended	in	30	ml	TB	buffer	(10	mM	Hepes,	15	mM	CaCl2,	250	mM	KCl,	and	55	mM	MnCl2).	After	10	min	incubation	on	ice,	cells	were	pelleted	and	resuspended	in	8	ml	TB	buffer	supplemented	with	DMSO	to	7%	final	concentration.	The	cells	were	incubated	for	 another	 10	min.	 Aliquots	 of	 competent	 cells	 were	 flash-frozen	 in	 liquid	 nitrogen	 and	stored	at	-80°C.			
2.2.2 Cloning	and	plasmid	preparation	
For	DNA	amplication	Phusion	polymerase	was	used.	PCRs	were	carried	out	as	described	in	the	manual.	For	DNA	insertions	into	plasmids	the	Sequence	and	Ligation	Independent	(SLIC)	method	was	used	as	described	(Scholz	et	al.,	2013).	Briefly,	 inserts	were	amplified	by	PCR	using	primers	that	contained	25	bp	overhangs	homologous	to	the	5’	and	3’	flanking	regions	of	the	target	plasmid.	The	plasmid	was	linearized	by	PCR	using	the	reverse	complements	of	the	overhangs	as	primers.	For	the	recombination	reaction	100	ng	of	linearized	plasmid	were	mixed	with	the	insert	PCR	product	(molar	ratio	of	plasmid:insert	=	1:3)	in	RecA	buffer	(NEB).	1	µl	RecA	(2µg/ml)	was	added,	the	sample	was	incubated	at	37°C	for	30	min	and	transformed	into	chemocompetent	E.	coli	Omnimax	cells.	For	this,	the	sample	was	mixed	with	50	µl	of	cells	on	ice	and	incubated	for	30	min,	followed	by	a	heat-shock	at	42°C	for	45	s.	After	cooling	down	on	ice,	the	sample	was	supplemented	with	1	ml	of	LB	medium	and	incubated	at	37°C	for	1	h.	The	bacteria	where	then	spread	on	LB	agar	plates	containing	the	appropriate	antibiotics	and	incubated	at	37°C.	Plasmids	were	prepared	from	5	ml	cultures	in	LB	medium	after	overnight	incubation	using	the	NucleoSpin	Plasmid	miniprep	kit	(Macherey-Nagel).		For	 small	 inserts	 the	 RecA	 reaction	 was	 rather	 inefficient.	 In	 this	 case,	 the	 insert	 was	introduced	 via	 primers	 for	 plasmid	 linearization	 followed	 by	 re-ligation.	 The	 reverse	 and	forward	 primers	were	 homologous	 to	 the	 5’	 and	 3’	 flanking	 regions	 of	 the	 insertion	 site,	respectively,	and	contained	the	sequence	of	either	half	of	the	insert	in	their	overhangs.	The	PCR	product	was	then	treated	with	DpnI	to	remove	template	DNA	and	purified	via	an	agarose	
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gel.	 The	 DNA	 was	 incubated	 with	 T4	 polynucleotide	 kinase	 at	 37°C	 for	 30	 min	 to	phosphorylate	the	ends	of	the	PCR	products.	Afterwards,	T4	DNA	ligase	was	added	and	the	sample	was	incubated	at	16°C	overnight.	This	method,	however,	required	to	screen	a	larger	set	of	colonies.	First,	colony-PCR	was	performed	with	one	primer	binding	to	the	insert,	the	other	one	to	the	backbone.	Positive	colonies	then	were	checked	by	sequencing	as	base	pair	deletions	happened	frequently	at	the	ligation	site.			
2.2.3 Genomic	manipulation	of	yeast	
Deletions	 and	 genomic	 addition	 of	 tags	 in	 yeast	 were	 carried	 out	 using	 homologous	recombination	 of	 transformed	 DNA	 cassettes.	 The	 cassettes	were	 amplified	 from	 a	 set	 of	cassette	plasmids	and	primers	were	designed	accordingly	(Janke	et	al.,	2004).	The	PCR	was	carried	out	as	described	above.	The	strain	to	be	manipulated	was	grown	at	30°C	until	an	OD600	of	0.3.	10	ml	of	culture	per	reaction	were	centrifuged	at	1,000	g	for	10	min.	The	pellet	was	resuspended	in	1	ml	of	sterile	water	and	 transferred	 to	an	Eppendorf	 tube.	After	 centrifugation	at	1,000	g	 for	5	min	 the	pellet	was	washed	with	1	ml	LiAc	Buffer	(100	mM	lithium	acetate,	10	mM	Tris	pH	8.0,	1	mM	EDTA).	 Afterwards,	 the	 pellet	 was	 resuspended	 in	 50	 µl	 LiAc	 Buffer	 per	 reaction	 and	incubated	at	30°C	for	15	min.	50	µl	of	this	suspension	were	mixed	with	5	µl	of	ssDNA	(salmon	sperm	DNA	heated	to	95°C	for	5	min	and	cooled	on	ice),	10	µl	PCR	product	and	300	µl	PEG	Buffer	(40%	PEG	3350,	100	mM	lithium	acetate,	10	mM	Tris	pH	8.0,	1	mM	EDTA).	Samples	were	incubated	at	30°C	for	1	h	at	moderate	shaking.	Then,	35	µl	DMSO	were	added,	carefully	mixed	and	the	samples	were	heat-shocked	at	42°C	for	30	min.	The	cells	were	pelleted	at	500	g	for	5	min	and	the	pellet	was	resuspended	in	2	ml	YPD	and	incubated	by	shaking	at	30°C	for	5	h.	The	culture	was	pelleted	at	1,000	g	for	5	min,	resuspended	in	100	µl	YPD	and	plated	on	a	YPD-agar	 plate	 containing	 the	 appropriate	 antibiotics.	 If	 the	 cassette	 contained	 an	autotrophic	marker,	cells	were	washed	once	with	PBS	after	the	heat-shock	and	directly	plated	on	SD-agar	plates	lacking	the	appropriate	amino	acid.		The	plates	were	incubated	for	at	least	two	days	at	30°C.	Colonies	were	picked	and	streaked	out	 on	 fresh	 plates	 to	 ensure	 there	was	 no	 contamination	with	 background	 colonies.	 The	correct	insertion	of	the	cassette	was	verified	by	PCR.	Colonies	were	picked	and	resuspended	in	100	µl	Extraction	Buffer	(200	mM	lithium	acetate,	1%	SDS)	and	incubated	for	15	min	at	70°C.	The	samples	were	mixed	with	300	µl	pure	ethanol	and	centrifuged	at	17,000	g	for	3	min.	The	pellet	was	washed	with	500	µl	of	70%	ethanol	and	then	dissolved	in	20	µl	of	water.	Cell	debris	was	pellet	by	centrifugation	at	17,000	g	for	20	s	and	1	µl	of	DNA	solution	was	used	in	the	PCR	reaction.		
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2.2.4 Plasmid	transformation	into	yeast	cells	
CEN	plasmids	were	 expressed	 in	 yeast	 cells	without	 integration	 into	 the	 genome.	 For	 the	transformation	of	these	plasmids	a	modified	protocol	was	used.	1	µg	of	plasmid	was	mixed	with	85	µl	One	Step	Buffer	(47%	PEG	3550,	0.24	M	lithium	acetate),	10	µl	of	1	M	DTT	and	5	µl	ssDNA	(salmon	sperm	DNA	heated	to	95°C	for	5	min	and	cooled	down	on	ice).	A	small	amount	of	the	yeast	strain	to	be	transformed	was	picked	from	an	agar	plate	and	resuspended	in	the	transformation	 mix.	 The	 samples	 were	 incubated	 for	 30	 min	 at	 45°C,	 pelleted	 by	centrifugation	at	500	g	for	5	min,	washed	once	in	PBS	and	plated	on	SD-agar	plates	lacking	the	corresponding	amino	acid.		
	
2.3 Biochemical	methods	
2.3.1 SDS-PAGE	and	Western	blotting	
For	 most	 applications	 SDS-acrylamide	 gels	 were	 prepared	 as	 follows:	 The	 mix	 for	 the	separation	 gel	 contained	 10	 to	 15%	 acrylamide	 (Rotiphorese	 Gel	 30	 acrylamide/bis-acrylamide	solution,	Roth),	375	mM	Tris	pH	8.8,	0.1%	SDS,	0.1%	ammonium	persulfate,	and	0.1%	TEMED	(N,N,N',N'-tetramethylethane-1,2-diamine).	The	separation	gel	was	topped	with	a	 stacking	 gel	 containing	 4%	 acrylamide,	 125	 mM	 Tris	 pH	 6.8	 and	 0.1%	 each	 of	 SDS,	ammonium	persulfate	and	TEMED.	The	gel	was	run	in	a	Mini-Protean	chamber	(BioRad)	filled	with	SDS	Running	Buffer	(25	mM	Tris,	192	mM	glycine,	0.1%	SDS)	with	80	V	for	the	stacking	and	160	V	 for	 the	 separation	 gel.	 The	 samples	were	 loaded	 together	with	 the	BenchMark	Protein	Ladder	(Invitrogen)	or	the	Novex	Sharp	Pre-stained	Protein	Standard	(Invitrogen)	as	marker	for	Coomassie	stained	gels	or	Western	blots,	respectively.	For	direct	staining	of	the	protein	bands	the	gel	was	incubated	in	Coomassie	Staining	solution	(0.2%	Coomassie	Brilliant	Blue	 R250,	 30%	 ethanol,	 10%	 acetic	 acid)	 for	 1	 h,	 followed	 by	 incubation	 in	 Destaining	solution	 (40%	 ethanol,	 10%	 acetic	 acid)	 until	 the	 background	 was	 fully	 destained.	 For	antibody	 detection	 of	 proteins	Western	 blots	 were	 performed.	 The	 gel	 was	 incubated	 in	Blotting	buffer	(50	mM	Tris	base,	39	mM	glycine,	20%	methanol,	0.037%	SDS)	for	10	min.	A	PVDF	membrane	corresponding	to	the	size	of	the	gel	(BioRad)	was	first	incubated	in	100%	methanol	 for	 1	min	 and	 then	 10	min	 in	 Blotting	 buffer.	 The	 gel	 and	 the	membrane	were	sandwiched	between	two	pieces	of	Extra	thick	filter	paper	(BioRad)	soaked	in	Blotting	buffer.	Blotting	was	performed	in	a	Transblot	SD	semidry	blotting	chamber	(BioRad)	at	15	V	for	30	min	to	1	h	depending	on	the	size	of	the	protein.	Afterwards,	the	membrane	was	blocked	in	TBS-T	(25	mM	Tris	pH	7.4,	150	mM	NaCl,	0.05%	Tween-20)	containing	5%	milk	powder	for	
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1	h	at	 room	temperature.	The	membrane	was	washed	with	TBS-T	and	 incubated	with	 the	primary	 antibody	 diluted	 in	 TBS-T	 containing	 2%	 BSA	 and	 0.02%	 sodium	 azide.	 After	incubation	for	2	h	at	room	temperature	or	at	4°C	over	night,	the	membrane	was	washed	three	times	 in	 TBS-T	 for	 5	min	 and	 incubated	 for	 1	 h	 at	 room	 temperature	with	 the	 secondary	antibody	 (HRP-conjugated)	 diluted	 in	 TBS-T	 with	 5%	 milk	 powder.	 The	 membrane	 was	washed	 again	 three	 times.	 It	 was	 incubated	 with	 SuperSignal	 West	 Pico	 Plus	chemiluminescence	 substrate	 (Thermo)	 and	 subsequently	 imaged	 in	 a	 G:Box	 chamber	(Syngene).	To	stain	different	proteins	in	the	same	sample,	the	membrane	was	incubated	in	Stripping	buffer	(100	mM	NaOH,	2%	SDS,	0.5%	DTT)	for	30	min	at	room	temperature,	washed	five	times	with	TBS-T	and	incubated	with	5%	milk	powder	in	TBS-T	for	1	h.	Staining	with	a	different	antibody	was	then	performed	as	described	before.	Band	intensities	were	quantified	using	ImageJ	and	its	built-in	band-quantification	tool.				
2.3.2 Crosslinking	
As	crosslinkers	react	with	primary	amines	such	as	Tris-HCl,	size	exclusion	chromatography	during	Agt11	purification	was	performed	using	Atg11	HEPES	buffer	(25	mM	HEPES	pH	7.2,	275	mM	 KCl,	 5%	 glycerol).	 Other	 proteins	 that	 contained	 Tris-HCl	 were	 re-buffered	 into	Atg11	 HEPES	 buffer	 using	 Zeba	 Desalting	 spin	 columns	 (Thermo).	 For	 glutaraldehyde	crosslinking,	proteins	were	diluted	with	Atg11	HEPES	buffer	to	a	final	concentration	of	5	µM,	supplemented	with	up	to	5	mM	glutaraldehyde	and	incubated	at	room	temperature	for	up	to	5	min.	The	reactions	were	stopped	by	addition	of	Tris	pH	8.0	to	a	final	concentration	of	100	mM.	 To	 overcome	 the	 problems	 of	 aggregation	 with	 glutaraldehyde	 crosslinking,	 the	photocrosslinker	Sulfo-LC-SDA	(Thermo)	was	used.	Either	Atg11	or	Atg32SE	were	mixed	with	the	crosslinker	(molar	ratio	protein:crosslinker	between	1:10	and	1:50).	The	reaction	was	carried	out	for	30	min	at	room	temperature	and	quenched	with	Tris	pH	8.0	at	100	mM	final	concentration.	To	remove	residual	crosslinker	 the	sample	was	applied	 to	a	Zeba	Desalting	spin	column	equilibrated	in	Atg11	HEPES	buffer.	Labeled	Atg11	was	mixed	with	unlabeled	Atg32SE	(molar	ratio	=	1:3)	or	vice	versa	and	exposed	to	UV	light	for	30	s	to	30	min.		
	
2.4 Protein	purification	
2.4.1 Purification	of	Atg11	
To	improve	the	expression	of	full-length	Atg11	the	pCoofy37-Atg11-linker	plasmid	was	co-transformed	with	the	pG-KJE8	plasmid	(Takara)	into	E.	coli	BL21	(DE3).	The	bacteria	were	
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grown	at	37°C	in	3	l	of	TB	(Terrific	broth)	medium	(2.4%	yeast	extract,	1.2%	tryptone,	0.5%	glycerol,	0.017	mM	KH2PO4,	0.072	mM	K2HPO4)	supplemented	with	35	µg/ml	kanamycin	and	24	 µg/ml	 chloramphenicol.	 After	 1	 h,	 expression	 of	 chaperones	 was	 induced	 by	 adding	arabinose	 to	0.2%	and	tetracycline	 to	5	ng/ml	 final	concentration.	Cells	were	grown	to	an	OD600	of	0.6	and	shifted	to	18°C.	Expression	of	Atg11	was	induced	with	0.3	mM	IPTG	at	an	OD600	of	1.6	and	carried	out	at	18°C	for	20	h.	The	cells	were	harvested	by	centrifugation	(15	min	at	4,500	g	and	4°C)	and	resuspended	in	Atg11	Lysis	Buffer	(100	mM	Tris	pH	8.0,	300	mM	KCl,	10%	glycerol,	20	mM	imidazole,	0.2%	Tween-20,	5	mM	β-mercaptoethanol,	1	mM	PMSF)	to	a	final	volume	of	150	ml	and	supplemented	with	500	µl	Protease	Inhibitor	cocktail	(Sigma-Aldrich)	 and	 20	 µl	 Sm	DNase.	 The	 sample	was	 sonicated	 four	 times	 for	 1	min	with	 80%	amplitude	and	2s/5s	on/off	pulse	(Ultrasonic	500	W,	Fisher	Scientific).	The	lysate	was	cleared	by	centrifugation	for	1	h	at	50,000	g	and	4°C.	The	supernatant	was	loaded	on	a	HisTrap	5	ml	column	with	 an	Äkta	Prime	 system,	 the	 flow	 through	was	 collected	 and	 loaded	 two	more	times	resulting	in	a	total	incubation	time	of	3	h.	The	column	was	washed	with	200	ml	of	Atg11	Wash	Buffer	(50	mM	Tris	pH	8.0,	500	mM	KCl,	10%	glycerol,	80	mM	imidazole)	and	eluted	with	20	ml	of	Atg11	Elution	Buffer	(25	mM	Tris	pH	7.2,	500	mM	KCl,	10%	glycerol,	250	mM	imidazole).	2	ml	fractions	were	collected	and	the	peak	fractions	of	the	elution	were	pooled	(8-10	ml	total	volume)	and	concentrated	to	400	µl	using	an	Amicon	Ultra-20	centrifugal	filter	with	50	kDa	MWCO	(Merck	Millipore).	The	sample	was	supplemented	with	DTT	and	EDTA	to	1	mM	final	 concentration	each	and	mixed	with	5	µl	His-PreScission	and	5	µl	His-TEV.	The	sample	was	 incubated	at	4°C	over	night	and	centrifuged	for	20	min	at	17,000	g	to	remove	larger	aggregates.	The	supernatant	was	 loaded	on	a	Superose	6	Increase	10/300	(GE)	size	exclusion	column	equilibrated	in	Atg11	Buffer	(25	mM	Tris	pH	7.2,	275	mM	KCl,	5%	glycerol).	Peak	fractions	were	pooled	and	concentrated	using	an	Amicon	Ultra-4	centrifugal	filter	with	50	kDa	MWCO	(Merck	Millipore).	Due	to	the	low	stability	of	Atg11,	the	concentrated	sample	was	kept	at	4°C	and	used	within	the	following	two	days.	To	remove	possible	aggregates	that	formed	after	size	exclusion,	the	sample	was	ultracentrifuged	at	160,000	g	for	20	min	prior	to	use.			
2.4.2 Purification	of	Atg11	variants	
Atg11ΔC	and	Atg11Δdim	were	expressed	from	the	pCoofy37	plasmid	in	E.	coli	BL21.	Cells	were	grown	at	37°C	in	3	l	LB	medium	supplemented	with	50	µg/ml	kanamycin.	The	expression	was	induced	with	0.3	mM	 IPTG	at	an	OD600	of	0.8	and	carried	out	at	18°C	 for	20	h.	Cells	were	harvested	by	centrifugation	 for	15	min	at	4,500	g	and	4°C.	The	pellet	was	resuspended	 in	Atg11	Lysis	Buffer	(100	mM	Tris	pH	8.0,	300	mM	KCl,	10%	glycerol,	20	mM	imidazole,	0.2%	
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Tween-20,	5	mM	β-mercaptoethanol,	1	mM	PMSF,	0.25%	PI,	10	µl	Sm	DNase)	to	a	final	volume	of	100	ml.	The	cells	were	lysed	by	sonicating	four	times	for	30	s	at	80%	amplitude	and	2s/5s	on/off	pulse	(Ultrasonic	500	W,	Fisher	Scientific).	The	lysate	was	cleared	by	centrifugation	for	1	h	at	50,000	g	and	4°C.	The	supernatant	was	mixed	with	2	ml	of	washed	Ni-NTA	agarose	beads	and	 incubated	at	4°C	 for	2	h.	The	beads	were	washed	6	times	with	25	ml	KCl	Wash	Buffer	(25	mM	Tris	pH	8.0,	300	mM	KCl,	10%	glycerol,	20	mM	imidazole)	in	a	glass	column	with	fritted	disc	and	the	protein	was	eluted	with	5	ml	KCl	Elution	Buffer	(25	mM	Tris	pH	7.4,	300	mM	NaCl,	500	mM	imidazole,	10%	glycerol).	The	MBP-tag	was	cleaved	off	by	addition	of	10	 µl	 His-PreScission	 and	 incubation	 at	 room	 temperature	 for	 1	 h.	 Then	 the	 sample	was	loaded	on	a	Superdex	200	16/60	size	exclusion	column	equilibrated	in	Atg11	Buffer	(25	mM	Tris	pH	7.2,	275	mM	KCl,	5%	glycerol).	Peak	fractions	were	pooled	and	concentrated	using	a	Spin-X	 UF	 concentrator	with	 30	 kDa	MWCO	 (Corning).	 Concentrated	 samples	were	 flash-frozen	in	liquid	nitrogen	and	stored	at	-80°C	until	further	use.			
2.4.3 Purification	of	other	Atg	proteins	
2.4.3.1 Atg17,	Atg29,	Atg31	
Atg17,	 Atg29	 and	 Atg31	 were	 co-expressed	 from	 the	 pST39	 plasmid	 for	 polycistronic	expression.	 Different	 constructs	were	 used	 to	 co-express	 all	 three	 proteins,	 to	 co-express	Atg29	(wild	type	and	phosphomimetic	mutant)	with	Atg31,	and	to	express	Atg17	alone.	All	constructs	were	transformed	into	the	E.	coli	BL21	Rosetta	strain	for	improved	codon	usage	and	 grown	 in	 3	 l	 LB	 medium	 supplemented	 with	 100	 µg/ml	 ampicillin	 and	 24	 µg/ml	chloramphenicol.	The	expression	was	induced	with	0.3	mM	IPTG	at	an	OD600	of	0.8	and	carried	out	at	18°C	for	20	h.	Cells	were	harvested	by	centrifugation	for	15	min	at	4,500	g	and	4°C.	The	pellet	 was	 resuspended	 in	 Lysis	 Buffer	 8.0	 (100	 mM	 Tris	 pH	 8.0,	 300	 mM	 NaCl,	 10	 mM	imidazole,	10%	glycerol,	5	mM	β-mercaptoethanol,	1	mM	PMSF,	0.25%	Protease	Inhibitor,	10	µl	Sm	DNase)	to	a	final	volume	of	100	ml.	The	cells	were	lysed	by	sonicating	four	times	for	30	s	at	80%	amplitude	and	2s/5s	on/off	pulse	(Ultrasonic	500	W,	Fisher	Scientific).	The	lysate	was	cleared	by	centrifugation	for	1	h	at	50,000	g	and	4°C.	The	supernatant	was	mixed	with	2	ml	of	washed	Ni-NTA	agarose	beads	and	incubated	at	4°C	for	2	h.	Then,	the	suspension	was	moved	to	a	glass	column	with	fritted	disc.	The	beads	were	washed	6	times	with	25	ml	Wash	Buffer	7.4	(25	mM	Tris	pH	7.4,	300	mM	NaCl,	20	mM	imidazole,	10%	glycerol)	and	the	protein	was	eluted	with	5	ml	Elution	Buffer	7.4	(25	mM	Tris	pH	7.4,	300	mM	NaCl,	500	mM	imidazole,	10%	glycerol).	Finally,	the	eluate	was	applied	to	a	Superdex	200	16/60	size	exclusion	column	and	peak	fractions	were	pooled	and	concentrated	using	a	Spin-X	UF	concentrator	with	30	kDa	
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MWCO	(Corning).	Concentrated	samples	were	flash-frozen	in	liquid	nitrogen	and	stored	at	-80°C	until	further	use.			
2.4.3.2 Atg13	
The	pCoofy37-Atg13-TEV-His	plasmid	was	transformed	into	the	E.	coli	BL21	Rosetta	strain.	Bacteria	were	grown	in	6	l	of	LB	medium	and	induced	with	0.3	mM	IPTG	at	an	OD600	of	0.5.	Proteins	 were	 expressed	 for	 4	 h	 at	 27°C.	 Cells	 were	 harvested	 and	 the	 cell	 pellet	 was	resuspended	in	Lysis	Buffer	8.0	(100	mM	Tris	pH	8.0,	300	mM	NaCl,	10	mM	imidazole,	10%	glycerol,	0.2%	Tween-20,	5	mM	β-mercaptoethanol,	1	mM	PMSF,	0.25%	Protease	Inhibitor,	10	µl	Sm	DNase)	 to	a	 final	volume	of	100	ml.	The	cell	 suspension	was	passed	 three	 times	through	an	Emulsiflex	C3	 (Avestin)	applying	1.5	kbar	pressure.	The	 lysate	was	 cleared	by	centrifugation	for	1	h	at	50,000	g	and	4°C.	The	supernatant	was	loaded	on	a	HisTrap	FF	5	ml	(GE)	and	 the	 flowthrough	was	 loaded	again.	The	column	was	washed	with	30	ml	of	Wash	Buffer	7.4	(25	mM	Tris	pH	7.4,	300	mM	NaCl,	20	mM	imidazole,	10%	glycerol)	supplemented	with	0.05%	Tween-20	and	5	mM	β-mercaptoethanol	and	eluted	with	a	gradient	of	0-20%	Elution	 Buffer	 7.4	 (25	mM	 Tris	 pH	 7.4,	 300	mM	NaCl,	 500	mM	 imidazole,	 10%	 glycerol)	supplemented	with	5	mM	β-mercaptoethanol.	Atg13	containing	 fractions	were	pooled	and	mixed	 with	 30	 µl	 each	 of	 His-PreScission	 and	 His-TEV	 to	 cleave	 N-	 and	 C-terminal	 tags,	respectively.	After	incubation	at	4°C	over	night,	the	sample	was	diluted	with	Atg13	Dilution	Buffer	(25	mM	Tris	pH	7.4,	5%	glycerol,	2	mM	DTT)	to	a	final	concentration	of	135	mM	NaCl.	The	sample	was	 loaded	on	a	HiTrap	Q	1	ml	(GE)	anion	exchange	column.	The	column	was	washed	with	5	ml	of	Atg13	HiTrap	Buffer	(25	mM	Tris	pH	7.4,	125	mM	NaCl,	5%	glycerol,	2	mM	DTT)	and	Atg13	was	eluted	with	a	linear	gradient	from	125	mM	to	250	mM	NaCl	in	Atg13	HiTrap	Buffer	over	50	ml.	To	concentrate,	the	Atg13	peak	fractions	were	pooled	and	diluted	with	Atg13	Dilution	Buffer	to	135	mM	NaCl.	The	sample	was	loaded	again	on	the	cleaned	and	equilibrated	HiTrap	Q	1	ml	column,	 followed	by	an	elution	step	with	Atg13	HiTrap	Buffer	containing	 300	mM	NaCl.	 Peak	 fractions	were	 pooled,	 flash-frozen	 in	 liquid	 nitrogen	 and	stored	at	-80°C	until	further	use.			
2.4.3.3 Atg9	
The	pET28a-Atg9core	plasmid,	containing	the	core	domain	of	Atg9	(residues	281-779)	with	three	mutations	(I327V,	L328F,	M439L),	was	transformed	into	the	E.	coli	BL21	Rosetta	strain.	The	bacteria	were	grown	in	3	l	TB	medium	and	induced	at	an	OD600	of	1.0	with	0.3	mM	IPTG.	Protein	expression	was	carried	out	for	20	h	at	18°C.	Cells	were	harvested	and	resuspended	in	
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Atg9	Lysis	Buffer	(100	mM	Tris	pH	8.0,	500	mM	KCl,	10%	glycerol)	supplemented	with	1	mM	PMSF,	0.15%	protease	 inhibitor	and	20	µl	Sm	DNase	to	 final	volume	of	200	ml.	Cells	were	lysed	by	passing	the	suspension	three	times	through	an	Emulsiflex	C3	(Avestin)	applying	1.5	kbar	pressure.	The	lysate	was	centrifuged	10	min	at	24,000	g.	The	supernatant	was	collected	and	 centrifuged	 for	 another	 10	 min.	 Finally,	 the	 supernatant	 was	 transferred	 to	 an	ultracentrifuge	and	membranes	were	collected	for	1	h	at	150,000	g.	The	membrane	pellet	was	resuspended	 in	100	ml	Atg9	Lysis	Buffer	 supplemented	with	0.1%	protease	 inhibitor	 and	centrifuged	again	for	1	h	at	150,000	g.	The	pellet	was	resuspended	with	80	ml	of	Atg9	Lysis	Buffer	per	g	of	pellet,	supplemented	with	0.1%	of	protease	inhibitor,	20	mM	imidazole	and	0.5%	(w/v)	LDAO.	The	membranes	were	solubilized	for	1	h	at	4°C	and	remaining	particles	were	removed	by	ultracentrifugation	at	150,000	g	for	30	min.	The	supernatant	was	passed	two	times	over	a	HisTrap	FF	5	ml	column.	The	column	was	washed	with	100	ml	of	Atg9	Wash	Buffer	(25	mM	Tris	pH	8.0,	500	mM	KCl,	40	mM	imidazole,	10%	glycerol,	0.1%	LDAO)	and	Atg9	was	eluted	with	Atg9	Elution	Buffer	(25	mM	Tris	pH	8.0,	200	mM	KCl,	500	mM	imidazole,	10%	glycerol,	0.1%	LDAO).	Peak	fractions	were	pooled	and	concentrated	to	4	ml.	The	sample	was	loaded	on	a	Superdex	200	16/60	size	exclusion	column	equilibrated	with	Atg9	SEC	Buffer	(25	mM	 Tris	 pH	 8.0,	 150	mM	NaCl,	 0.05%	 LDAO).	 Fractions	 of	monomeric	 Atg9	 (elution	volume	 of	 73	 ml)	 were	 pooled	 and	 concentrated	 to	 4	 mg/ml	 using	 an	 Amicon	 Ultra-20	centrifugal	filter	with	30	kDa	MWCO	(Merck	Millipore).	The	sample	was	flash-frozen	in	liquid	nitrogen	and	stored	at	-80°C.			
2.4.3.4 Atg1	
Atg1	was	expressed	 in	baculovirus-infected	 insect	 cells	based	on	a	protocol	developed	 for	multi-gene	expression	(Fitzgerald	et	al.,	2006).	The	pCoofy29-Atg1	plasmid	was	transformed	into	chemocompetent	DH10Bac	cells	according	to	the	standard	protocol	with	some	changes.	After	the	heat-shock,	cells	were	incubated	for	4	h	and	plated	on	LB	agar	plates	containing	50	µg/ml	kanamycin,	7	µg/ml	gentamicin,	10	µg/ml	tetracyclin,	40	µg/ml	IPTG,	and	100	µg/ml	Bluo-gal.	The	plates	were	incubated	for	2	days	at	37°C	allowing	the	negative	clones	to	show	a	strong	blue	color.	Colonies	with	successful	transfer	of	the	Atg1	gene	to	the	bacmid	DNA	lacked	the	blue	color	and	were	streaked	on	fresh	plates	to	confirm	the	phenotype.		Bacmid	DNA	was	prepared	from	a	2	ml	overnight	culture	in	LB	medium	containing	kanamycin	and	gentamicin.	The	cell	pellet	was	lysed	by	alkaline	lysis	using	Resuspension	(A1),	Lysis	(A2)	and	Neutralization	Buffer	(N3)	from	the	Qiagen	Miniprep	Kit.	The	lysate	was	centrifuged	at	17,000	g	for	5	min	and	the	supernatant	was	transferred	to	a	new	tube	and	centrifuged	for	another	 15	 min	 to	 completely	 remove	 the	 particles.	 Isopropanol	 was	 added	 to	 the	
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supernatant	 to	 40%	 concentration	 and	DNA	was	 pelleted	 by	 centrifugation	 for	 10	min	 at	17,000	g	and	4°C.	The	pellet	was	washed	twice	with	500	µl	70%	ethanol	and	was	dried	under	a	sterile	hood.	The	pellet	was	resuspended	in	50	µl	sterile	water.	Sf9	cells	were	diluted	to	0.4	x	106	cells/ml	and	seeded	into	a	6-well	plate	(2	ml	culture	per	well).	 Cellfectin	 II	was	mixed	with	1	µg	bacmid	DNA	 in	200	µl	medium	and	 incubated	 for	45	min	 at	 room	 temperature.	 The	 transfection	mix	was	 added	 to	 the	 cells	 followed	by	 an	incubation	 for	 3-5	 h	 at	 27°C.	 Afterwards,	 the	medium	was	 substituted	with	 3	ml	 of	 fresh	medium.	After	65	h,	the	medium	was	collected	and	centrifuged	for	5	min	at	200	g	to	remove	cells	 and	debris.	The	 cleared	 supernatant	 (Virus	 stock	V0)	was	 added	 to	25	ml	of	 Sf9	 cell	culture	at	a	density	of	0.8	x	106	cells/ml.	The	cells	were	counted	every	24	h	and	if	required,	medium	was	added	to	keep	the	cell	number	below	1.0	x	106.	After	proliferation	arrest,	the	culture	was	incubated	for	another	48	h.	The	cells	were	removed	by	centrifugation	for	5	min	at	150	g	and	the	supernatant	was	transferred	to	a	fresh	tube	(Virus	stock	V1).	Atg1	expression	was	performed	in	High	Five	cells.	The	cells	were	diluted	into	3	l	of	ExCell	420	insect	cell	medium	(Sigma-Aldrich)	to	reach	a	final	density	of	0.8	x	106	cells/ml	and	infected	with	Virus	 stock	V1	at	a	volume	ratio	of	200:1	 followed	by	 incubation	at	27°C.	Cells	were	counted	every	24	h	and	medium	was	added	to	keep	cell	number	below	1.0	x	106	cells/ml	if	needed.	After	proliferation	arrest,	the	culture	was	incubated	for	48	h.	Cells	were	harvested	by	centrifugation	(2,000	g,	20	min)	and	the	pellet	was	resuspended	in	100	ml	Atg1	Lysis	Buffer	(100	mM	Tris	pH	7.4,	300	mM	NaCl,	20	mM	imidazole,	5%	glycerol,	1%	Triton-X100,	5	mM	β-mercaptoethanol,	 1	mM	PMSF,	 0.5%	protase	 inhibitor,	 10	 µl	 Sm	DNase).	 Cells	were	 lysed	using	a		douncer	and	the	lysate	was	cleared	by	centrifugation	for	1	h	at	50,000	g	and	4°C.	The	supernatant	was	loaded	on	a	HisTrap	FF	5	ml	column	using	a	150	ml	superloop.	The	column	was	 washed	 with	 50	 ml	 Atg1	 Wash	 Buffer	 (25	 mM	 Tris	 pH	 7.4,	 300	 mM	 NaCl,	 20	 mM	imidazole,	5%	glycerol,	0.1%	Triton	X-100).	Protein	was	eluted	with	Atg1	Elution	Buffer	(25	mM	Tris	 pH	7.4,	 300	mM	NaCl,	 500	mM	 imidazole,	 5%	glycerol)	 and	peak	 fractions	were	concentrated	 to	4	ml	using	 an	Amicon	Ultra-20	 centrifugal	 filter	with	50	kDa	MWCO.	The	sample	was	loaded	on	a	Superdex	200	16/60	size	exclusion	column	equilibrated	with	Atg1	Buffer	(25	mM	Tris	pH	7.4,	300	mM	NaCl,	5%	glycerol).	Atg1	fractions	(peak	elution	volume	of	65	ml)	were	pooled	and	concentrated	to	a	concentration	of	about	2	mg/ml	using	an	Amicon	Ultra-4	centrifugal	filter	with	50	kDa	MWCO.			
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2.5 Biophysical	methods	
2.5.1 Preparation	of	small	unilamellar	vesicles	(SUVs)	
Synthetic	lipids	were	mixed	in	chloroform	to	give	1	mg	of	total	lipid	consisting	of	20	mol%	cholesterol,	 60%	 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine	 (POPC),	 10%	 1-palmitoyl-2-oleoyl-sn-glycero-3-phospho-L-serine	 (POPS),	 10%	 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphoethanolamine	 (POPE)	 and	 0.1%	 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine-N-(lissamine	 rhodamine	 B	 sulfonyl)	 (rhodamine-PE).	 Lipids	 were	dried	under	a	nitrogen	stream	and	traces	of	chloroform	were	removed	by	applying	vacuum	for	1	h.	The	lipid	film	was	resuspended	in	1	ml	of	Liposome	Buffer	(20	mM	HEPES	pH	7.0,	100	mM	NaCl)	by	vortexing	for	1	min	giving	rise	to	a	suspension	of	multilamellar	vesicles	(MLVs).	To	be	used	as	control	samples,	the	suspension	was	sonicated	under	the	same	conditions	as	for	Atg9	proteoliposomes	to	obtain	SUVs.				
2.5.2 Reconstitution	of	Atg9	into	proteoliposomes	
A	 suspension	 of	 MLVs	 was	 prepared	 as	 described	 above	 except	 that	 the	 lipid	 film	 was	resuspended	in	1	ml	of	detergent-free	Atg9	Buffer	(25	mM	Tris	pH	8.0,	150	mM	NaCl).	Then,	LDAO	was	 added	 to	 0.15%	 (6.5	mM)	 final	 concentration	 to	 solubilize	 the	 lipids.	 Purified	Atg9core	was	centrifuged	for	20	min	at	17,000	g	to	remove	larger	aggregates	and	was	added	to	the	lipids	in	a	molar	protein:lipid	ratio	of	1:200	(460	µg	Atg9core	per	mg	of	lipids).	After	20	min	incubation	at	room	temperature,	the	sample	was	mixed	with	30	ml	of	detergent-free	Atg9	Buffer	to	quickly	dilute	to	well	below	the	critical	micellar	concentration	(1.7	mM).	Then,	the	solution	 was	 ultracentrifuged	 for	 30	 min	 at	 150,000	 g	 to	 collect	 the	 liposomes.	 The	supernatant	was	completely	removed	and	the	pellet	was	resuspended	in	1	ml	of	Liposome	Buffer	(20	mM	HEPES	pH	7.0,	100	mM	NaCl).			
2.5.3 Floatation	assays	
Atg9	liposomes	or	protein-free	MLVs	were	sonicated	10	times	for	30	s	with	20	s	break	in-between	to	break	down	the	liposome	aggregates	and	generate	LUVs.	100	µl	of	liposomes	were	immediately	mixed	with	the	proteins	of	interest	and	buffer	to	a	total	sample	volume	of	280	µl.	For	the	competition	assay,	Atg9	proteoliposomes	were	incubated	with	Atg11	for	10	min	on	ice	before	Atg17	was	added.	After	30	min	incubation	on	ice,	250	µl	of	the	liposome	mix	was	mixed	 with	 a	 80%	 Histodenz	 solution	 to	 reach	 a	 final	 concentration	 of	 40%	 Histodenz,	transferred	to	an	ultracentrifuge	tube	and	overlaid	with	300	µl	of	30%	Histodenz	in	Liposome	
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Buffer,	followed	by	200	µl	Liposome	Buffer.	The	samples	were	ultracentrifuged	at	165,000	g	for	1	h	at	4°C	and	liposomes	that	floated	at	the	Histodenz/buffer	interface	were	collected	in	a	final	volume	of	80	µl,	mixed	with	20	µl	5x	SDS	sample	buffer	and	incubated	overnight	at	room	temperature.			
2.5.4 Cryo-electron	microscopy	
500	µl	of	Atg9	proteoliposomes	were	sonicated	for	10	s	to	break	down	large	aggregates	and	mixed	with	160	µg	Atg11.	The	sample	was	co-sonicated	for	20	min	with	0.2	s	on	/	1.8	s	off	time	with	the	lowest	power	setting	(21%)	on	a	Sonics	Vibra-Cell	VC750	sonicator.	The	sample	was	 divided	 into	 two	 halves	 and	mixed	 with	 either	 Atg32SE	 (1:3	molar	 ratio	 of	 Atg11	 to	Atg32SE)	or	an	equal	amount	of	buffer.	Cryo-electron	microscopy	was	performed	with	Gérard	Pehau-Arnaudet	at	the	UTechS	Biolmagerie	Ultrastructurale,	Institut	Pasteur.	Samples	were	loaded	on	a	glow	discharged	Lacey	carbon	grid	and	mounted	on	a	Leica	EM	GP	system,	blotted	for	1	sec	and	plunge-frozen	in	liquid	ethane.	The	samples	were	visualized	on	a	Tecnai	F20	cryo-electron	microscope	and	images	were	recorded	in	low-dose	mode	on	a	Falcon	II	direct	electron	detector.	
	
2.6 In	vivo	methods	
2.6.1 Growth	of	yeast	cultures	
Genomically	modified	yeast	strains	were	stored	at	-80°C	in	medium	containing	20%	glycerol	and	were	streaked	out	on	agar	plates	prior	to	use.	For	expression	from	CEN	plasmids,	yeast	cells	 were	 freshly	 transformed	 as	 described	 before.	 Pre-cultures	 were	 inoculated	 with	colonies	from	the	plate	in	either	YPD	medium	(1%	yeast	extract,	2%	peptone,	2%	glucose,	supplemented	with	antibiotics	depending	on	 the	 selection	marker)	or	SD	medium	(0.67%	yeast	nitrogen	base,	2%	glucose,	0.2%	amino	acid	mix	 lacking	 the	appropriate	amino	acid	depending	 on	 the	 selection	 marker)	 and	 grown	 overnight	 at	 30°C.	 Large	 cultures	 were	inoculated	 from	 the	 pre-cultures	 and	 grown	 to	 an	 OD600	 of	 0.8	 to	 1.0.	 For	 starvation	experiments,	 cells	 were	 pelleted	 at	 1,000	 g	 for	 5	 min,	 washed	 twice	 in	 SD-N	 starvation	medium	 (0.17%	 yeast	 nitrogen	 base,	 2%	 glucose)	 and	 resuspended	 in	 the	 initial	 culture	volume	with	SD-N.	Culturing	of	the	cells	was	continued	for	up	to	6	h.			
Materials	and	methods	
41	
2.6.2 Preparation	of	whole	cell	lysates	
To	 compare	 protein	 levels	 in	 different	 samples	 by	Western	 blot,	whole	 cell	 extracts	were	prepared	basically	as	described	(Zhang	et	al.,	2011).	1	OD	of	yeast	cells	was	taken	for	each	sample.	The	cells	were	pelleted	and	resuspended	in	100	µl	of	2	M	lithium	acetate.	After	5	min	incubation	on	ice,	cells	were	pelleted	and	resuspended	in	100	µl	of	0.4	M	NaOH.	After	another	5	min	incubation	on	ice,	cells	were	pelleted,	the	NaOH	was	completely	removed	and	the	pellet	was	resuspended	in	50	µl	1x	SDS	sample	buffer.	The	samples	were	incubated	at	95°C	for	5	min	and	debris	was	removed	by	centrifugation.		
2.6.3 Immunoprecipitation	experiments	
Yeast	cells	corresponding	to	50	OD	of	yeast	culture	were	harvested	by	centrifugation.	For	the	anti-ubiquitin	IP	the	amount	was	increased	to	500	OD.	The	pellet	was	resuspended	in	0.5	to	2.0	ml	of	IP	Buffer	(25	mM	Tris	pH	7.2,	150	mM	NaCl,	200	mM	sorbitol,	1	mM	MgCl2,	0.1%	Tween-20)	supplemented	with	3	mM	PMSF	and	3-5%	protease	inhibitor	mix.	Acid-washed	glass	beads	 (425-600	µm)	were	added	 to	 the	 suspension	 to	50%	of	 the	 total	 volume.	The	samples	were	vortexed	six	times	for	1	min	with	1	min	of	cooling	time	in-between.	The	lysate	was	transferred	to	a	fresh	tube	and	larger	components	were	removed	by	centrifugation	for	1	min	at	5000	g.	The	supernatant	was	supplemented	with	Tween-20	to	1%	final	concentration	and	was	incubated	for	10	min	on	ice.	The	sample	was	centrifuged	for	15	min	at	17,000	g	and	the	supernatant	was	mixed	with	10	µg	of	antibody	(20	µg	for	anti-ubiquitin	antibody).	After	incubation	for	2	h	at	4°C	the	sample	was	mixed	with	20	µl	(40	µl	for	anti-ubiquitin	antibody)	of	Protein	A	coupled	magnetic	beads	(Thermo	Scientific).	The	suspension	was	incubated	for	30	min	at	4°C,	the	lysate	was	removed	and	the	beads	were	washed	four	times	with	IP	buffer	containing	0.5%	Tween-20.	Finally,	the	beads	were	resuspended	in	50	µl	SDS-PAGE	loading	buffer	and	incubated	for	5	min	at	95°C.			
2.6.4 Proteasomal	block	assay	
The	function	of	the	proteasome	was	specifically	inhibited	by	the	chemical	MG132.	The	strains	used	 for	 the	 proteasomal	 block	 assays	 contained	 an	 additional	 deletion	 of	 the	 drug	 efflux	pump	Pdr5	to	increase	the	intracellular	concentration	of	the	inhibitor.	Cells	were	grown	in	SD	medium	and	split	into	two	at	an	OD600	of	0.7.	Either	a	5	mM	MG132	solution	in	DMSO	was	added	 to	 a	 final	 concentration	 of	 50	 µM,	 or	 the	 same	 volume	of	DMSO	 as	 a	 control.	 After	incubation	at	30°C	for	1	h	cells	were	harvested	and	resuspended	in	SD-N	starvation	medium.	
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MG132	was	added	to	a	final	concentration	of	75	µM,	or	the	same	volume	of	DMSO	as	a	control,	and	cultures	were	incubated	at	30°C	for	4	h.	1	OD	of	cells	was	taken	at	various	time	points	and	whole	cell	lysates	were	prepared	as	described	above.			
2.7 Mass	spectrometry	
For	 the	 cross-linking	 experiment	 samples	 were	 run	 on	 a	 NuPage	 4-12%	 Bis-Tris	polyacrylamide	gel	(Thermo	Fisher)	and	stained	with	Bio-Safe	Coomassie	Solution	(Bio-Rad).	Bands	 were	 cut	 out,	 digested	 with	 trypsin	 and	 analyzed	 by	 nanoLC-MS/MS	 in	 the	 Mass	Spectrometry	for	Biology	Utechs	(MSBio)	platform	at	Institut	Pasteur.	Measurements	were	performed	by	Christian	Malosse	and	 the	data	was	analyzed	by	Christian	Malosse	and	 Julia	Chamot-Rooke.				
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3 Results	
3.1 Protein	purifications	
3.1.1 Purification	of	Atg11	
Atg11	is	a	large	protein	of	about	135	kDa	rendering	expression	in	E.	coli	inefficient.	The	gene	encoding	Atg11	was	cloned	into	the	pCoofy37	plasmid	by	Dr.	Nena	Matscheko.	This	plasmid	contains	an	N-terminal	MBP-tag	for	increased	solubility	followed	by	a	PreScission	protease	cleavage	 site,	 as	well	 as	a	C-terminal	His6-tag.	The	His6-tag	 served	 to	 remove	C-terminally	degraded	 fragments	 of	 Atg11.	 Although	 the	 protein	 was	 expressed	 with	 a	 MBP-tag,	 the	solubility	was	very	low.	To	increase	folding	of	Atg11	in	E.coli,	the	Atg11	fusion	protein	was	co-expressed	with	chaperones	from	the	Takara	pG-KJE8	plasmid.	Figure	4	shows	an	anti-His6	Western	blot	of	cell	lysates	from	different	expression	conditions.	This	test	revealed	that	the	yield	of	full-length	Atg11	is	strongly	enhanced	when	expressed	in	the	presence	of	chaperones	at	a	temperature	of	18°C	for	16	h.	The	yield	was	further	increased	when	cells	were	grown	in					
	
Figure	4:	Expression	test	for	the	Atg11	fusion	protein.	Western	blot	of	samples	prepared	from	whole	cell	pellets	and	stained	using	anti-His	antibody.	Tested	conditions	included	the	medium	(LB	or	TB),	the	temperature	after	IPTG	induction	(3	h	expression	at	30°C	or	16	h	at	18°C),	and	the	bacterial	strain	(BL21,	BL21	Rosetta	for	improved	codon	usage	or	BL21	co-transformed	with	pG-KJE8	for	chaperone	expression).			
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Figure	5:	Schematic	of	the	Atg11	fusion	protein	for	improved	binding	to	the	HisTrap.	The	drawing	illustrates	the	self-inhibition	of	Atg11	by	its	C-terminal	domain,	which	might	render	a	C-terminal	tag	less	accessible.	A	double	His6-tag	was	designed	to	improve	binding	to	the	resin	(the	tags	are	not	drawn	to	scale).			Terrific	Broth	(TB)	medium	compared	to	LB	medium	(last	two	lanes	in	Figure	4).	Even	though	the	C-terminal	His6-tag	helped	to	remove	N-terminal	Atg11	fragments,	the	binding	efficiency	of	the	full-length	fusion	protein	to	the	HisTrap	resin	was	very	low.	To	overcome	this	problem	a	longer	C-terminal	tag	was	designed	by	introducing	a	TEV	recognition	site	for	a	later	cleavage	of	the	tag,	 followed	by	a	His6-tag,	a	11	amino	acid	spacer	and	a	second	His6-tag	(Figure	5).	With	this	change	the	yield	of	Atg11	could	be	strongly	increased.	The	large	scale	purification	of	Atg11	using	a	HisTrap	column	is	depicted	in	Figure	6.	Major	contaminations	could	be	washed	from	the	column	at	low	imidazole	concentrations	(lane	“1”).	A	 slight	 increase	 in	 imidazole	 concentration	and	 continuous	washing	over	 several	 column	volumes	 could	 strongly	 enhance	 the	 purity	 of	 the	 protein	 preparation,	 even	 though	 some	Atg11	was	lost	at	this	step	(lane	“2”).	The	eluate	was	concentrated	and	both	N-	and	C-terminal	tags	were	cleaved	prior	to	size	exclusion	chromatography	(last	two	lanes	of	the	SDS-PAGE	in	Figure	 6).	 Gel	 filtration	 was	 performed	 on	 a	 Superose	 6	 Increase	 column	 and	 the	chromatogram	is	depicted	in	Figure	7.	Atg11	was	primarily	detected	in	the	elution	volume	range	of	9	ml	to	15	ml	(grey	box	1).	This	can	be	explained	by	the	aggregation-prone	nature	of	Atg11.	Monomeric	Atg11	eluted	at	13.1	ml	(marked	by	an	asterisk)	and	was	detected	as	a	strong	band	in	SDS-PAGE.	This	elution	volume	corresponds	roughly	to	that	of	thyroglobulin	with	a	molecular	weight	of	669	kDa	(product	information	by	GE	Life	Sciences)	indicating	an	elongated	 shape	 of	 Atg11.	 The	 Superose	 6	 Increase	 column	 was	 chosen	 because	 of	 its	resolution	 capacity	 in	 the	 high	 molecular	 weight	 range,	 which	 allowed	 the	 separation	 of	monomeric	Atg11	from	Atg11	aggregates.			
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Figure	6:	HisTrap	purification	of	Atg11.	(A)	Chromatogram	of	the	washing	and	elution	step.	Absorption	at	280	nm	is	drawn	in	black,	imidazole	concentrations	in	grey.	(B)	Samples	of	different	purification	steps	were	analyzed	by	SDS-PAGE	and	Coomassie	staining.				
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Figure	7:	Size	exclusion	chromatography	of	Atg11.	(A)	Chromatogram	of	the	gelfiltration	on	a	Superose	6	Increase	column	showing	the	absorption	at	280	nm.	(B)	Samples	of	elution	fractions	were	analyzed	by	SDS-PAGE.				
3.1.2 Purification	of	other	Atg	proteins	
3.1.2.1 Atg11	variants	
Atg11ΔC	(residues	1-667)	 lacks	 the	C-terminal	domain	 comprising	 coiled-coil	domains	CC3	and	CC4.	 It	was	 expressed	 in	E.	 coli	BL21	 from	 the	pCoofy37	plasmid	with	 a	 cleavable	N-terminal	MBP-tag	and	a	C-terminal	His6-tag.	The	fusion	protein	was	bound	to	a	Ni-NTA	resin	and	the	MBP-tag	was	cleaved	off	after	imidazole	elution	(Figure	8A,	SDS-PAGE,	first	lane).	The	sample	 was	 further	 purified	 on	 a	 Superdex	 200	 16/60	 size	 exclusion	 column	 to	 remove	aggregates	and	smaller	impurities	including	the	MBP	tag.	Atg11ΔC	eluted	at	62	ml	(grey	area	2).	 Another	 impurity	 of	 about	 65	 kDa	 could	not	 be	 separated	 from	 the	Atg11ΔC	 construct,	which	is	most	likely	a	N-terminally	truncated	degradation	product	as	already	observed	for	full-length	 Atg11.	 By	 comparison	 with	 the	 elution	 volumes	 of	 different	 globular	 proteins	(aldolase	 has	 a	 molecular	 weight	 of	 158	 kDa	 and	 elutes	 at	 a	 volume	 of	 65	 ml;	 product	
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information	by	GE	Life	Sciences)	 the	molecular	weight	of	Atg11ΔC	 is	estimated	to	be	about	200	kDa.	This	suggests	that	Atg11ΔC	has	an	elongated	shape	as	expected	for	full-length	Atg11	and/or	 that	 this	 variant	 is	 forming	 dimers.	 The	 possible	 dimerization	 is	 consistent	 with	analytical	ultracentrifugation	experiments	conducted	by	Dr.	Nena	Matscheko.	These	showed	an	 increase	of	 the	sedimentation	coefficient	at	higher	protein	concentration	 in	the	sample,	indicating	the	formation	of	oligomers.	Atg11Δdim	(residues	1-456)	is	a	N-terminal	fragment	of	Atg11	that	only	contains	coiled-coil	domain	CC1.	Thus,	 it	 lacks	 the	 coiled-coil	domains	 reported	 to	be	 required	 for	Atg11	self-interaction	 (Yorimitsu	 and	 Klionsky,	 2005).	 Atg11Δdim	 was	 expressed	 and	 purified	 as			
	
Figure	8:	Purification	of	Atg11	variants.	MBP-Atg11ΔC-His6	(A)	and	MBP-Atg11Δdim-His6	(B)	were	bound	to	Ni-NTA	resin,	the	MBP-tag	was	cleaved	after	elution	and	the	sample	was	applied	to	a	Superdex	200	size	exclusion	column.	Gelfiltration	profiles	(280	nm	absorption)	are	shown	on	the	right,	Coomassie-stained	acrylamide	gels	of	gelfiltration	samples	are	shown	on	the	left.			
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described	for	Atg11ΔC.	Purification	using	Ni-NTA	resin	already	achieved	a	high	purity	(Figure	8B,	SDS-PAGE	lane	1).	The	MBP-tag	was	cleaved	using	PreScission	protease	and	removed	via	size	exclusion	chromatography	on	a	Superdex	200	16/60	column	alongside	other	impurities.	Atg11Δdim	eluted	at	78	ml	(grey	box	4).	This	elution	volume	corresponds	to	a	globular	protein	of	about	60	kDa,	which	is	close	to	the	molecular	weight	of	Atg11Δdim	of	53	kDa.	This	strongly	indicates	that	Atg11Δdim	is	a	monomer	in	solution.	As	for	full-length	Atg11	and	Atg11ΔC,	but	only	to	a	small	percentage,	a	N-terminally	truncated	contamination	of	10	kDa	difference	co-eluted	with	Atg11Δdim	from	the	column.			
3.1.2.2 Components	of	the	trimeric	complex	
Atg17,	 Atg31-Atg29	 and	 the	 Atg17-Atg31-Atg29	 trimeric	 complex	were	 expressed	 from	 a	pST39a	 polycistronic	 vector	 and	 purified	 according	 to	 an	 established	 protocol	 (Rao	 et	 al.,	2016).	Atg17	was	purified	via	a	His-Trap	column.	The	N-terminal	His6-tag	was	cleaved	off	by	PreScission	 protease	 treatment	 and	Atg17	was	 separated	 from	 remaining	 impurities	 on	 a	Superdex	200	size	exclusion	column	with	a	peak	elution	volume	of	64	ml	(Figure	9A).	The	Atg31-Atg29	subcomplex	was	bound	to	Ni-NTA	resin	via	an	N-terminal	His6-tag	on	Atg29.	The	tag	was	cleaved	off	by	PreScission	protease	 treatment	and	the	sample	was	separated	on	a	Superdex	200	16/60	size	exclusion	column	(Figure	9B).	The	complex	eluted	at	72	ml	but	was	partly	overlapping	with	the	elution	volume	of	a	larger	contamination	of	about	70	kDa	and	a	contamination	of	about	35	kDa	that	could	be	a	truncated	version	of	Atg31.	Therefore,	only	fractions	from	66	ml	to	73	ml	elution	volume	were	collected.				
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Figure	9:	Purification	of	 trimeric	 complex	 subunits.	His6-Atg17	 (A)	 and	His6-Atg29-Atg31	 (B)	were	bound	 to	 a	 HisTrap	 column	 or	 Ni-NTA	 beads,	 respectively.	 The	 His-tag	 was	 cleaved	 after	 elution	 by	PreScission	protease	and	the	sample	was	applied	to	a	Superdex	200	size	exclusion	column.	Gelfiltration	profiles	(280	nm	absorption)	are	shown	on	the	right,	Coomassie-stained	acrylamide	gels	of	gelfiltration	samples	are	shown	on	the	left.		
3.1.2.3 Atg32SE	
Atg32	 was	 purified	 as	 a	 C-terminally	 truncated	 protein	 (Atg321-376)	 lacking	 the	transmembrane	and	intramitochondrial	domain.	Additionally,	serine	114	was	mutated	to	a	glutamate	(Atg32SE)	to	obtain	a	phosphomimetic	variant	resembling	active	Atg32	(Aoki	et	al.,	2011).	Atg32SE	was	expressed	in	E.	coli	from	a	pCoofy1	plasmid	with	a	N-terminal	His6-tag	cleavable	via	a	PreScission	site.	The	protein	was	purified	by	affinity	chromatography	using	a			
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Figure	10:	Purification	of	Atg32SE.	His6-Atg32SE	was	bound	to	Ni-NTA	beads,	eluted	with	high	imidazole	concentration	 and	 separated	 on	 a	 Superdex	 200	 size	 exclusion	 column.	 Gelfiltration	 profiles	 (280	 nm	absorption)	are	shown	on	the	right,	Coomassie-stained	acrylamide	gels	of	protein	samples	are	shown	on	the	left.			Ni-NTA	 resin.	 After	 cleaving	 the	 tag	 the	 sample	 was	 further	 purified	 by	 size	 exclusion	chromatography.	Atg32SE	eluted	at	a	volume	of	75	ml	from	a	Superdex	200	16/60	gelfiltration	column	Figure	10.		
3.1.2.4 Atg9	
For	 in	vitro	experiments	a	 truncated	version	of	Atg9	was	used,	 termed	Atg9core	 (Rao	et	al.,	2016).	The	Atg9core	was	expressed	in	E.	coli	and	purified	from	the	membrane	fraction	via	a	C-terminal	 His6-tag	 (Figure	 11).	 The	 supernatant	 after	 low-speed	 centrifugation	 of	 the	 cell	lysate	(S24)	was	applied	to	ultracentrifugation	to	collect	the	membrane	fraction	(P140).	The	membrane	pellet	was	solubilized	in	presence	of	detergent	and	Atg9core	was	purified	by	affinity	chromatography	 using	 a	 HisTrap	 column.	 The	 protein	 was	 then	 further	 purified	 by	 size	exclusion	chromatography.		Even	though	there	is	no	Atg9	band	visible	in	the	elution	fraction	on	the	acrylamide	gel,	UV	absorption	indicated	a	high	protein	concentration	of	the	sample.	Generally,	it	could	be	observed	that	Atg9	bands	were	hardly	visible	in	samples	from	HisTrap	elution	 fractions.	 This	was	probably	due	 to	 the	KCl	 and	 imidazole	 in	 the	buffer,	 as	 strong	bands	were	seen	in	samples	of	gelfitration	samples	where	KCl	was	replaced	by	NaCl	(lanes	1-5).	 Monomeric	 Atg9	 eluted	 at	 72	 ml	 from	 a	 Superdex	 200	 16/60	 gelfiltration	 column.	However,	 as	 seen	 in	 the	 SDS-PAGE	 image	 the	 majority	 of	 Atg9	 was	 in	 an	 oligomeric	 or	aggregated	state	and	eluted	close	to	the	void	volume.			
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Figure	11:	Purification	of	Atg9core.	His6-Atg9core	was	purified	 from	the	solubilized	membrane	 fraction	(P140).	In	a	first	step	the	protein	was	purified	by	affinity	chromatography	using	a	HisTrap	column	followed	by	size	exclusion	chromatography	on	a	Superdex	200	column.	Gelfiltration	profiles	(280	nm	absorption)	are	shown	on	the	right,	Coomassie-stained	acrylamide	gels	of	protein	samples	are	shown	on	the	left.				
3.1.2.5 Atg13	
Atg13	was	expressed	with	a	N-terminal	MBP-tag	for	better	solubility	and	a	C-terminal	His6-tag,	 both	 of	 them	 cleavable.	 Purification	was	performed	basically	 as	 described	 (Rao	 et	 al.,	2016).	The	fusion	protein	was	bound	to	a	HisTrap,	eluted	with	high	imidazole	and	the	tags	were	cleaved	off.	Due	to	poor	separation	from	contaminations	on	a	size	exclusion	column,	the	sample	was	bound	 to	a	HiTrap	anion	exchange	column.	Atg13	was	eluted	 in	a	125	mM	to	260	mM	NaCl	gradient	over	50	ml	(Figure	12).	Peak	fractions	were	pooled	and	concentrated	by	binding	to	a	HiTrap	anion	exchange	column	followed	by	a	step	elution	with	300	mM	NaCl.			
	
Figure	12:	Purification	of	Atg13.	Anion	exchange	chromatography	of	Atg13	was	performed	as	a	second	purification	step	after	HisTrap	purification.	A	NaCl	gradient	from	125	mM	to	260	mM	was	applied	to	elute	Atg13.	The	anion	exchange	and	profile	(280	nm	absorption)	is	shown	on	the	right,	the	Coomassie-stained	acrylamide	gel	of	protein	samples	is	shown	on	the	left.	
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3.1.2.6 Atg1	
Atg1	was	expressed	using	baculovirus	infection	of	insect	cells	(HighFive)	due	to	the	improved	expression	and	protein	folding.	Atg1	was	purified	basically	as	described,	with	a	N-terminal	MBP-tag	 and	 a	 C-terminal	His6-tag	 (Rao	 et	 al.,	 2016).	 The	 initial	method	 of	 choice	was	 to	induce	expression	by	adding	a	frozen	stock	of	baculovirus	infected	insect	cells	(BIICs)	to	the	cell	culture	(Wasilko	et	al.,	2009).	However,	this	was	not	suitable	for	Atg1	as	the	prolonged	storage	of	BIICs	resulted	in	a	strong	decrease	of	Atg1	expression.	In	order	to	maintain	a	high	yield	the	virus	had	to	be	used	for	Atg1	expression	immediately	after	virus	production.	As	the	virus	 degraded	 quickly	 after	 harvesting,	 the	 time	 required	 to	 perform	 a	 virus	 titer	determination	would	 have	 been	 enough	 to	 decrease	 the	 expression	 of	 Atg1.	 Therefore,	 a	protocol	was	used	that	does	not	rely	on	measuring	the	virus	titer	and	that	allowed	to	directly	add	the	freshly	produced	virus	stock	to	the	expression	culture	(Fitzgerald	et	al.,	2006).	This	way,	high	yield	(around	1	mg	protein	/	liter)	and	purity	were	achieved.	Atg1	was	purified	by	affinity	chromatography	using	a	HisTrap	column.	Both	N-	and	C-terminal	tags	were	cleaved	off.	The	sample	was	then	further	separated	by	gelfiltration	and	it	eluted	at	a	volume	of	64	ml	from	a	Superdex	200	16/60	size	exclusion	column	(Figure	13).					
	
Figure	13:	Purification	of	Atg1.	Atg1	was	purified	on	a	HisTrap	 followed	by	cleavage	of	 the	 tags	and	separation	on	a	Superdex	200	16/60	size	exclusion	column.	The	gelfiltration	profile	(280	nm	absorption)	is	shown	on	the	right,	the	Coomassie-stained	acrylamide	gel	of	protein	samples	is	shown	on	the	left.			 	
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3.2 In	vitro	analysis	of	Atg11-Atg32	interaction	
Atg32	 is	 the	mitochondrial	 cargo	 receptor	 that	 is	 integrated	 into	 the	 outer	mitochondrial	membrane.	In	vivo	studies,	based	on	co-immunoprecipitation	and	yeast	two-hybrid	assays,	suggested	 that	 Atg11	 directly	 interacts	 with	 Atg32	 when	 the	 latter	 is	 phosphorylated	 on	serine	114	(Aoki	et	al.,	2011).	To	confirm	that	both	proteins	indeed	physically	interact,	the	binding	of	purified	recombinant	proteins	was	investigated.			
3.2.1 Requirement	of	Atg9	for	interaction	of	Atg11	with	Atg32	
It	was	not	possible	to	identify	the	formation	of	an	Atg11-Atg32	complex	in	solution	by	size	exclusion	chromatography.	To	test,	whether	the	recruitment	of	the	proteins	to	a	membrane	facilitates	their	interaction,	floatation	assays	with	Atg9	proteoliposomes	were	performed.	For	this,	the	Atg9core	was	reconstituted	into	synthetic	liposomes	to	obtain	Atg9	proteoliposomes.	During	ultracentrifugation	in	a	Histodenz	gradient	these	liposomes	move	to	an	area	of	lower	density	together	with	bound	proteins	while	unbound	proteins	stay	at	the	bottom	of	the	tube	(the	experimental	setup	is	illustrated	in	Figure	14).		Figure	15	shows	a	 floatation	assay	performed	to	evaluate	 the	binding	of	 full-length	Atg11,	Atg11ΔC	and	Atg11Δdim	to	Atg9	proteoliposomes	in	presence	and	absence	of	Atg32SE.	All	three	Atg11	variants	were	co-floating	with	Atg9	proteoliposomes	which	confirms	direct	interaction	with	Atg9	 independently	of	Atg32.	Although	Atg11	coiled-coil	domains	CC1	and	CC2	were	reported	to	be	required	for	interaction	with	Atg9	(Chang	et	al.,	2006),	Atg11Δdim,	which	lacks	CC2,	was	sufficient	to	bind	Atg9	in	vitro.	For	Atg32	some	binding	to	Atg9	proteoliposomes	was	observed	even	in	absence	of	other	factors.	A	similar	amount	of	Atg32	was	co-floating	in				
	
Figure	14:	Illustration	of	a	floatation	assay.	Left:	Liposomes	(red-white	circles)	are	mixed	with	proteins	(green	and	blue)	as	well	as	Histodenz	to	40%	final	concentration	at	the	bottom	of	a	tube	(input	fraction).	A	layer	each	of	30%	Histodenz	and	buffer	is	put	on	top.	Right:	After	ultracentrifugation,	liposomes	float	at	the	30%/0%	interface	together	with	the	bound	proteins	while	unbound	proteins	remain	 in	the	bottom	fraction.		
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Figure	15:	Interaction	of	Atg11	variants	and	Atg32	with	Atg9	proteoliposomes.	Binding	was	assessed	by	 floatation	 and	 subsequent	 SDS-PAGE	 of	 liposome	 fractions.	 All	 Atg11	 variants	 interact	 with	 Atg9	proteoliposomes	independently	of	Atg32.	Atg32	itself	shows	some	binding	to	Atg9	proteoliposomes	(last	lane)	but	the	amount	of	bound	protein	was	increased	in	presence	of	full-length	Atg11.			presence	 of	 both	 truncated	 Atg11	 variants.	 However,	 in	 presence	 of	 full-length	 Atg11	 a	stronger	binding	of	Atg32	was	observed,	consistent	with	previous	studies	that	claim	a	direct	interaction	of	Atg32	with	the	C-terminal	domain	of	Atg11	(Aoki	et	al.,	2011).		Interestingly,	 an	 in	 vivo	 co-immunprecipitation	 experiment	 conducted	 by	 Dr.	 Nena	Matscheko	 showed	 decreased	 levels	 of	 Atg9	 co-precipitating	 with	 Atg11ΔC	 and	 Atg11Δdim	compared	to	full-length	Atg11	(data	not	shown).	While	all	variants	were	co-floating	with	Atg9	proteoliposomes	in	vitro,	the	interaction	with	Atg32	might	be	required	in	vivo	for	efficient	recruitment	of	Atg11	to	the	autophagic	cargo.			
3.2.2 Atg32-dependent	dimerization	of	Atg11	
Atg11	was	reported	to	self-interact	via	its	coiled-coil	domains	CC2	and	CC3	(Yorimitsu	and	Klionsky,	2005).	When	recombinant	Atg11	was	analyzed	by	analytical	ultracentrifugation	by	Dr.	Nena	Matscheko	and	Stefan	Uebel	(MPIB	core	facility),	its	sedimentation	coefficient	was	independent	of	protein	concentration.	This	suggested	that	Atg11	is	present	as	a	monomer	in	solution.	In	contrast,	Atg11ΔC	showed	a	concentration-dependent	sedimentation	coefficient,	which	is	typical	for	an	oligomer.	As	Atg32	interacts	with	the	C-terminal	domain	of	Atg11,	it	was	reasoned	that	the	cargo	receptor	might	induce	dimerization	or	oligomerization	of	Atg11.	
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To	test	this	hypothesis	crosslinking	was	used,	in	order	to	identify	specific	complexes	by	SDS-PAGE.		As	 Atg11ΔC	 was	 observed	 to	 oligomerize	 in	 solution	 it	 was	 used	 to	 establish	 crosslinking	conditions.	 As	 shown	 on	 the	 SDS-PAGE	depicted	 in	 Figure	 16,	 a	 distinct	 band	 of	 150	 kDa	appeared	under	all	 tested	conditions.	This	 corresponds	 to	double	 the	molecular	weight	of	Atg11ΔC	 (77	kDa)	 indicating	 the	specific	 formation	of	an	Atg11ΔC	dimer.	 In	addition,	 larger	structures	 could	 be	 observed	 in	 the	 acrylamide	 gel	 that	 correspond	 to	 oligomers	 and	aggregates.	 However,	 these	 might	 be	 artifacts	 due	 to	 excessive	 crosslinking	 by	glutaraldehyde.	Considering	 the	elution	volume	of	Atg11ΔC	 from	the	size	exclusion	column	(see	paragraph	3.1.2.1),	these	results	suggest	that	Atg11ΔC	forms	dimers	in	solution.		Next,	crosslinking	was	performed	with	full-length	Atg11	in	presence	and	absence	of	Atg32SE.	Furthermore,	 a	 mix	 of	 Atg11,	 Atg32SE	 and	 Atg9	 proteoliposomes	 was	 treated	 with	glutaraldehyde	 due	 to	 the	 Atg11-Atg32	 interaction	 observed	 by	 floatation.	 However,	incubation	with	 glutaraldehyde	 either	 had	 no	 effect	 at	 lower	 concentrations	 or	 led	 to	 the	extensive	 formation	 of	 aggregates,	 but	 not	 a	 distinct	 complex,	 at	 higher	 concentrations	(Figure	17).				
	
Figure	16:	 Crosslinking	 of	 Atg11ΔC.	 Purified	 Atg11ΔC	 (molecular	 weight	 of	 77	 kDa)	 was	 mixed	 with	glutaraldehyde	in	different	concentrations	for	two	different	incubation	times	and	analyzed	by	SDS-PAGE	and	Coomassie	staining.	Besides	larger	crosslinked	complexes	at	the	top	of	the	gel	there	was	a	distinct	band	of	about	150	kDa	corresponding	to	an	Atg11ΔC	dimer.	Thus,	truncation	of	Atg11	results	 in	dimerization	without	the	requirement	for	additional	factors.				
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Figure	17:	Glutaraldehyde	crosslinking	of	full-length	Atg11.	Atg11	was	incubated	with	Atg9	proteo-liposomes	and	mixed	with	different	concentrations	of	glutaraldehyde	in	presence	or	absence	of	Atg32SE.	Samples	were	analyzed	by	SDS-PAGE	and	Coomassie	staining.			Therefore,	 another	 crosslinker,	 Sulfo-LC-SDA,	 was	 used.	 This	 compound	 is	 a	heterobifunctional	 crosslinker.	 The	 N-hydroxysuccinimide	 (NHS)	 ester	 group	 reacts	 with	primary	amines	while	the	diazirine	group,	upon	induction	by	UV	light,	reacts	with	any	amino	acid	side	chain	or	the	peptide	backbone.	Upon	incubation	with	one	specific	protein,	unreacted	crosslinker	was	removed	before	addition	of	other	proteins,	followed	by	exposure	to	UV	light.	Thus,	this	system	allows	a	better	control	as	crosslinking	events	are	restricted	to	the	vicinity	of	 a	 specific	 protein.	 First,	 the	 initial	 crosslinking	 step	was	 carried	 out	with	Atg11	 before	Atg32SE	was	added.	However,	only	the	formation	of	aggregates	but	no	distinct	complex	was	observed.	This	was	 likely	due	 to	 the	 tendency	of	Atg11	 to	 form	aggregates	 in	 solution.	To	overcome	 this	 problem,	 the	 crosslinker	 was	 first	 added	 to	 Atg32SE	 and	 crosslinking	 was	induced	in	presence	of	unlabeled	Atg11.	Indeed,	a	distinct	band	could	be	observed	upon	UV	exposure	 of	 the	 mixture	 but	 not	 for	 Atg11	 or	 Atg32SE	 alone,	 indicating	 specific	 complex	formation	between	Atg32	and	Atg11	(Figure	18A).	The	samples	of	the	cross-linked	complex	were	re-applied	to	a	7%	acrylamide	gel	 for	better	resolution	 in	 the	high	molecular	weight	region	(Figure	18B).	Besides	confirming	the	presence	of	a	prominent	complex	band	upon	UV	light	exposure,	a	weaker	band	of	lower	molecular	weight	was	detectable	as	well.	This	might	correspond	 to	 a	 complex	 with	 a	 different	 subunit	 combination.	 To	 estimate	 the	 possible	complex	compositions,	the	approximate	size	of	the	complex	was	calculated	from	the	running	distance	in	the	acrylamide	gel.	The	running	distance	of	the	marker	bands	was	used	to	fit	a	logarithmic	trendline	(Figure	19).	This	gave	a	calculated	mass	of	340	kDa	for	 the	stronger	band	and	294	kDa	for	the	weaker	band	(compare	Table	6).	Table	6	further	lists	the	theoretical	masses	of	possible	Atg11-Atg32	complexes.	The	estimated	size	of	the	larger	complex	roughly	corresponds	 to	 two	 Atg11	 and	 two	 Atg32SE	molecules.	 This	 suggests	 that	 Atg32SE	 indeed	induces	the	dimerization	of	Atg11.	
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Figure	18:	 Crosslinking	of	Atg11	and	Atg32.	(A)	Atg32SE	was	labelled	with	LC-SDA	before	incubation	with	Atg11.	Samples	were	exposed	to	UV	light	for	up	to	15	min.	Specific	bands	emerged	after	UV	exposure	of	a	mix	of	both	protein.	Crosslinked	and	control	samples	were	run	on	a	pre-cast	4-12%	Bis-Tris	gradient	gel.	(B)	Crosslinked	samples	from	Fig.	B	were	run	on	a	7%	acrylamide	gel	for	better	separation	in	the	high	molecular	 weight	 region,	 revealing	 a	 second,	 weaker	 complex	 band.	 The	 gel	 was	 used	 for	 the	 size	estimation	of	the	cross-linked	complexes	(Figure	19	and	Table	6).							
	
Figure	19:	Size	estimation	of	crosslinked	complexes.	A	logarithmic	trendline	was	fitted	to	the	running	distance	of	the	marker	bands	(circles).	This	was	used	to	calculate	the	molecular	weight	of	the	crosslinked	complexes	visible	as	a	strong	and	a	weak	band	(square	and	diamond,	respectively)	in	Figure	18B.	Values	are	given	in	Table	6.		
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Table	6:	Size	estimation	of	crosslinked	complexes.	The	molecular	weight	of	the	crosslinked	complexes	was	calculated	from	the	running	distance	as	shown	in	Figure	19.	The	complex	most	likely	contains	an	Atg11	dimer	with	either	one	or	two	Atg32	molecules.		
Sample	 Calculated	mass	Strong	band	 340	kDa	Weak	band	 294	kDa	Atg11	band	 152	kDa		 	
Complex	combinations	 Theoretical	mass	Atg11	 135	kDa	Atg32	 42	kDa	Atg11	+	Atg32	 177	kDa	Atg11	+	2x	Atg32	 219	kDa	2x	Atg11	+	Atg32	 312	kDa	2x	Atg11	+	2x	Atg32	 354	kDa			To	 further	 verify	 that	 the	 crosslinked	 complex	 contained	 both,	 Atg11	 and	 Atg32SE,	 mass	spectrometry	was	performed.	Bands	were	cut	out	 from	the	acrylamide	gel	as	 indicated	by	colored	boxes	in	Figure	20.	Proteins	were	digested,	extracted	from	the	gel	and	analyzed	by	mass	spectrometry.	The	measurement	and	the	data	analysis	were	carried	out	by	Christian	Malosse	and	Julia	Chamot-Rooke	at	 the	UTechS	MSBio	core	 facility	at	 Institut	Pasteur.	The	number	of	peptides	corresponding	to	Atg11	and	Atg32	as	well	as	the	sequence	coverage	are	indicated	in	Figure	20.	As	expected,	only	Atg11	(yellow)	or	Atg32	(blue)	were	identified	in	the	single	protein	controls.	In	the	sample	of	the	protein	band	emerging	after	crosslinking	(red)	both	proteins	were	detectable,	indicating	that	they	indeed	are	forming	a	complex.	The	sample	taken	prior	to	UV	light	exposure	served	a	negative	control	(green	box)	but	Atg11	and	Atg32	were	 detectable	 as	well.	 This	might	 be	 due	 to	 contaminations	 or	 crosslinking	 events	 that	happened	without	 additional	 activation	 by	 UV	 light.	 However,	 the	 number	 of	 peptides	 of	Atg11	and	Atg32	was	significantly	higher	after	UV	exposure,	confirming	they	both	participate	in	complex	formation.				
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Figure	20:	 Results	 of	 mass	 spectrometry	 analysis	 of	 crosslinking	 experiment.	 Proteins	 were	extracted	from	gel	slices.	Bands	from	the	gel	already	shown	in	Figure	18A	were	cut	out	(as	indicated	by	colored	boxes)	and	analyzed	by	mass	spectrometry.	The	number	of	peptides	for	both,	Atg11	and	Atg32,	was	 increased	 upon	 UV	 exposure	 (red	 box)	 as	 compared	 to	 the	 unexposed	 sample	 (green	 box).	 This	confirms	that	the	cross-linked	species	contains	Atg11	and	Atg32.				
3.2.3 Atg11	dimerization	leads	to	tethering	of	Atg9	proteoliposomes		
Atg11	 is	a	monomer	 in	solution	but	dimerizes	upon	 interaction	with	Atg32SE.	Futhermore,	Atg11	strongly	binds	to	Atg9	proteoliposomes.	This	raised	the	question	whether	Atg11	can	tether	Atg9	proteoliposomes	upon	dimer	formation,	as	observed	for	Atg17	homodimers.		To	 test	 the	 effects	 of	 Atg11	 on	 Atg9	 proteoliposomes	 their	 hydrodynamic	 radius	 was	measured	 by	 dynamic	 light	 scattering	 (DLS).	 This	 method	 had	 been	 used	 previously	 to	investigate	liposome	tethering	by	Atg17	(Rao	et	al.,	2016).	Figure	21	shows	the	hydrodynamic	radii	of	Atg9	proteoliposomes	and	protein-free	SUVs	 in	presence	of	 the	 indicated	proteins	(measurements	where	 conducted	 by	 Dr.	 Yijian	 Rao).	 SUVs	 had	 a	 hydrodynamic	 radius	 of	approximately	50	to	60	nm,	independently	of	the	added	proteins	(black	columns).	In	absence	of	 any	 additional	 protein,	 Atg9	 proteoliposomes	 tend	 to	 cluster.	 Due	 to	 this	 polydisperse	solution	it	was	not	possible	to	measure	the	hydrodynamic	radius	(Figure	21A).	The	addition	of	the	tether	Atg17	resulted	in	a	monodisperse	signal	with	a	hydrodynamic	radius	of	about	130	nm.	Thus,	the	tethering	function	of	Atg17	leads	to	an	approximately	two-fold	increase	in	the	size	of	the	liposomes.	A	similar	result	was	obtained	for	Atg11ΔC,	while	in	presence	of	full-length	Atg11	the	size	of	the	Atg9	proteoliposomes	was	comparable	to	SUVs.	As	Atg11ΔC	is,	like	Atg17,	a	constitutive	dimer	but	full-length	Atg11	is	a	monomer	in	solution,	dimerization	of	Atg11	might	be	required	for	the	increase	in	the	hydrodynamic	radius.	
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Figure	 21:	 Dynamic	 light	 scattering	 to	 determine	 tethering.	 Atg9	 proteoliposomes	 or	 protein-free	liposomes	were	co-sonicated	with	the	indicated	proteins	and	their	hydrodynamic	radius	was	measured	by	DLS.	 (A)	Full	 length	Atg11	does	not	 tether	Atg9	proteoliposomes.	However,	 the	Atg11ΔC	variant	 tethers	vesicles	 in	a	similar	 fashion	as	Atg17.	(B)	Atg11	is	able	to	tether	Atg9	proteoliposomes	when	the	cargo	receptor	Atg32	is	present.		nd:	 In	absence	of	a	tethering	factor	Atg9	proteoliposome	tend	to	cluster	and	no	monodisperse	signal	 is	detectable.	DLS	measurements	were	conducted	by	Dr.	Yijian	Rao.			To	test	whether	a	similar	effect	can	be	achieved	with	an	Atg11-Atg32	complex,	Atg32SE	was	added	 to	 the	 sample	 (Figure	21B).	 Indeed,	 presence	of	Atg32SE	 significantly	 increased	 the	hydrodynamic	 radius	 of	 Atg9	 proteoliposomes	 as	 compared	 to	 Atg11	 alone.	 This	 is	 in	agreement	with	the	observed	induction	of	Atg11	dimerization	by	Atg32SE.		Even	 though	 the	 changes	 in	 radii	 resembled	 the	observations	made	previously	 for	Atg17-dependent	tethering,	other	possible	effects	could	not	be	ruled	out.	The	increase	in	size	could	also	be	explained	by	fusion	of	the	liposomes	or	the	assembly	of	elongated	Atg11	dimers	on	the	liposomes.	In	order	to	identify	the	function	of	Atg11	dimers	cryo-electron	microscopy	was	performed.	 Figure	 22	 shows	 cryo-EM	 images	 of	 Atg9	 proteoliposomes	 that	 where	 either	incubated	with	 Atg11	 or	with	 both,	 Atg11	 and	Atg32SE.	When	Atg32SE	was	 present	 in	 the	sample	 (right	 panel)	 tethering	 events	 could	 be	 observed	 that	 resulted	 in	 membrane	deformation	 (indicated	 by	 white	 arrow	 heads).	 Membranes	 of	 adjacent	 liposomes	 were	flattened	and	forming	tight	contacts	of	about	25	nm	on	average	in	size.	This	is	remarkable,	as	such	 membrane	 deformations	 are	 energetically	 unfavorable	 and	 cannot	 be	 explained	 by	unspecific	effects.	Furthermore,	cryo-EM	revealed	that	 in	each	case	the	 lipid	bilayers	were	still	separated	and	no	fusion	of	the	liposomes	was	induced.	When	only	Atg11	was	present	in	the	 sample,	 Atg9	 proteoliposomes	were	mostly	 dispersed	 (left	 panel).	While	 some	 of	 the	liposomes	 came	 into	 close	 proximity	 to	 each	 other,	 no	 tight	 tethering	 could	 be	 observed.	
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Therefore,	 these	results	support	 the	model	 that	Atg11	specifically	and	tightly	 tethers	Atg9	proteoliposomes	upon	its	dimerization	when	activated	by	interaction	with	Atg32.								
	
Figure	22:	 Cryo-electron	 microscopy	 imaging	 of	 Atg9	 proteoliposome	 tethering.	 Atg9	proteoliposomes	were	co-sonicated	with	Atg11,	frozen	in	liquid	ethane	and	imaged	by	cryo-EM.	Images	show	 single	 liposomes	without	 specific	 tethering	 events	 (left	 panel).	 However,	 in	 presence	 of	 Atg32SE,	tethering	 of	 liposomes	 was	 observed	 (right	 panel).	 The	 resulting	 tethering	 was	 very	 tight	 leading	 to	membrane	deformation	and	the	formation	of	large	contact	areas	(marked	with	white	arrow	heads).			 	
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3.3 Atg11	and	Atg17	compete	for	liposome	binding	
In	vitro	experiments	confirmed	that	Atg11	as	well	as	Atg17	bind	to	Atg9	proteoliposomes.	Furthermore,	 both	 proteins	 share	 a	 similar	 mode	 of	 action	 by	 tethering	 these	 liposomes	through	 dimer	 formation.	 However,	 it	 was	 unclear	 how	 their	 binding	 to	 Atg9	 vesicles	 is	influence	by	each	other.	To	address	this	question	a	floatation-based	competition	assay	was	established.	Atg9	proteoliposomes	were	 incubated	with	Atg11	 followed	by	 the	addition	of	increasing	amounts	of	Atg17	(from	equimolar	amounts	to	a	50-times	excess).	Protein	binding	was	then	assessed	by	a	floatation	assay	were	and	subsequent	SDS-PAGE	(see	Figure	23A).	For	statistical	 analysis,	 the	 amount	 of	 protein	 co-floating	 with	 Atg9	 proteoliposomes	 was	determined	from	the	measured	band	intensities	and	the	known	protein	amounts	in	the	“1:1”	input	 sample	 (9	 pmol	 Atg11,	 14	 pmol	 Atg9	 and	 9	 pmol	 Atg17).	 To	 correct	 for	 different	liposome	concentrations	in	the	floatation	fractions,	Atg11	and	Atg17	amounts	were	corrected	by	 the	 amount	 of	 Atg9	 in	 each	 sample	 relative	 to	 the	Atg9	 amount	 in	 the	 “1:0”	 floatation	fraction.	The	quantification	result	is	presented	in	Figure	23B.	When	the	same	molar	amount	of	both	proteins	was	present	in	the	input,	the	floatation	fraction	contained	16	pmol	of	Atg11	but	only	3	pmol	of	Atg17	 (sample	 “1:1”).	This	 indicates	a	 strong	binding	of	Atg11	 to	Atg9	compared	to	Atg17.	Atg17	amounts	in	the	floatation	fractions	increased	with	the	amount	of	Atg17	 in	 the	 input	 (10	 pmol	 co-floating	 Atg17	 at	 a	 50-times	 stoichiometric	 excess	 in	 the	input).	In	contrast,	Atg11	amounts	declined	to	7	pmol	in	the	1:50	sample.	Still,	a	25-fold	excess	of	 Atg17	 was	 required	 to	 achieve	 binding	 of	 similar	 amounts	 of	 Atg11	 and	 Atg17.	Interestingly,	the	sum	of	the	molar	amounts	of	both	proteins	remained	almost	constant	over	all	 ratios	 tested,	 with	 an	 estimated	 Atg9	 saturation	 of	 65%	 (Figure	 23C).	 This	 takes	 into	account	that	only	half	of	the	Atg9	molecules	are	inserted	correctly	with	the	cytoplasmic	side	exposed	to	the	buffer,	while	the	others	are	inverted	with	the	cytoplasmic	side	facing	to	the	liposome	lumen.	The	constant	saturation	suggests	that	Atg11	and	Atg17	both	compete	for	the	same	or	at	least	overlapping	Atg9	binding	sites.	The	results	further	confirm	the	high	affinity	of	Atg11	to	Atg9	and	the	requirement	 for	a	high	stoichiometric	excess	of	Atg17	to	replace	Atg11.	However,	similar	expression	levels	were	reported	for	Atg11	and	Atg17	in	vivo	(Kulak	et	al.,	2014).	Thus,	under	physiological	conditions	most	Atg9	vesicles	might	be	sequestered	by	 Atg11.	 Upon	 starvation	 additional	 regulatory	 mechanisms	 would	 then	 be	 required	 to	facilitate	the	replacement	of	Atg11	by	Atg17.		
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Figure	23:	 Competition	for	Atg9	proteoliposome	binding.	Atg11	bound	to	Atg9	proteoliposomes	can	be	replaced	by	Atg17.	(A)	Coomassie-stained	polyacrylamide	gel	showing	the	result	of	a	floatation	assay.	Atg17	was	added	 to	Atg11-bound	Atg9	proteoliposomes	 in	up	 to	50-times	molar	excess.	The	 liposome	fractions	after	floatation	showed	increased	binding	of	Atg17	with	increased	amounts	in	the	input,	while	the	amount	of	bound	Atg11	was	decreasing.	(B)	Molar	amount	of	bound	Atg11	(black)	and	Atg17	(grey)	calculated	from	quantified	band	intensities.	(C)	The	total	amount	of	bound	protein	is	independent	of	the	amount	of	added	Atg17.	On	average,	Atg9	was	saturated	to	65%	without	significant	changes	between	the	different	ratios.			 	
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3.4 The	role	of	Atg29	phosphorylation	in	autophagy	initiation	
Atg29	was	reported	to	be	phosphorylated	upon	starvation	by	a	yet	uncharacterized	kinase.	Furthermore,	Atg11	was	demonstrated	to	co-immunoprecipitate	with	Atg29	from	lysates	of	starved	cells	but	not	with	an	Atg29	mutant	where	all	phosphorylation	sites	were	changed	to	alanine	 (23STA).	 Atg2923STA	 also	 exhibited	 a	 significant	 decrease	 in	 autophagic	 flux,	suggesting	the	requirement	of	interaction	between	Atg29	and	Atg11	to	initiate	non-selective	autophagy.	The	mutation	of	only	three	residues	close	to	the	C-terminus,	serines	197,	199	and	201	(Atg293SA),	resulted	in	a	higher	autophagic	activity	yet	less	than	a	mutation	of	the	20	other	residues	(Atg2920STA).	This	indicated	the	importance	of	the	C-terminal	serines	in	autophagy	(Mao	et	al.,	2013).	In	order	to	avoid	excessive	modification	of	Atg29,	only	mutations	of	serines	197,	 199	 and	 201	 were	 considered	 in	 this	 thesis.	 These	 three	 residues	 were	mutated	 to	aspartate	 to	generate	a	phosphomimetic	mutant	 (Atg29SD).	Under	nutrient-rich	conditions	the	co-localization	of	fluorescent	labelled	Atg17	and	Atg9	in	living	yeast	cells	was	significantly	increased	in	presence	of	Atg29SD	compared	to	wild-type	Atg29	(experiment	conducted	by	Dr.	Nena	Matscheko;	data	not	shown).	This	indicated	that	phosphorylation	of	Atg29	might	drive	the	 recruitment	of	Atg17	 to	Atg9	vesicles.	To	 further	 investigate	 the	 interactions	between	Atg9,	Atg11	and	subunits	of	the	Atg1	kinase	complex,	these	components	were	reconstituted	in	vitro.			
3.4.1 Differences	in	the	stability	of	the	Atg17TC	and	Atg17TC,SD	complex	
In	order	to	purify	the	wild-type	(Atg17-Atg31-Atg29	or	Atg17TC)	and	mutant	(Atg17-Atg31-Atg29SD	or	Atg17TC,SD)	 trimeric	 complexes	 for	 subsequent	 in	vitro	 experiments,	His-tagged	Atg17	 was	 co-expressed	 with	 Atg31	 and	 wild-type	 or	 mutant	 Atg29.	 After	 affinity	chromatography,	Atg17TC	eluted	as	a	single	peak	from	the	size	exclusion	column,	indicating	the	formation	of	a	stable	complex.	However,	for	the	mutant	only	Atg17	was	recovered	from	the	 Ni-NTA	 resin	 while	 Atg31	 and	 Atg29SD	 remained	 in	 the	 flow-through	 and	 the	 wash	fractions.	This	indicates	that	the	phosphorylation	of	Atg29	might	have	a	direct	effect	on	the	stability	of	the	trimeric	complex.	However,	it	does	not	influence	the	interaction	with	Atg31	as	both,	 the	 wild-type	 and	 mutant	 Atg31-Atg29	 complex,	 could	 be	 purified	 without	 any	difference.		To	 further	characterize	 the	 trimeric	complex	 formation,	Atg17	and	Atg31-Atg29	or	Atg31-Atg29SD	 were	 purified	 separately,	 reconstituted	 and	 purified	 by	 size	 exclusion	chromatography	on	a	Superdex	200	10/300	column.	Under	these	conditions	both,	wild-type	and	mutant	trimeric	complex,	formed	and	eluted	at	a	volume	of	14.7	ml	(Figure	24A).		
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Figure	24:	Stability	of	the	trimeric	complex	in	respect	to	Atg29	phosphorylation.	(A)	Size	exclusion	chromatography	reveals	that	incubation	of	Atg17	with	both,	Atg31-Atg29	(black)	and	Atg31-Atg29SD	(grey)	results	in	incomplete	complex	formation.	(B)	The	isolated	complexes	showed	comparable	stability	when	re-applied	 to	 SEC,	 independent	 of	wild-type	 or	mutant	 Atg29.	 (C)	DSF	measurement	 to	 determine	 the	melting	temperature.	Atg17	was	incubated	with	Atg31-Atg29	or	Atg31-Atg29SD	in	a	1:1	molar	ratio.	Top:	Intrinsic	fluorescence	given	as	350	nm	to	330	nm	ratio.	Bottom:	First	derivative	of	the	fluorescence	curve	with	 the	 maximum	 giving	 the	 melting	 temperature.	 (D)	 The	 graph	 displays	 the	 difference	 in	 melting	temperatures	between	wild-type	and	mutant	(TMWT	–	TMSD).	The	TM	of	the	wild-type	trimeric	complex	was	significantly	higher	for	all	protein	ratios	and	salt	concentrations	tested	compared	to	the	mutant	(second	to	fifth	 column).	 In	 contrast,	without	 Atg17	 the	 TM	 of	wild-type	Atg31-Atg29	was	 lower	 than	 the	mutant	complex	indicating	a	specific	effect	of	the	mutation	on	trimeric	complex	formation.			Moreover,	 complex	 formation	 was	 incomplete	 independently	 of	 the	 Atg29	 variant	 as	additionally	elution	of	the	subunits	was	observed.	When	the	fractions	containing	the	trimeric	complex	were	re-applied	to	size	exclusion	chromatography	no	dissociation	could	be	observed	(Figure	 24B).	 Thus,	 even	 though	 the	 conditions	 during	 co-expression	 or	 affinity	chromatography	disassembled	Atg17TC,SD,	Atg29SD	is	still	able	to	form	a	trimeric	complex.		To	test	whether	Atg29SD	indeed	destabilizes	the	trimeric	complex	the	stability	of	Atg17TC	and	Atg17TC,SD	were	analyzed	by	differential	 scanning	 fluorimetry	 (DSF).	This	method	uses	 the	intrinsic	tryptophan	fluorescence	of	proteins	that	changes	depending	on	the	environment	of	
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the	amino	acid.	Thus,	protein	unfolding	can	be	recorded	as	an	increase	in	the	ratio	of	350	nm	to	330	nm	 fluorescence.	 Figure	24C	 shows	 the	 fluorescence	 ratio	 for	 an	 equimolar	mix	of	Atg17	with	Atg31-Atg29	(black)	or	Atg31-Atg29SD	(grey)	at	increasing	temperatures	(upper	graph).	The	inflection	point,	determined	from	the	maximum	of	the	first	derivative	as	shown	in	 the	 lower	 graph,	 corresponds	 to	 the	 melting	 temperature	 and	 can	 be	 used	 as	 a	measurement	for	complex	stability.	Indeed,	the	melting	temperature	was	significantly	lower	in	 the	 presence	 of	 Atg29SD.	 This	 shift	 was	 observed	 at	 different	 salt	 concentrations	 and	different	 ratios	 between	 Atg17	 and	 Atg31-Atg29.	 As	 shown	 in	 Figure	 24D,	 the	 melting	temperature	of	 the	wild-type	 complex	was	between	0.4	and	0.7°C	higher	 than	 the	mutant	complex.	 To	 exclude	 that	 this	 temperature	 difference	 was	 caused	 by	 a	 change	 in	 Atg29	stability	 due	 to	 the	 mutation,	 Atg31-Atg29	 and	 Atg31-Atg29SD	 were	 tested	 in	 absence	 of	Atg17.	 In	 contrast	 to	 the	 trimeric	 complex	 the	 melting	 temperature	 of	 Atg31-Atg29	 was	slightly	 decreased	 compared	 to	 Atg31-Atg29SD	 (Figure	 24D).	 This	 suggests	 that	 the	phosphomimetic	mutation	of	Atg29	specifically	influences	the	interaction	of	Atg17	with	the	Atg31-Atg29	subcomplex.				 	
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3.4.2 Atg29	phosphorylation	has	no	effect	on	interaction	with	Atg9	or	Atg11	
In	order	to	test	the	direct	interactions	of	Atg29	and	its	phosphomimetic	variant	with	Atg9	and	Atg11	floatation	assays	were	performed.	Atg29	and	Atg29SD	were	purified	as	subcomplexes	with	 Atg31	 to	 ensure	 their	 stability	 and	 solubility.	 SDS-PAGE	 of	 the	 floatation	 fractions	showed	binding	of	both	subcomplexes	to	Atg9	proteoliposomes	(Figure	25).	This	interaction	was	specific	to	Atg9	as	no	protein	was	co-floating	with	protein-free	SUVs.	Furthermore,	the	band	 intensities	 of	 Atg29	 and	 Atg31	were	 comparable	 in	 both,	 the	wild-type	 and	mutant	sample,	indicating	that	interaction	with	Atg9	is	independent	of	the	phosphorylation	state	of	Atg29.	Next,	Atg9	proteoliposomes	were	pre-incubated	with	Atg11	to	test	interaction	of	the	subcomplexes	with	Atg11.	However,	while	 large	 amounts	 of	Atg11	were	 recovered	 in	 the	floatation	 fraction,	 there	 was	 no	 significant	 increase	 in	 Atg31-Atg29	 and	 Atg31-Atg29SD	compared	to	the	Atg11-free	samples.	This	suggests	that	there	is	no	direct	interaction	of	wild-type	or	mutant	Atg29	with	Atg11,	at	least	when	bound	to	Atg9	proteoliposomes.	Interestingly,	Atg11	in	solution	in	absence	of	Atg9	proteoliposomes	and	Atg31	could	be	co-precipitated	with	GST-tagged	Atg29	and	Atg29SD	(assay	conducted	by	Dr.	Yijian	Rao;	data	not	shown).	However,	even	though	interaction	was	observed	in	this	experimental	setup	it	was	not	influenced	by	the	Atg29	mutation	 as	 well.	 Thus,	 the	 Atg29SD	 mutant	 is	 not	 sufficient	 to	 induce	 or	 increase	interaction	with	Atg11.				
	
Figure	25:	 Effects	of	Atg29	phosphorylation	on	protein-protein	interactions.	Binding	of	Atg31-Atg29	was	assessed	by	floatation	assays	followed	by	SDS-PAGE	and	Coomassie	staining.	Atg31-Atg29	as	well	as	the	 phosphomimetic	 mutant	 (Atg31-Atg29SD)	 were	 incubated	 with	 protein-free	 SUVs	 or	 Atg9	proteoliposomes	 (Atg9-PL).	 There	 is	 specific	 binding	 to	 Atg9-PLs	 but	 not	 to	 SUVs;	 however,	 without	significant	difference	between	wildtype	and	mutant.	While	Atg11	bound	strongly	 to	Atg9-PLs	(last	 two	lanes)	it	did	not	increase	recruitment	of	Atg31-Atg29.			
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3.4.3 Atg29	phosphorylation	does	not	alter	Atg17	binding	to	Atg9	proteoliposomes	
The	phosphomimetic	mutation	of	Atg29	did	not	change	the	recruitment	of	the	Atg31-Atg29	subcomplex	to	Atg9	proteoliposomes.	However,	Atg31-Atg29	forms	a	constitutive	complex	with	Atg17	in	vivo	and	the	mutation	decreased	the	stability	of	this	complex	in	solution.	Thus,	floatation	 assays	 were	 used	 to	 investigate	 the	 binding	 of	 Atg17TC	 and	 Atg17TC,SD	 to	 Atg9	proteoliposomes	and	Atg11.	The	 trimeric	complexes	were	purified	by	 incubation	of	Atg17	with	Atg31-Atg29	or	Atg31-Atg29SD	followed	by	size	exclusion	chromatography.	As	shown	in	Figure	26	the	amount	of	Atg17	recovered	in	the	floatation	fraction	of	the	wild-type	sample	was	significantly	lower	than	that	of	Atg11.	This	is	in	agreement	with	the	competition	assay	between	Atg11	and	Atg17	that	confirmed	a	higher	efficiency	of	Atg11	binding.	However,	the	amount	 of	 co-floating	 Atg11	 and	 Atg17	 in	 presence	 of	 the	 Atg29SD	 mutant	 remained	unchanged	 compared	 to	 the	 wild-type	 sample.	 This	 suggests	 that	 the	 phosphorylation	 of	Atg29	does	not	directly	influence	the	competition	of	Atg11	and	Atg17	for	Atg9	binding	sites.						
	
Figure	26:	Recruitment	of	the	Atg17	trimeric	complex	to	Atg9	proteoliposomes.	Coomassie-stained	acrylamide	gel	of	samples	from	floatation	assay	(input	and	liposome	fraction	after	floatation).	Atg11	binds	strongly	 to	 Atg9	 proteoliposomes	 compared	 to	 the	 Atg17	 trimeric	 complex.	 Also,	 the	 phosphomimetic	Atg29SD	mutant	did	not	influence	the	binding	of	the	trimeric	complex	to	Atg9	proteoliposomes.				 	
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3.4.4 Atg11	might	increase	recruitment	of	the	Atg1	kinase	complex	in	vitro	
The	constitutive	Atg17	trimeric	complex	interacts	with	Atg1	and	Atg13	upon	starvation	to	form	the	fully	active	Atg1	kinase	complex.	Therefore,	it	was	tested	whether	the	starvation-induced	phosphorylation	of	Atg29	 impacts	 the	 recruitment	 of	 the	Atg1	kinase	 complex	 to	Atg9	proteoliposomes.	Atg31-Atg29	or	Atg31-Atg29SD	were	incubated	with	Atg17,	Atg13	and	Atg1	and	the	pentameric	Atg1	kinase	complexes	(Atg1PC,WT	or	Atg1PC,SD)	were	purified	by	size	exclusion	 chromatography.	 The	 complexes	 were	 incubated	 with	 Atg9	 proteoliposomes	 in	presence	or	absence	of	Atg11	and	protein	binding	was	assessed	by	floatation	assays	(Figure	27A).	 As	 observed	 previously	 for	 Atg17TC	 and	 the	 Atg31-Atg29	 subcomplex,	 no	 improved	binding	of	Atg1PC,SD	was	observed	compared	to	wild-type	Atg1PC.	To	better	compare	the	effect	of	Atg11	on	the	recruitment	of	Atg1PC	to	Atg9	proteoliposomes	the	samples	of	the	floatation	fractions	shown	in	Figure	27A	were	analyzed	again	by	SDS-PAGE	in	a	changed	order	(Figure	27B).	While	 the	Atg17	band	 could	not	 be	 clearly	 separated	 from	 the	Atg9	band,	 the	 band	intensities	of	all	other	subunits	of	Atg1PC	were	slightly	increased	in	presence	of	Atg11.	This				
	
Figure	 27:	 Floatation	 assay	 to	 determine	 binding	 of	 the	 Atg1	 kinase	 complex	 (Atg1PC)	 to	 Atg9	
proteoliposomes.	 (A)	 and	 (B)	 Coomassie-stained	 acrylamide	 gel	 of	 samples	 from	 input	 and	 liposome	fractions	after	floatation.	The	pentameric	complex	containing	either	wild-type	Atg29	(Atg1PC)	or	Atg29SD	(Atg1PC,SD)	was	mixed	with	Atg9	proteoliposomes	with	or	without	Atg11.	(B)	Floatation	samples	from	(A)	were	applied	again	to	SDS-PAGE	for	better	comparison	between	samples	with	and	without	Atg11.	Atg11	might	slightly	increase	the	amount	of	bound	protein	while	Atg29SD	did	not	influence	the	recruitment	of	the	complex.		
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effect	has	not	been	observed	for	Atg17TC,	 indicating	that	Atg1	or	Atg13	might	 increase	the	recruitment	of	the	Atg1	kinase	complex	in	an	Atg11-dependent	manner.	This	is	in	agreement	with	a	previous	study	suggesting	a	direct	interaction	of	Atg1	with	Atg11	(Mao	et	al.,	2013).	However,	the	observed	effect	was	very	small.	Furthermore,	under	all	tested	conditions	Atg11	bound	more	efficiently	to	Atg9	proteoliposomes	than	Atg17.	Therefore,	another	mechanism	has	to	exist	that	facilitates	the	binding	of	Atg17	and	the	replacement	of	Atg11	as	a	membrane	tether.		
3.4.5 Atg13	phosphorylation	influences	protein-protein	interactions	
The	 TOR	 kinase	 phosphorylates	 Atg13	 during	 nutrient-rich	 conditions	 but	 is	 deactivated	upon	starvation.	The	resulting	dephosphorylation	of	Atg13	is	required	to	induce	the	assembly	of	 the	Atg1	 kinase	 complex	 and	 thus	 the	 activation	 of	 Atg17-dependent	 tethering	 of	 Atg9	vesicles	(Rao	et	al.,	2016).	However,	during	nutrient-rich	conditions	Atg13	was	reported	to	interact	 with	 Atg11	 (Kamber	 et	 al.,	 2015).	 To	 test	 the	 recruitment	 of	 Atg13	 by	 Atg11,	floatation	assays	were	performed.	When	incubated	with	Atg9	proteoliposomes	in	absence	of	other	factors,	very	weak	binding	of	unphosphorylated	Atg13	was	observed	(Figure	28A).	This	binding	was	strongly	enhanced	in	presence	of	Atg17TC	and	Atg11.	This	was	expected	and	is	consistent	with	previous	studies	that	showed	direct	interaction	of	Atg13	with	Atg17TC	(Rao	et	al.,	2016).	However,	Atg11	alone	is	not	sufficient	to	increase	the	binding	of	Atg13	(Figure	28B).	 To	 test	 the	 possible	 recruitment	 of	 Atg13	by	Atg11	during	 nutrient-rich	 conditions,	Atg13	was	phosphorylated	 in	vitro	by	catalytic	amounts	of	Atg1.	As	 shown	 in	Figure	28A,	phosphorylated	 Atg13	 migrated	 slower	 on	 an	 SDS-PAGE	 gel	 than	 unmodified	 Atg13.	However,	no	phosphorylated	Atg13	was	recovered	in	the	floatation	fractions	independently	of	other	factors.	As	expected,	Atg17TC	is	not	sufficient	to	recruit	Atg13	as	complex	formation	requires	 Atg13	 dephosphorylation.	 However,	 the	 absence	 of	 phosphorylated	Atg13	 in	 the	floatation	fraction	even	in	presence	of	Atg11	indicates	that	there	is	likely	no	direct	interaction	between	Atg11	and	Atg13	during	vegetative	conditions.				
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Figure	28:	 Interaction	 of	 Atg13	with	 Atg9	 proteoliposomes.	The	 binding	 of	 unphosphorylated	 and	phosphorylated	Atg13	to	Atg9	proteoliposomes	was	assessed	by	floatation	assays	followed	by	SDS-PAGE	and	Coomassie	staining.	(A)	Recruitment	of	unphosphorylated	Atg13	to	Atg9	proteoliposomes	is	increased	in	presence	of	Atg11	and	Atg17TC.	However,	after	phosphorylation	of	Atg13	(13-P),	no	recruitment	was	observed.	(B)	Control	experiment	that	showed	weak	binding	of	Atg13	to	Atg9	proteoliposomes	but	not	to	protein-free	 liposomes.	 Atg13	 recruitment	 was	 not	 increased	 in	 presence	 of	 Atg11	 or	 Atg1	 and	 thus	requires	Atg17	for	efficient	binding.				 	
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3.5 Competition	between	Atg11	and	Atg17	in	vivo	
Atg11	binds	more	efficiently	 to	Atg9	proteoliposomes	 than	Atg17	 in	vitro.	This	required	a	high	stoichiometric	excess	of	Atg17	to	replace	Atg11.	However,	similar	levels	of	both	proteins	are	present	in	the	cell	(Kulak	et	al.,	2014).	Interestingly,	a	consistent	decrease	of	Atg11	levels	had	 been	 observed	 in	 lysates	 of	 starved	 cells,	 suggesting	 its	 specific	 degradation	 upon	induction	of	non-selective	autophagy.		
3.5.1 Atg11	is	degraded	upon	starvation	
As	non-selective	autophagy	degrades	bulk	cytoplasm,	 the	observed	decline	 in	Atg11	 levels	could	 be	 caused	 by	 autophagy-dependent	 degradation.	 To	 test	 this	 possibility,	 HA-tagged	Atg11	was	expressed	in	wild-type	and	atg7Δ	cells.	Atg7	allows	the	initiation	of	autophagy	but		
	
Figure	29:	 Atg11	degradation	upon	starvation	in	vivo.	(A)	Western	blot	of	cell	lysates	of	wild-type	and	
atg7Δ	cells	expressing	HA-tagged	Atg11.	Staining	against	the	HA-tag	showed	a	decrease	of	Atg11	protein	levels	in	both	cases.	As	an	internal	loading	control,	the	blot	was	stained	against	Pgk1.	(B)	Band	intensities	from	anti-HA	blots	of	 four	 independent	experiments	were	quantified	and	normalized	against	Pgk1.	The	graph	displays	Atg11	levels	relative	to	non-starved	cells.	There	is	no	significant	difference	between	wild-type	and	mutant	background.		
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blocks	the	expansion	of	the	phagophore.	Atg11	levels	were	determined	by	Western	blotting	of	 lysates	 of	 starved	 and	 non-starved	 cells.	 As	 shown	 in	 Figure	 29A,	 there	 was	 a	 strong	decrease	in	band	intensity	in	both,	wild-type	and	atg7Δ	cells.	The	band	intensities	from	four	independent	experiments	were	quantified	and	normalized	against	the	Pgk1	levels.	Figure	29B	shows	 the	 Atg11	 levels	 relative	 to	 non-starved	 wild-type	 or	 mutant	 cells.	 In	 both	 cases,	approximately	 90%	 of	 Atg11	 was	 degraded	 after	 6	 h	 of	 starvation	 and	 no	 significant	difference	between	wild-type	 and	atg7Δ	 cells	 could	be	observed.	Thus,	Atg11	 is	 degraded	upon	starvation	in	an	autophagy-independent	manner.	To	further	confirm	that	Atg11	is	not	transported	to	the	vacuole	for	degradation,	Atg11	levels	in	the	pep4Δ	strain	were	determined.		
	
Figure	30:	Atg11	degradation	in	pep4Δ	background.	(A)	Western	blot	of	cell	lysates	of	wild-type	and	
pep4Δ	cells	expressing	HA-tagged	Atg11.	Staining	against	the	HA-tag	showed	a	decrease	of	Atg11	protein	levels	in	both	cases.	As	an	internal	loading	control,	the	blot	was	stained	against	Pgk1.	(B)	Band	intensities	from	anti-HA	blots	of	 four	 independent	experiments	were	quantified	and	normalized	against	Pgk1.	The	graph	displays	Atg11	levels	relative	to	non-starved	cells	without	showing	a	significant	difference	between	wild-type	and	mutant.		
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This	mutant	 lacks	 the	vacuolar	protease	Pep4	 that	 is	 required	 for	 the	maturation	of	other	vacuolar	hydrolases	(Woolford	et	al.,	1986).	As	shown	in	Figure	30A,	Atg11	levels	declined	in	both,	wild-type	and	mutant	cells.	The	quantification	of	band	intensities	confirmed	that	there	was	 no	 significant	 difference	 between	 the	 two	 strains	 (Figure	 30B).	 Thus,	 Atg11	 is	 not	degraded	within	the	vacuole.	To	test	whether	the	degradation	is	specific	to	Atg11,	the	protein	levels	of	Atg17	during	starvation	were	determined	as	well	(Figure	31A).	As	shown	in	Figure	31B,	Atg17	levels	did	not	significantly	decline	during	6	h	of	starvation.					
	
Figure	31:	Atg17	protein	levels	during	starvation.	(A)	Protein	levels	of	myc-tagged	Atg17	were	assessed	by	Western	blotting	and	anti-myc	antibody	staining.	As	a	loading	control,	blots	were	stripped	and	stained	with	anti-pgk1	antibody.	(B)	Atg17	band	intensities	from	three	independent	experiments	were	quantified	and	normalized	against	Pgk1	band	intensities.	The	graph	displays	Atg17	levels	relative	to	non-starved	cells.			 	
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3.5.2 Proteasomal	degradation	of	Atg11	during	starvation	
Atg11	 degradation	 was	 found	 to	 be	 independent	 of	 autophagy	 and	 vacuolar	 proteases.	Therefore,	 the	observed	decline	 in	protein	 levels	could	be	the	result	of	degradation	by	the	proteasome.	 To	 test	 this	 hypothesis,	 cells	 were	 treated	 with	 the	 selective	 proteasome	inhibitor	MG132	(Lee	and	Goldberg,	1996).	To	enhance	the	inhibitory	effect,	the	intracellular	concentration	of	this	drug	was	increased	by	the	deletion	of	the	efflux	pump	Pdr5	(Fleming	et	al.,	 2002).	 As	 shown	 in	 Figure	 32A,	 Atg11	 degradation	 was	 blocked	 in	 cells	 treated	 with	MG132	but	not	in	presence	of	DMSO,	which	was	used	as	a	solvent	for	the	drug	and	served	as			
	
Figure	32:	Atg11	degradation	is	blocked	by	inhibition	of	the	proteasome.	(A)	Protein	levels	of	HA-tagged	Atg11	in	non-starved	and	starved	cells	were	determined	by	Western	blots.	Cells	were	either	treated	with	the	proteasome	inhibitor	MG132	or	DMSO,	which	was	used	as	a	solvent	for	the	drug.	(B)	Atg11	band	intensities	 from	 four	 independent	 experiments	 were	 quantified	 and	 normalized	 against	 the	 band	intensities	of	Pgk1.	Intensities	are	given	as	relative	values	with	non-starved	samples	set	to	1.		
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a	control.	The	inhibition	of	Atg11	degradation	by	MG132	was	significant	as	determined	by	the	quantification	of	band	intensities	(Figure	32B).		Proteasomal	degradation	requires	the	ubiquitination	of	the	target	protein.	In	order	to	further	characterize	the	degradation	of	Atg11	by	the	proteasome,	the	levels	of	ubiquitinated	Atg11	were	 examined.	 To	 ensure	 unchanged,	 native	 expression	 levels,	 Atg11	 was	 genomically	tagged	with	a	myc-tag.	Ubiquitinated	proteins	were	immunoprecipitated	from	non-starved	and	 starved	 cell	 lysates	 and	 Atg11	 was	 detected	 by	 Western	 blotting	 using	 anti-myc	antibodies.	As	shown	in	Figure	33A,	Atg11	bands	were	observed	in	the	immunoprecipitated	fraction	of	non-starved	and	starved	cells.	Moreover,	Atg11	specifically	precipitated	with	the	anti-ubiquitin	antibody	but	not	 the	Protein	A	resin	 itself	 (Figure	33A,	 last	 lane).	While	 the	overall	 level	 of	Atg11	decreased	upon	 starvation	 (compare	 input	 in	 Figure	33A),	 a	 strong	increase	 in	 the	 amount	 of	 ubiquitinated	 Atg11	 upon	 starvation	 was	 observed.	 A	 semi-quantitative	analysis	using	the	Atg11	band	intensities	normalized	to	the	Atg11	levels	in	the	input	revealed	a	three-fold	increase	in	Atg11	amounts	precipitated	from	lysates	of	starved	cells	 compared	 to	 non-starved	 cells	 (Figure	 33B).	 In	 non-starved	 cells,	 on	 average	0.019±0.008%	of	the	total	amount	of	Atg11	was	immunoprecipitated.	After	2	h	of	starvation	this	 value	 increased	 to	 0.051±0.010%.	 This	 significant	 increase	 indicates	 that	 Atg11	 is	specifically	 ubiquitinylated	 upon	 starvation.	 Considering	 the	 effect	 of	 MG132	 on	 Atg11	degradation	 these	 results	 strongly	 suggest,	 that	 Atg11	 is	 selectively	 targeted	 by	 the	proteasome	upon	starvation.				
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Figure	33:	 Ubiquitination	of	Atg11	upon	starvation.	(A)	Proteins	were	immunoprecipitated	using	an	anti-ubiquitin	antibody	bound	to	Protein	A	coupled	magnetic	beads.	Samples	were	analyzed	by	Western	blots	stained	against	myc-tag.	Atg11-myc	was	specifically	precipitated.	The	amount	of	bound	protein	was	higher	in	the	starved	sample	despite	the	decreased	amount	in	the	input.	(B)	Bands	from	three	independent	experiments	 were	 quantified.	 The	 graph	 shows	 the	 amount	 of	 immunoprecipitated	 Atg11-myc	 as	percentage	of	the	total	amount	in	the	input.		
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4 Discussion	
Autophagy	 is	 a	highly	 conserved	 recycling	pathway	 that	 engulfs	 cytoplasmic	material	 in	 a	newly	 formed	 double	membrane	 vesicle	 and	 delivers	 it	 to	 the	 lysosome	 for	 degradation.	While	material	 is	 non-selectively	 captured	 as	 a	 response	 to	 nutrient	 deprivation,	 cargo	 is	selectively	 degraded	 during	 nutrient-rich	 conditions	 to	 maintain	 cellular	 homeostasis.	 In	yeast,	a	special	set	of	vesicles	containing	the	transmembrane	protein	Atg9	are	required	for	autophagy.	Upon	starvation	but	not	during	nutrient-rich	conditions,	these	Atg9	vesicles	are	tethered	by	Atg17,	a	subunit	of	the	Atg1	kinase	complex.	Interestingly,	Atg11,	which	has	been	described	as	a	scaffolding	protein,	is	specifically	required	for	selective	autophagy.	However,	the	molecular	 function	of	 this	protein	was	unclear.	 In	this	 thesis	Atg11	was	 identified	as	a	novel	 tethering	factor	 for	Atg9	vesicles,	which	substitutes	 for	the	function	of	Atg17	during	nutrient-rich	conditions.	Furthermore,	the	regulation	of	this	event	by	a	cargo	receptor	could	be	revealed.	Thus,	the	results	presented	in	this	thesis	lead	to	a	new	model	of	autophagosome	biogenesis,	showing	that	a	decision	for	either	the	selective	or	the	non-selective	pathway	is	already	made	during	autophagy	initiation.	In	humans,	the	selective	removal	of,	for	example,	damaged	 organelles	 and	 protein	 aggregates	 serves	 as	 a	 protection	 against	 numerous	pathologies,	 including	 cancer	 and	 neurodegenerative	 diseases.	 However,	 although	 many	yeast	autophagic	proteins	have	human	homologues,	the	initiation	of	autophagy	in	human	cells	is	 poorly	 understood.	 Thus,	 the	mechanistic	 insights	 gained	 from	 the	 yeast	model	 system	might	contribute	to	our	understanding	of	selective	autophagy	in	humans.			
4.1 Atg11	directly	interacts	with	Atg9	vesicles	
Atg11	 had	 been	 identified	 to	 be	 an	 essential	 protein	 for	 selective	 autophagy.	 It	 had	 been	reported	to	bind	the	transmembrane	protein	Atg9	and	subunits	of	the	Atg1	kinase	complex,	as	well	as	to	cargo	receptors	in	vivo	(Chang	et	al.,	2006;	Yorimitsu	and	Klionsky,	2005).	In	order	 to	 investigate	 whether	 these	 are	 direct	 interactions,	 proteins	 were	 purified	 and	reconstituted	 in	 vitro.	 These	 experiments	 confirmed	 that	 Atg11	 binds	 specifically	 and	efficiently	to	Atg9	proteoliposomes	without	the	requirement	for	additional	factors.		Atg11	had	been	reported	previously	to	co-precipitate	with	Protein-A-tagged	Atg9	from	yeast	cell	lysates	(Chang	et	al.,	2006).	In	order	to	test	this	interaction	in	vitro,	a	truncated	version	of	Atg9	comprising	residues	281-779	was	reconstituted	into	liposomes.	Even	though	lacking	large	 portions	 of	 the	 unstructured	 N-	 and	 C-terminal	 regions,	 this	 construct,	 termed	 the	Atg9core,	was	shown	to	be	sufficient	to	bind	the	Atg9	vesicle	tether	Atg17	(Rao	et	al.,	2016).	This	 interaction	 largely	 depended	 on	 the	 conserved	 N-terminal	 helix	 preceding	 the	
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transmembrane	domain	(residues	281-315)	as	well	as	the	central	cytosolic	domain	(residues	424-507).	 In	 vivo,	 deletion	 of	 only	 the	 N-terminal	 helix	 and	 the	 central	 cytosolic	 domain	strongly	 reduced	 the	 amount	 of	 Atg17	 co-precipitating	 with	 Atg9	 from	 yeast	 cell	 lysates,	which	is	thus	in	agreement	with	the	in	vitro	data	(Rao	et	al.,	2016).	Interestingly,	Atg9core	also	interacted	 with	 Atg11.	 Recombinant	 Atg11	 efficiently	 bound	 to	 Atg9	 proteoliposomes	 in	floatation	assays.	This	interaction	was	even	stronger	than	for	Atg17.	Although	equal	molar	amounts	of	Atg11	and	Atg17	were	present	in	the	input,	the	amount	of	Atg11	recovered	from	the	floatation	fraction	was	more	than	five	times	higher	than	that	of	Atg17.	Furthermore,	the	binding	of	Atg11	to	the	proteoliposomes	was	specific	to	Atg9	as	no	Atg11	could	be	recovered	with	protein-free	liposomes.	This	indicates	a	high	similarity	of	Atg11	and	Atg17	in	respect	to	Atg9	interaction.	This	finding	is	also	surprising	as	a	requirement	for	Atg9	residues	154-201	for	interaction	with	Atg11	in	vivo	had	been	reported	previously	(Chang	et	al.,	2006).	However,	the	results	provided	by	Chang	and	colleagues	were	based	on	yeast	two-hybrid	screens	and	co-immunoprecipitation	experiments.	Thus,	the	observations	made	for	the	Δ154-201	variant	could	be	an	indirect	effect,	for	example	by	affecting	the	proper	maturation	of	Atg9	vesicles.	Also,	this	domain	could	have	a	regulatory	role	in	the	recruitment	of	Atg11	to	Atg9	vesicles	in	vivo,	that	is	not	required	for	the	direct	interaction	between	Atg11	and	Atg9	in	vitro.		Furthermore,	the	coiled-coil	domains	CC1	and	CC2	of	Atg11	were	reported	to	be	required	for	its	interaction	with	Atg9	(Chang	et	al.,	2006).	As	expected,	the	Atg11ΔC	variant,	which	contains	both	coiled-coil	domains,	was	efficiently	binding	to	Atg9	proteoliposomes.	Interestingly,	also	the	Atg11Δdim	variant	could	be	recovered	with	Atg9	proteoliposomes	in	the	floatation	fraction	even	though	it	was	lacking	coiled-coil	domain	CC2.	This	suggests	that	the	CC2	domain	is	not	required	for	direct	interaction	between	Atg11	and	Atg9	in	vitro.		Surprisingly,	 co-immunoprecipitation	 experiments	 conducted	 by	 Dr.	 Nena	 Matscheko	showed,	that	the	amounts	of	Atg9	co-precipitating	with	the	Atg11ΔC	and	Atg11Δdim	variants	were	 strongly	decreased	 compared	 to	 full-length	Atg11.	Both	 variants	 lack	 the	C-terminal	domain	that	contains	coiled-coil	domains	CC3	and	CC4.	The	latter	had	been	reported	to	be	the	binding	 region	 for	 cargo	 receptors	 that	 activate	 cargo	 for	 degradation	 by	 autophagy	(Yorimitsu	and	Klionsky,	2005).	Thus,	the	interaction	of	Atg11	with	Atg9	might	require	the	activation	 of	 Atg11	 by	 a	 cargo	 receptor.	 However,	 in	 vitro	 the	 binding	 of	 Atg11	 to	 Atg9	proteoliposomes	 was	 independent	 of	 Atg32.	 Still,	 cargo	 receptors	 might	 facilitate	 the	recruitment	of	Atg11	to	the	site	of	autophagosome	biogenesis	as	a	possible	requirement	for	efficient	interaction	with	Atg9	vesicles.		
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4.2 Atg11	dimerizes	upon	complex	formation	with	Atg32	
Previous	studies	reported	that	Atg11	can	self-interact	in	vivo.	However,	recombinant	Atg11	was	monomeric	in	solution.	In	this	thesis	it	could	be	shown	that	Atg11	directly	interacts	with	the	cargo	receptor	Atg32.	This	 induces	dimerization	of	Atg11,	suggesting	cargo-dependent	activation	of	Atg11.	By	utilizing	yeast	two-hybrid,	fluorescence	microscopy	and	co-immunoprecipitation	assays	the	self-interaction	region	of	Atg11	had	been	mapped	to	two	of	the	four	predicted	the	coiled-coil	 domains,	 CC2	 and	CC3	 (Yorimitsu	 and	Klionsky,	 2005).	 Similar	 results	were	 obtained	from	experiments	conducted	by	Dr.	Nena	Matscheko	utilizing	co-expression	of	two	differently	tagged	Atg11	copies.	Self-interaction	was	assessed	by	 the	co-precipitation	of	different	HA-tagged	Atg11	variants	with	myc-tagged	full-length	Atg11.	Interaction	was	observed	with	full-length	Atg11	as	well	as	with	Atg11ΔC,	which	lacks	the	C-terminal	domain	containing	CC3	and	CC4.	However,	no	co-precipitation	was	observed	 for	Atg11Δdim,	a	N-terminal	 fragment	 that	lacks	all	coiled-coil	domains	but	CC1.	This	suggests	that	Atg11	self-interacts	requires	the	CC2	domain	 but	 not	 CC3	 and	 CC4.	 However,	 analytical	 ultracentifugation	 revealed	 that	recombinant	 Atg11	 is	 monomeric	 in	 solution,	 indicating	 the	 requirement	 for	 additional	factors	 to	 facilitate	 the	 direct	 or	 indirect	 interaction	 between	 two	 Atg11	 molecules.	Interestingly,	in	contrast	to	the	full-length	protein,	recombinant	Atg11ΔC	is	a	dimer	in	solution.	This	suggested	that	there	is	indeed	direct	self-interaction,	yet	this	interaction	is	inhibited	by	the	Atg11	C-terminal	domain.	The	most	C-terminal	coiled-coil	domain	of	Atg11,	CC4,	had	been	reported	to	be	the	binding	region	for	cargo	receptors	(Yorimitsu	and	Klionsky,	2005).	This	raised	the	question,	whether	the	dimerization	of	Atg11	can	be	induced	by	the	binding	of	a	cargo	receptor	like	the	mitochondrial	protein	Atg32.	However,	it	was	not	possible	to	observe	complex	formation	by	methods	like	size	exclusion	chromatography.	This	could	be	due	to	weak	binding	that	results	in	the	disassembly	of	the	complex	upon	the	separation	from	its	subunits.	When	Atg11	was	recruited	to	the	membrane	of	giant	unilamellar	vesicles	(GUVs),	 this	was	sufficient	to	specifically	recruit	Atg32	to	the	membrane	as	well	(data	not	shown;	experiment	conducted	 by	 Dr.	 Nena	 Matscheko).	 Here,	 Atg11	 was	 present	 in	 a	 very	 high	 local	concentration,	which	might	 favor	the	 interaction	with	Atg32.	Moreover,	subunits	were	not	separated,	which	might	have	 increased	complex	 formation.	 In	vivo,	 the	 recruitment	of	 the	different	factors	to	the	PAS	would	result	 in	a	high	local	concentration	of	proteins	and	thus	might	 favor	 the	 interaction	 between	 Atg11	 and	 Atg32	 specifically	 at	 the	 site	 of	autophagosome	biogenesis.		In	order	to	observe	a	direct	interaction	between	Atg11	and	Atg32	as	well	as	possible	changes	in	the	oligomeric	state	of	Atg11,	crosslinking	was	used.	This	allowed	to	stabilize	a	complex	in	
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solution	and	in	absence	of	other	factors	and	membranes	and	to	determine	its	size	by	SDS-PAGE.	However,	commonly	used	crosslinkers	like	glutaraldehyde	resulted	in	the	formation	of	aggregates	but	not	distinct	complexes.	This	might	have	been	caused	by	the	tendency	of	Atg11	to	 aggregate	 over	 time	 in	 solution.	 This	 problem	 could	 be	 solved	 by	 the	 use	 of	 LC-SDA,	 a	hetero-bifunctional	crosslinker,	that	allows	better	control	through	a	two-step	process.	First,	the	crosslinker	was	only	added	to	Atg32	to	allow	the	reaction	of	the	NHS	ester	group	with	primary	amines	of	the	protein.	Only	then	Atg11	was	added	and	crosslinking	was	induced	by	activation	of	the	diazirine	group	with	UV	light.	This	way,	Atg32	could	crosslink	with	proteins	in	 close	proximity	while	 unspecific	 crosslinking	between	Atg11	molecules	was	prevented.	With	this	crosslinker	 it	was	possible	 to	detect	 the	 formation	of	a	distinct	complex	by	SDS-PAGE.	The	crosslinking	of	one	Atg32	with	one	Atg11	molecule	would	result	in	a	complex	of	177	kDa.	However,	no	band	of	such	size	was	observed	by	SDS-PAGE.	Instead,	distinct	bands	of	higher	molecular	weight	were	detected	upon	UV	activation.	The	molecular	weight	of	the	stronger	band	was	estimated	to	be	about	340	kDa	which	corresponds	to	a	complex	of	two	Atg11	and	two	Atg32	molecules.	Mass	spectrometry	analysis	of	this	band	revealed	that	both	proteins	were	present.	Thus,	these	results	strongly	suggest	that	Atg32	directly	interacts	with	Atg11,	thereby	inducing	the	formation	of	Atg11	dimers.	As	Atg11	molecules	should	not	have	been	 able	 to	 crosslink	 each	 other,	 the	 detection	 of	 this	 high	 molecular	 weight	 band	 also	indicated	 that	 Atg32	 has	 crosslinked	 not	 only	 with	 the	 Atg11	 molecule	 it	 was	 directly	interacting	with	but	also	with	the	second	Atg11	molecule.	This	might	be	an	explanation	for	the	presence	of	a	second,	weaker	but	again	specific	band	in	the	acrylamide	gel.	Its	molecular	weight	 corresponds	 to	 approximately	 two	 Atg11	 molecules	 and	 one	 Atg32	 molecule.	Presumably,	Atg11	dimer	formation	was	again	induced	by	two	Atg32	molecules	but	only	one	of	them	might	have	crosslinked	with	the	Atg11	molecules.			
4.3 Atg11	is	a	cargo-activated	membrane	tether	
Atg11	is	a	monomer	in	solution	but	dimerizes	upon	interaction	with	the	cargo	receptor	Atg32.	This	 indicated	 a	 specific	 function	 of	 the	 Atg11	 dimer.	 Using	 in	 vitro	 assays,	 Atg11	 was	identified	as	a	novel	tethering	factor	for	Atg9	vesicles	in	a	cargo	receptor-dependent	manner.		In	vitro	experiments	strongly	supported	the	model	of	Atg11	dimerization	specifically	upon	activation	 by	 a	 cargo	 receptor.	 However,	 the	 function	 provided	 by	 the	 dimer	 formation	remained	unclear.	Recently,	a	Atg17-like	region	was	identified	in	the	N-terminal	domain	of	Atg11	 (Li	 et	 al.,	 2014).	 Furthermore,	 both	 bind	 to	Atg9	 proteoliposomes	 and	 form	homo-dimers.	As	the	dimerization	of	Atg17	is	crucial	for	the	tethering	of	Atg9	proteoliposomes,	it	was	tested	whether	Atg11	dimerization	exhibits	a	similar	 function.	The	tethering	of	Atg17	
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had	been	previously	characterized	using	dynamic	light	scattering	of	Atg9	proteoliposomes.	As	a	consequence	of	tethering,	the	incubation	with	Atg17,	which	constitutively	forms	dimers,	but	not	with	a	monomeric	variant	of	Atg17	led	to	an	increase	of	their	hydrodynamic	radius	(Rao	et	al.,	2016).	The	same	approach	was	used	for	Atg11.	Full-length	Atg11	did	not	increase	the	hydrodynamic	radius	of	Atg9	proteoliposomes,	which	is	in	agreement	with	its	monomeric	state.	 In	 contrast,	Atg11ΔC	 increased	 the	hydrodynamic	 radius	of	Atg9	proteoliposomes	 as	observed	 previously	 for	 Atg17.	 This	 suggested	 that	 Atg11,	 like	 Atg17,	 tethers	 Atg9	proteoliposomes	upon	dimerization.	When	Atg32	was	 co-incubated	with	 full-length	Atg11	and	Atg9	proteoliposomes,	the	hydrodynamic	radius	increased	to	a	similar	level	as	measured	in	 presence	 of	 Atg11ΔC.	 This	 indicated	 that	 the	 cargo	 receptor-dependent	 dimerization	 of	Atg11	leads	to	tethering	of	Atg9	vesicles.		Even	though	the	similarities	to	Atg17	in	the	DLS	measurements	were	striking,	the	increase	in	the	hydrodynamic	radius	cannot	only	be	explained	by	tethering	but	could	as	well	be	the	result	of,	 for	example,	 fusion	or	 the	clustering	of	proteins	 to	 the	 liposome	membrane.	Therefore,	Atg9	proteoliposomes	were	visualized	by	cryo-electron	microscopy.	When	co-incubated	with	Atg11	in	absence	of	Atg32,	some	liposomes	were	observed	in	close	proximity	but	no	specific	tethering	 was	 visible.	 The	 liposomes	 contained	 phosphatidylserine,	 which	 is	 negatively	charged	at	a	neutral	pH	and	would	thus	cause	the	liposomes	to	repulse	each	other.	However,	the	 self-interaction	 of	 Atg9	 overcomes	 this	 repulsion	 and	 leads	 to	 the	 clustering	 of	proteoliposomes.	This	was	the	reason	 for	 the	high	polydispersity	of	Atg9	proteoliposomes	that	 interfered	with	 the	measurement	of	 the	hydrodynamic	radius	by	DLS.	This	clustering	could	be	prevented	by	the	binding	of	Atg11	to	Atg9	resulting	in	a	monodisperse	signal.	Indeed,	the	liposomes	visualized	by	cryo-EM	were	mostly	dispersed	and	did	not	show	any	clustering.	The	observation	that	some	liposomes	were	in	close	proximity	to	each	other	was	presumably	due	to	the	binding	of	Atg11,	which	could	shield	the	negative	charges	of	the	lipids.	However,	as	suggested	by	the	DLS	measurements,	this	effect	is	not	sufficient	for	stable	tethering.	This	was	further	confirmed	by	cryo-EM	of	Atg9	proteoliposomes	that	were	incubated	with	both,	Atg11	and	Atg32.	Specifically	in	presence	of	Atg32	tight	tethering	could	be	detected.	This	was	striking,	as	the	tethering	led	to	membrane	deformations	and	the	generation	of	large	contact	areas	which	does	not	happen	spontaneously.	Comparable	observations	had	so	far	only	been	reported	as	an	intermediate	of	SNARE-mediated	membrane	fusion.	The	use	of	mutant	SNARE	proteins,	 that	allowed	only	 incomplete	zippering	and	were	thus	fusion	incompetent,	 led	to	similar	tight	tethering	events	(Yavuz	et	al.,	2018).	This	strongly	suggests	that	the	dimerization	of	Atg11	upon	interaction	with	Atg32	specifically	induces	the	tethering	of	Atg9	vesicles.	Even	though	 complex	 formation	 induced	 membrane	 deformations	 it	 was	 insufficient	 to	 drive	fusion	of	the	membranes.	In	all	tight	tethering	events	observed	the	two	lipid	bilayers	were	
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intact	and	no	hemifusion	had	occurred.	Hemifusion	would	result	 in	the	fusion	of	the	outer	leaflets	of	the	lipid	bilayer	while	the	inner	leaflets	remain	intact.	This	had	been	reported	as	an	 intermediate	 step	 in	 SNARE-mediated	 fusion	 (Hernandez	 et	 al.,	 2012).	 The	 clear	separation	of	the	lipid	bilayers	of	Atg9	proteoliposomes	thus	indicate	a	role	of	Atg11	in	vesicle	tethering	but	not	fusion.	Instead,	fusion	most	probably	requires	the	presence	of	SNAREs,	as	it	had	been	proposed	previously	(Nair	et	al.,	2011).		Generally,	 the	 finding	 that	 Atg17	 and	 Atg11	 are	 membrane	 tethers	 is	 highly	 interesting.	Despite	 the	different	mode	of	 regulation,	 their	 tethering	 function	 is	very	similar.	Although	they	 clearly	 differ	 from	 other	 known	 membrane	 tethers	 some	 similarities	 can	 be	 found,	especially	 to	 multi-subunit	 tethering	 complexes	 like	 HOPS.	 HOPS	 contains	 two	 different	subunits	that	bind	either	of	the	membranes,	thus	complex	formation	is	required	for	tethering.	Likewise,	 Atg11	 and	 Atg17	 only	 bind	 to	 one	 Atg9	 vesicle	 and	 tether	 only	 upon	 dimer	formation.	HOPS	tethers	membranes	by	binding	the	membrane-anchored,	active	form	of	the	Rab	 GTPase	 Ypt7.	 Rab	 GTPases	 are	 common	 regulators	 of	 membrane	 trafficking	 events	throughout	 the	 cell.	 In	 contrast,	 Atg11	 and	 Atg17	 tether	 membranes	 by	 binding	 to	 the	autophagy-specific	membrane	 protein	 Atg9.	 Generally,	 the	 observed	 tethering	 function	 of	Atg11	 and	 Atg17	 applies	 to	 the	 initiation	 of	 autophagsome	 biogenesis.	 Previous	 studies	reported	 that	 Atg9	 vesicles	 are	 not	 sufficient	 for	 autophagsome	 formation	 and	 additional	membrane	sources,	most	likely	COPII	vesicles	derived	from	the	ER,	are	presumably	required	(Yamamoto	 et	 al.,	 2012).	 Interestingly,	 even	 though	 a	membrane	 tether	 itself,	 Atg17	was	reported	to	interact	with	the	COPII	vesicle	tether	TRAPPIII	and	thus	might	indirectly	aid	in	the	tethering	of	vesicles	other	than	Atg9	vesicles.			
4.4 Atg11	and	Atg17	are	mutually	exclusive	Atg9	vesicle	tethers	
It	could	be	shown	that	both,	Atg11	and	Atg17,	share	a	highly	similar	function	as	they	both	tether	Atg9	proteoliposomes	in	vitro	upon	dimer	formation.	However,	they	differ	in	the	way	they	are	regulated	requiring	either	the	interaction	with	a	cargo	receptor	or	the	starvation-induced	formation	of	the	Atg1	kinase	complex.	In	vitro	assays	revealed	that	Atg11	and	Atg17	are	 competing	 for	 Atg9	 binding	 sites,	 suggesting	 that	 both	 proteins	 tether	 Atg9	 vesicles	independently	from	each	other	to	exclusively	initiate	selective	or	non-selective	autophagy.	It	had	been	reported	previously	that	Atg11	interacts	with	Atg17	based	on	yeast	two-hybrid	screens	(Yorimitsu	and	Klionsky,	2005).	However,	direct	protein-protein	interaction	had	not	been	confirmed.	Using	a	defined	in	vitro	system	with	recombinant	Atg11	and	Atg17	as	well	as	Atg9	proteoliposomes	revealed	no	physical	interaction	between	the	two	tethers.	Instead,	both	proteins	were	competing	for	the	same	or	similar	binding	sites	in	Atg9.	Atg11	was	binding	
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to	Atg9	proteoliposomes	more	efficiently	than	Atg17	but	increasing	amounts	of	Atg17	in	the	input	could	gradually	replace	Atg11	in	the	interaction	with	Atg9	proteoliposomes.	The	total	amount	of	bound	proteins	 remained	constant	 in	all	 tested	conditions,	 indicating	 that	both	tethers	bind	to	the	same	or	overlapping	binding	sites	of	Atg9.		Even	 though	Atg11	 could	 be	 eventually	 outcompeted	 by	Atg17,	 a	 25-fold	molar	 excess	 of	Atg17	 was	 necessary	 to	 substitute	 50%	 of	 the	 Atg11	 molecules	 bound	 to	 Atg9	proteoliposomes.	 However,	 similar	 expression	 levels	 had	 been	 reported	 in	 vivo	 under	growing	conditions	(Kulak	et	al.,	2014).	Yet,	when	equal	molar	amounts	of	Atg11	and	Atg17	were	incubated	with	Atg9	proteoliposomes,	Atg11	made	up	85%	of	the	total	amount	of	bound	proteins.	 This	 suggests	 that	 in	 vivo	 Atg9	 vesicles	might	 be	 largely	 sequestered	 by	 Atg11.	During	nutrient-rich	conditions	Atg17	forms	a	constitutive	complex	with	Atg31-Atg29.	This	trimeric	 complex	 was	 shown	 to	 fully	 inhibit	 the	 tethering	 function	 of	 Atg17	 and	 partly	decrease	the	binding	to	Atg9	(Rao	et	al.,	2016).	Therefore,	the	stronger	interaction	of	Atg11	with	Atg9	might	prevent	the	sequestering	of	a	large	portion	of	Atg9	vesicles	during	nutrient-rich	conditions	by	inactive	Atg17	molecules.		Upon	 induction	 of	 non-selective	 autophagy	 Atg11	 needs	 to	 be	 replaced	 by	 Atg17.	Fluorescence	microscopy	conducted	by	Dr.	Nena	Matscheko	showed	a	decrease	of	Atg11	PAS	localization	upon	starvation	 in	wild-type	but	not	 in	atg17Δ	 cells.	Moreover,	 the	amount	of	Atg9	that	co-precipitated	with	Atg11	upon	starvation	was	increased	in	atg17Δ	cells,	indicating	that	Atg17	replaces	Atg11	in	vivo	as	well.	Upon	starvation	the	assembly	of	the	full	Atg1	kinase	complex	activates	the	tethering	activity	of	Atg17	and	increases	its	interaction	with	Atg9	(Rao	et	al.,	2016).	However,	as	demonstrated	by	the	in	vitro	assays	even	active	Atg17,	either	Atg17	alone	or	the	full	Atg1	kinase	complex,	is	not	sufficient	to	outcompete	Atg11	when	present	in	equal	amounts.	Thus,	additional	regulatory	mechanisms	are	required	to	remove	Atg11	from	Atg9	vesicles	and	facilitate	Atg17	binding.			
4.5 A	possible	effect	of	protein	phosphorylation	on	Atg11-Atg17	competition			
Atg11	and	Atg17	 function	 as	 tethers	 for	Atg9	vesicles.	While	both	 competed	 for	 exclusive	binding	 to	 Atg9	 proteoliposomes	 the	 observed	 interaction	 of	 Atg9	 with	 Atg11	 was	substantially	stronger	than	that	with	Atg17.	Therefore,	additional	mechanisms	are	required	to	 facilitate	 the	replacement	of	Atg11	by	Atg17.	Starvation	 induces	 the	phosphorylation	of	Atg29	and	the	dephosphorylation	of	Atg13.	However,	these	modifications	were	not	sufficient	to	outcompete	Atg11	by	Atg17	in	vitro.		It	had	been	reported	previously	 that	Atg29	 is	specifically	phosphorylated	upon	starvation,	which	induces	its	interaction	with	Atg11	(Mao	et	al.,	2013).	This	indicated,	that	Atg11	might	
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recruit	the	Atg1	kinase	complex	upon	starvation.	In	vivo	experiments	conducted	by	Dr.	Nena	Matscheko	revealed	that	the	phosphomimetic	Atg29SD	mutant	decreased	the	amount	of	Atg9	co-precipitating	 with	 Atg11	 under	 nutrient-rich	 conditions	 compared	 to	 wild-type	 Atg29.	This	observation	led	to	the	hypothesis	that	the	recruitment	of	the	Atg1	kinase	complex	via	phosphorylated	 Atg29	 could	 aid	 in	 the	 replacement	 of	 Atg11	 by	 Atg17.	 However,	 in	 the	reconstituted	system	no	effect	of	the	Atg29SD	mutant	on	protein-protein	interaction	could	be	observed.	Both	subcomplexes,	Atg31-Atg29	and	Atg31-Atg29SD,	were	binding	weakly	to	Atg9	proteoliposomes	but	binding	was	not	increased	for	either	of	them	in	presence	of	Atg11.	Thus,	the	 phosphomimetic	 mutation	 of	 Atg29	 did	 not	 induce	 interaction	 with	 Atg11.	 Also,	 no	increased	 binding	 of	 Atg17	 or	 decreased	 binding	 of	 Atg11	 to	 Atg9	 proteoliposomes	 was	detectable	when	using	the	mutant	trimeric	complex	Atg17-Atg31-Atg29SD	or	the	mutant	Atg1	kinase	complex.	Thus,	a	role	of	Atg29	phosphorylation	in	Atg17	recruitment	and	replacement	of	Atg11	through	direct	interactions	could	not	be	confirmed	in	vitro.	The	observations	made	in	 vivo	 might	 have	 therefore	 derived	 from	 indirect	 effects.	 However,	 the	 underlying	mechanism	remains	unclear.		Another	regulatory	effect	could	be	provided	by	the	phosphorylation	state	of	Atg13.	Atg13	is	phosphorylated	 during	 nutrient-rich	 conditions	 by	 the	 TOR	 kinase,	 which	 prevents	 the	interaction	 of	 the	 Atg1-Atg13	 subcomplex	 with	 the	 Atg17	 trimeric	 complex.	 The	dephosphorylation	of	Atg13	upon	starvation	facilitates	the	assembly	of	the	full	Atg1	kinase	complex	to	enhance	the	binding	of	Atg17	to	Atg9	vesicles	and	to	activate	its	tethering	function.	Even	 though	 binding	 of	 the	 Atg1	 kinase	 complex	 to	 Atg9	 proteoliposomes	 was	 slightly	increased	in	presence	of	Atg11,	the	complex	formation	was	not	sufficient	to	compete	with	the	efficient	binding	of	Atg11.	It	had	been	previously	reported	that	Atg13	binds	to	Atg11	during	nutrient-rich	 conditions	 (Kamber	 et	 al.,	 2015).	 To	 examine	 this	 interaction	 in	 the	reconstituted	system,	Atg13	was	phosphorylated	in	vitro	by	Atg1.	Unphosphorylated	Atg13	was	found	to	interact	very	weakly	with	Atg9	proteoliposomes	but	was	strongly	recruited	in	presence	of	the	trimeric	complex	due	to	the	interaction	with	Atg17.	However,	no	significant	increase	in	Atg13	binding	was	detected	in	presence	of	Atg11.	After	phosphorylation,	no	Atg13	was	 co-floating	 with	 Atg9	 proteoliposomes.	 As	 expected,	 Atg17	 was	 not	 able	 to	 recruit	phosphorylated	Atg13	to	the	proteoliposomes,	but	surprisingly	Atg11	was	not	either.	It	could	possibly	 be	 that	 the	 reported	 interaction	 of	 phosphorylated	 Atg13	 with	 Atg11	 during	vegetative	 conditions	 in	 vivo	 was	 only	 an	 indirect	 effect.	 On	 the	 other	 hand,	 Atg13	 is	phosphorylated	by	the	TOR	kinase	and	not	by	Atg1,	which	could	result	in	different	properties	of	native	and	recombinant	Atg13.			
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4.6 Atg11	degradation	could	aid	in	Atg17	recruitment			
Atg11	binds	Atg9	proteoliposomes	stronger	than	Atg17	but	neither	the	starvation-induced	phosphorylation	of	Atg29	nor	 the	 formation	of	 the	Atg1	kinase	complex	were	sufficient	 in	vitro	to	increase	recruitment	of	Atg17.	However,	it	could	be	shown	that	Atg11	is	degraded	by	the	 proteasome	 specifically	 upon	 starvation,	 which	 could	 free	 binding	 sites	 on	 Atg9	 and	consequently	allow	recruitment	of	Atg17.	In	 the	 search	 of	 another	 mechanism	 that	 explains	 the	 switch	 from	 Atg11	 to	 Atg17	 as	membrane	tethers,	an	interesting	observation	was	made.	In	Western	blots	of	in	vivo	studies	the	 amount	 of	 Atg11	 in	 cell	 lysates	 decreased	 upon	 starvation.	 Quantification	 of	 band	intensities	in	Western	blots	revealed	a	strong	and	significant	decline	in	Atg11	levels,	whereas	Atg17	protein	 levels	 remained	constant.	This	 indicated	 that	Atg11	 is	degraded	specifically	upon	 starvation.	 Generally,	 the	 degradation	 of	 cytosolic	 proteins	 depends	 on	 one	 of	 two	different	pathways.	Proteins	can	be	either	sequestered	by	autophagosomes	and	transported	to	 the	vacuole	or	ubiquitinated	and	subsequently	degraded	by	the	proteasome.	Due	to	 the	localization	of	Atg11	to	the	site	of	autophagosome	formation	it	was	hypothesized	that	Atg11	might	be	captured	non-selectively	in	autophagosomes	along	with	other	cytoplasmic	material	upon	 starvation.	 However,	 a	 block	 in	 autophagy	 by	 deletion	 of	 Atg7	 did	 not	 inhibit	 the	degradation	 of	 Atg11.	 To	 further	 confirm	 this	 finding,	 Atg11	 levels	 in	 pep4Δ	 cells	 were	determined.	Pep4	is	a	vacuolar	protease	that	activates	other	proteases	and	is	thus	essential	for	protein	degradation	within	the	vacuole	(Woolford	et	al.,	1986).	As	observed	for	atg7Δ	cells,	the	deletion	of	Pep4	had	no	impact	on	the	degradation	of	Atg11.	Thus,	Atg11	is	most	likely	targeted	by	the	proteasome	pathway.			This	hypothesis	was	investigated	using	the	proteasome	inhibitor	MG132.	Indeed,	addition	of	this	 inhibitor	 blocked	 the	 degradation	 of	 Atg11	 in	 starved	 cells.	 Quantification	 of	 band	intensities	even	revealed	a	slight	increase	in	Atg11	levels.	This	was	not	highly	significant	but	could	indicate	that	Atg11	expression	continues	during	starvation	and	that	protein	levels	are	mostly	 regulated	 via	 its	 proteasomal	 degradation.	 To	 further	 investigate	 the	 proteasomal	degradation	 of	 Atg11,	 ubiquitinated	 proteins	were	 immunoprecipitated	 from	 non-starved	and	 starved	 cell	 lysates.	 Atg11	 could	 be	 specifically	 precipitated	 with	 an	 anti-ubiquitin	antibody	 and	 the	 amount	 of	 immunoprecipitated	 Atg11	 increased	 upon	 starvation.	 This	indicates	that	Atg11	is	specifically	ubiquitinated	upon	starvation,	which	is	consistent	with	the	observed	stabilization	of	Atg11	upon	proteasome	inhibition.	However,	only	when	a	protein	is	modified	with	a	special	type	of	poly-ubiquitin	chain,	where	the	C-terminus	of	one	ubiquitin	is	linked	to	lysine	48	of	another	ubiquitin,	it	is	recognized	by	the	proteasome	(Thrower	et	al.,	2000).	Thus,	increased	ubiquitination	is	not	a	direct	proof	for	proteasomal	degradation	but	
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could	 also	 have	 a	 regulatory	 effect	 (Ikeda	 and	 Dikic,	 2008).	 To	 analyze	 the	 type	 of	ubiquitination	and	map	the	ubiquitinated	sites	of	Atg11	mass	spectrometry	was	performed.	However,	the	amount	of	protein	extracted	from	an	SDS-PAGE	gel	was	not	sufficient	to	identify	the	ubiquitination	sites	or	the	type	of	ubiquitin	chains.	Nevertheless,	the	observation	that	a	proteasome	 inhibitor	 stabilized	 Atg11	 levels	 but	 not	 a	 block	 in	 autophagy	 or	 vacuolar	degradation	 strongly	 suggests	 the	 specific	 degradation	 of	 Atg11	 by	 the	 proteasome	 upon	starvation.		In	vitro	experiments	showed	that	Atg11	binds	more	efficiently	to	Atg9	proteoliposomes	than	Atg17.	Thus,	Atg9	vesicles	are	likely	sequestered	by	Atg11	and	degradation	of	Atg11	could	allow	binding	of	Atg17	 to	Atg9.	From	this	and	 the	 findings	discussed	before	a	model	 for	a	selectivity	switch	at	the	time	of	autophagy	initiation	can	be	proposed	(see	Figure	34).	Under	nutrient-rich	 conditions,	Atg11	 efficiently	 binds	Atg9	 vesicles	 but	 tethering	 is	 inhibited	 in	absence	 of	 cargo,	while	Atg17	 is	 inhibited	 by	 forming	 a	 constitutive	 complex	with	Atg31-Atg29.	Selective	autophagy	is	specifically	initiated	by	the	presence	of	a	cargo	receptor	that	induces	 Atg11	 dimerization	 and	 thus	 Atg9	 vesicle	 tethering.	 Upon	 starvation,	 Atg11	 is	degraded,	 which	 allows	 increased	 binding	 of	 Atg17	 to	 Atg9	 vesicles.	 Binding	 is	 further	enhanced	 by	 the	 starvation-induced	 assembly	 of	 the	 Atg1	 kinase	 complex,	 which	 also	activates	the	tethering	function	of	Atg17.	This	allows	autophagy	to	switch	from	the	selective	formation	 of	 autophagosomes	 exclusively	 around	 specific	 cargo	 to	 a	 non-selective,	 cargo-independent	pathway	to	ensure	survival	during	nutrient	deprivation.			
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Figure	34:	Model	for	Atg9	vesicle	tethering	in	autophagy	initiation.	During	nutrient-rich	conditions	binding	and	tethering	of	Atg17	is	inhibited	by	Atg31-Atg29.	Atg11	can	bind	Atg9	vesicles	but	dimerization	is	 blocked	 by	 its	 C-terminal	 domain.	 Binding	 of	 a	 cargo	 receptor	 to	 that	 domain	 activates	 Atg11	dimerization	und	thereby	leads	to	selective	autophagy.	Upon	starvation,	formation	of	the	full	Atg1	kinase	complex	allows	Atg9	vesicle	tethering	without	the	requirement	of	a	cargo	receptor,	thereby	leading	to	non-selective	autophagy.	At	 the	same	time,	Atg11	 is	degraded	which	can	 free	binding	places	 for	an	efficient	binding	of	Atg17	to	Atg9	vesicles.						
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4.7 Outlook	
Atg11	 had	 been	 reported	 previously	 to	 be	 an	 essential	 scaffolding	 protein	 in	 selective	autophagy	 in	 yeast.	 However,	 molecular	 details	 of	 its	 function	 remained	 unclear.	 By	employing	 an	 in	 vitro	 approach	 using	 recombinant	 proteins	 in	 a	 defined,	 reconstituted	system,	 it	 could	 be	 shown	 that	 Atg11	 functions	 as	 a	 tether	 for	 Atg9	 vesicles	 upon	 cargo	receptor-induced	 dimerization.	 Cryo-EM	 revealed	 that	 activated	 Atg11	 leads	 to	 tight	tethering	and	membrane	deformations,	but	was	not	sufficient	to	drive	fusion.	This	is	similar	to	Atg17,	which	was	also	shown	to	tether	but	not	fuse	Atg9	proteoliposomes	(Rao	et	al.,	2016).	Thus,	 the	 question	 remains	 which	 additional	 factors	 are	 required	 to	 facilitate	membrane	fusion.	Most	probably	these	are	SNAREs,	as	this	protein	family	is	involved	in	membrane	fusion	events	throughout	the	cell.	Several	SNAREs	had	been	reported	to	be	required	during	early	stages	of	autophagosome	biogenesis	(Nair	et	al.,	2011;	Tan	et	al.,	2013).	However,	it	remains	unclear	 whether	 they	 facilitate	 fusion	 specifically	 of	 Atg9	 vesicles.	 SNAREs	 required	 for	autophagy	are	known	to	play	roles	in	other	pathways	as	well,	which	makes	it	difficult	to	rule	out	indirect	effects	by	perturbations	of	vesicular	trafficking.	This	problem	can	be	solved	by	using	a	reconstituted	system.	In	vitro	fusion	assays	are	well	established	in	the	literature	and	had	been	used,	for	example,	to	investigate	the	acceleration	of	SNARE-mediated	fusion	by	the	HOPS	 tethering	 complex	 (Stroupe	 et	 al.,	 2009).	 This	 experimental	 setup	 allows	 to	 clearly	decipher	 the	 correct	 SNARE	 combination	 as	 well	 as	 the	 regulatory	 factors	 required	 for	efficient	SNARE	pairing.	So	far,	it	is	still	unclear	whether	Atg11	or	the	Atg1	kinase	complex	directly	interact	with	SNARE	proteins	to	mediate	fusion.	Recently,	interaction	of	Atg11	and	Atg17	with	the	vacuolar	SNARE	Vam7	had	been	reported	(Liu	et	al.,	2016).	However,	there	is	no	indication	that	Atg11	and	Atg17	play	a	direct	role	in	fusion,	as	Vam7	is	only	required	for	the	fusion	of	the	completed	autophagosome	with	the	vacuole.	It	is	also	likely	that	Atg11	and	Atg17	interact	with	additional	factors	that	regulate	SNARE	complex	formation	as	it	has	been	reported	for	various	multi-subunit	tethering	complexes.		In	vitro	experiments	revealed	a	competition	between	Atg11	and	Atg17	for	binding	to	Atg9	vesicles,	however	a	direct	proof	for	this	competition	in	vivo	is	still	missing.	The	degradation	of	Atg11	upon	starvation	possibly	facilitates	the	binding	of	Atg17	to	Atg9	vesicles.	To	further	support	this	model,	the	interaction	of	the	two	tethers	with	Atg9	vesicles	could	be	determined	depending	on	different	expression	levels	or	the	stabilization	of	Atg11	levels	by	inhibition	of	the	proteasome.	Furthermore,	 it	 is	 still	 an	open	question	how	 the	degradation	of	Atg11	 is	regulated.	 It	 is	unclear,	which	 factor	serves	as	 the	ubiquitin	 ligase	 for	Atg11	and	how	 it	 is	activated	in	a	starvation-dependent	manner.		
Discussion	
91	
The	results	presented	in	this	thesis	support	the	model	of	two	differently	regulated	tethers	for	Atg9	vesicles	that	allow	the	cell	to	switch	between	selective	and	non-selective	autophagy.	Also	in	 human	 cells	 both	 pathways	 exist.	 Selective	 autophagy	 is	 particularly	 important	 as	 a	protection	 against	 various	 diseases.	 Aggregates	 of	 misfolded	 proteins,	 for	 example,	 are	ubiquitinated	but	cannot	be	degraded	by	the	proteasome.	The	ubiquitin	adapter	protein	p62	binds	 these	 proteins	 and	 links	 them	 to	 the	 autophagic	machinery.	 The	 clearance	 of	 these	aggregates	 by	 autophagy	 is	 an	 important	 mechanism	 in	 the	 protection	 against	neurodegenerative	diseases	(Ross	and	Poirier,	2004).	Mitophagy	was	also	reported	to	depend	on	 ubiquitination	 of	 outer	 mitochondrial	 membrane	 proteins	 in	 order	 for	 dysfunctional	mitochondria	 to	 be	 recognized	 by	 p62	 (Geisler	 et	 al.,	 2010).	 One	 key	 player	 in	 the	ubiquitination	of	mitochondrial	proteins	is	Parkin,	which	is	 frequently	mutated	in	patients	with	Parkinson’s	disease	(Narendra	et	al.,	2008).	These	examples	illustrate	the	importance	of	selective	 autophagy	 in	 health.	Moreover,	 they	 show	 that	 the	 principle	 of	 adapters	 linking	specific	 cargo	 to	 the	 autophagic	 machinery	 is	 highly	 conserved.	 However,	 initiation	 of	autophagy	in	humans	is	poorly	understood	and	it	remains	unclear	whether	the	mechanisms	observed	in	yeast	applies	to	human	cells	as	well.	Ulk1	has	been	identified	as	a	homologue	of	yeast	Atg1.	It	forms	a	complex	with	Atg13,	FIP200	and	Atg101	to	initiate	autophagy	(Zachari	and	Ganley,	2017).	However,	molecular	details	of	the	function	of	the	Ulk1	complex	are	still	unclear.	FIP200	 is	 suggested	 to	be	a	homologue	of	yeast	Atg17,	despite	 its	high	molecular	weight	 (183	 kDa	 compared	 to	 49	 kDa	 of	 Atg17).	 Thus,	 FIP200	 might	 include	 additional	regulatory	domains,	for	example	to	substitute	the	function	of	yeast	Atg31-Atg29.	For	Atg11	it	is	unclear	whether	a	human	homologue	exists.	However,	Huntingtin	was	recently	discussed	as	a	possible	Atg11	homologue	(Ochaba	et	al.,	2014).	While	mutations	in	the	Huntingtin	gene	are	the	major	cause	for	Huntington’s	Disease,	the	normal	function	of	this	protein	is	poorly	understood.	Ochaba	and	colleagues	reported	 that	 the	C-terminal	domain	of	Huntingtin	co-precipitates	subunits	of	the	Ulk1	complex	as	well	as	the	cargo	receptor	p62	and	thus	might	act	as	a	scaffolding	protein	similar	to	Atg11.	Therefore,	the	principle	of	switching	between	non-selective	 and	 cargo-dependent	 autophagy	 initiation	 could	 be	 conserved	 in	 humans.	However,	to	clearly	decipher	the	molecular	function	of	the	human	proteins	a	similar	in	vitro	approach	as	presented	for	Atg17	and	Atg11	would	be	required.	This	would	allow	to	determine	whether	FIP200	and	Huntingtin	 function	as	Atg9	vesicle	 tethers	 to	 initiate	autophagy	and	how	these	processes	are	regulated.	For	a	 long	time,	yeast	Atg8	was	seen	as	 the	major	 link	between	cargo	receptor	and	phagophore	membrane.	Similarly,	links	are	found	between	cargo	receptors	and	the	human	homologues	of	Atg8.	However,	considering	the	insights	gained	from	the	 yeast	 system	 it	 would	 be	 interesting	 to	 see,	 whether	 there	might	 be	 a	mechanism	 in	humans	as	well	that	specifically	initiates	autophagy	at	the	appropriate	place	and	time.		
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